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(EEC) No 302/93 of 8 February 1993, the Centre became fully 
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• collecting and analysing existing data;
• improving data-comparison methods;
• disseminating data; 
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   and with non-EU countries.
The EMCDDA works exclusively in the field of information.
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his monograph contains the papers presented at the second European confer-
ence on the evaluation of drug prevention, ‘Evaluation: a key tool for improv-
ing drug prevention’, held in Strasbourg, France, from 2 to 4 December 1999.
In addition to the conference papers, the volume includes the recommendations
drawn up and adopted by the participants as the final outcome of the meeting. No
conference on the theme of evaluation would be credible without itself being as-
sessed, and this monograph also presents the results of an evaluation both of the
event as a whole and of its individual workshop sessions.
The conference was organised jointly by the European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA) and the European Commission, a partnership that
demonstrates the very real importance attached to evaluation in Europe today. The
meeting brought together 160 participants from the EU Member States, central and
eastern Europe, Canada, Chile, Iceland, Liechtenstein, Norway and the United
States, as well as representatives from the Pompidou Group of the Council of
Europe, the World Health Organisation and the United Nations International Drug
Control Programme.
At the first European conference on the evaluation of drug prevention, held in Lisbon
in March 1997, the EMCDDA presented its first tool designed specifically to facilita-
te this task, the Guidelines for the evaluation of drug prevention (1). This first confe-
rence highlighted the most common fears surrounding — and obstacles to — 
evaluation, and concluded that only by addressing these issues directly could resis-
tance be overcome and an evaluation culture gradually introduced throughout the EU.
The meeting identified the major problems confronting evaluation as:
• lack of interest in the concept;
• fear or apprehension;
• lack of necessary skills; 
• lack of resources.
Lack of interest
Evaluation involves clarifying and defining concepts and methods and assessing the
impact of interventions. By examining these elements, diverse, unfocused activities
prompted more by social anxieties than by genuine scientific research can be avoi-
ded and more efficient, targeted interventions introduced. Yet even today, three
years after the first evaluation conference was held, the needs and objectives of
drug-prevention programmes in Europe remain ill-defined. The large number of
7
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(1) Guidelines for the evaluation of drug prevention, Manuals No 1, Lisbon, EMCDDA, 1998. A working
document is also available to drug-prevention professionals in all 11 official EU languages directly
from the EMCDDA. 
T
requests the EMCDDA receives weekly for its evaluation guidelines from the EU
Member States (over 1 500 working copies have been disseminated in all 11 official
EU languages since 1997), however, demonstrates the growing interest of drug-
prevention professionals in evaluation.
Fear or apprehension
Nevertheless, despite this growing interest in evaluation tools and methodologies,
some of those responsible for implementing drug-prevention programmes are still
unsure about the concept of evaluation. This reserve is undoubtedly linked to fear
of the consequences of negative evaluation outcomes, since such results can lead to
reductions in funding, whether from public or private sources. How to counter this
problem was one of the main themes of this first conference.
Lack of necessary skills
Largely as a result of collaboration between national and European organisations,
drug-prevention professionals now have far greater access to evaluation skills and
examples of good practice. Among the materials and tools available are:
• the Handbook prevention of the Pompidou Group of the Council of Europe that
details specific methodologies for devising drug-prevention interventions (2);
• the Evaluation of action against drug abuse in Europe (COST A-6) publication
Evaluation research in regard to primary prevention of drug abuse that provides
an overview of evaluation theory in Europe, clarifying specific concepts and
terms (3);
• the EMCDDA’s Guidelines for the evaluation of drug prevention, which comple-
ment the Handbook prevention and facilitate the planning and evaluation of
drug-prevention interventions;
• the EMCDDA’s Evaluation instruments bank (EIB), a database of tools to support
professionals involved in evaluation (4); 
• the EMCDDA’s Exchange on drug demand-reduction action (EDDRA) on-line
information system, which provides details of demand-reduction projects and
evaluation methodology in the EU (5). EDDRA is also an educational and training
tool which helps practitioners in the field to describe and document programme
design.
There is now a real need to increase both the promotion and the acceptance of these
tools at EU level as well as to continue to develop and improve them.
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(2) Van der Stel, J. (Ed.) (1998), Handbook prevention: alcohol, drugs and tobacco, Strasbourg,
Pompidou Group of the Council of Europe.
(3) Springer, A., Uhl, A. (Eds) (1998), Evaluation research in regard to primary prevention of drug abuse,
Brussels, European Commission.
(4) For more on the EIB, see Chapter 6. 
(5) For more on EDDRA, see Chapters 11 and 12. EDDRA is available at (http://www.emcdda.org/
databases/databases_eddra.shtml). 
Lack of resources
The evaluation tools developed by the EMCDDA and other organisations are main-
ly designed for use in internal evaluations, since evaluations by external institutions
tend to be cost-intensive. Yet even in internal evaluations, the costs of allocating the
necessary human resources have to be considered. It has been demonstrated, how-
ever, that the more evaluation is integrated into a programme, the lower the tangible
costs and the higher the benefits in terms of continuous improvement. To this end,
there is clearly a need to increase communication with public and private funding
bodies to convince them of the value of investing in evaluation.
It has become evident via the EDDRA information system and through feedback
from the focal points of the Reitox network (6) as well as from drug-prevention pro-
fessionals that it is through practical experience that the feasibility of evaluation —
even under difficult conditions or at a modest level, and at any stage of a project —
must be demonstrated. This cannot only be done at scientific conferences and
through journal articles, but also requires practical tools and advice to be made
easily accessible.
Target groups
In addressing the four problem areas identified by the first evaluation conference,
the second European conference on the evaluation of drug prevention was targeted
above all at the ‘users’ of evaluations — the drug-prevention professionals respon-
sible for implementing specific initiatives and the political decision-makers 
responsible for allocating funding — rather than at scientific evaluation experts.
This focus was intended to demonstrate that evaluation should not be seen as a form
of control, but rather as a means of improving practice. In this context, results of less
successful interventions play just as significant a role in improving and guiding 
future programmes as results of more successful projects. Qualitative data and pro-
cess information, together with proper needs assessment, are as valuable for good
evaluation practice as quantitative outcome results.
The need to allay fears of the consequences of negative evaluation outcomes must
be balanced by the equal need to ensure that resources are allocated rationally.
Priority should be given to drug-prevention projects that include both needs assess-
ment and evaluation. Evaluation can facilitate the planning and design of drug-
prevention programmes at local and regional level by establishing quality criteria
which are not only based on outcomes. In this way, projects with adequate opera-
tional approaches but initially negative outcomes would not be automatically aban-
doned but would instead be reoriented. This concept of reorientation is crucial and
the fact that negative evaluation outcomes are as important as positive ones should
be a guiding principle of drug-prevention efforts.
9
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(6) Reitox is the European information network on drugs and drug addiction and is coordinated by the
EMCDDA in Lisbon. The network consists of a national focal point in each EU Member State, a focal
point at the European Commission and an observer focal point in Norway.
Developing an evaluation culture
Given the current low level of drug-prevention evaluation in Europe, an EU-wide
evaluation culture can only develop if programme designs are logical and coherent
and thus lend themselves more easily to evaluation rather than focusing primarily
on scientific demands. In the long term, and to ensure that evaluation is implemen-
ted as broadly as possible, including basic evaluation theory and knowledge in daily
programme practice should be promoted and unrealistic expectations as to their
impact avoided. In this context, the EMCDDA’s Guidelines for the evaluation of 
drug prevention do not profess to be the ultimate guide to comprehensive 
evaluation research, but cover just one of several possible evaluation procedures.
Feedback from the field
To correct one frequent misconception, the EMCDDA’s evaluation guidelines and
tools deliberately do not mention specific theories, approaches and concepts since
the Centre is not in a position to judge the theoretical foundations of all the diverse
drug-prevention programmes currently implemented in Europe. Equally, the
EMCDDA’s tools should not be seen as European ‘directives’. Instead, they are inten-
ded purely as a guide for improving practice and the Centre relies on feedback from
drug-prevention professionals to improve and further develop these tools.
Another theme of the second European conference was therefore to adapt the
EMCDDA’s strategies more adequately to the problems encountered in evaluation.
Cultural issues play an important role in this context, and in some Member States,
initiatives are already under way to adapt the Guidelines for the evaluation of drug
prevention — as well as drug-prevention programmes instituted in other countries
— to different cultures of scientific thinking and understanding, as well as to specific
national conditions.
Evaluation and the European Union
The European Commission is playing a crucial role in promoting evaluation. This is
reflected not only in the fact that it co-organised the second European conference
on the subject, but also in its commitment to spreading the culture of evaluation to
all European drug-prevention activities.
The concept of evaluation lies at the heart of the first Community action programme
for the prevention of drug dependence, which identifies data, research and evalua-
tion as the primary areas for action (7). In this context, the programme foresees the
recourse to EMCDDA information and to the possibilities offered by the EU Treaty to
facilitate greater understanding of drugs and drug addiction at European Union level.
10
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(7) Information on the Community action programme for the prevention of drug dependence is avail-
able at (http://europa.eu.int/comm/health/ph/programmes/drugs/index_en.htm).
It should be noted that, since 1998, completing the EDDRA reporting question-
naire has been an integral contractual requirement for the drug-prevention projects 
supported by the European Commission (8). The Commission also used the
EMCDDA’s evaluation guidelines and tools during its third European Drug
Prevention Week held in November 1998.
The European Union Drugs Strategy (2000–04), approved at the December 1999
European Council meeting in Helsinki, envisages evaluation of all the programmes
and policies it includes as a core task, another clear indication of the Commission’s
commitment to establishing a European-wide evaluation culture. In this context, the
recommendations of the second European conference on the evaluation of drug
prevention included in this monograph will no doubt play a central role both for the
EMCDDA and for the European institutions in general.
I would like to extend my thanks and appreciation to all the conference speakers
and workshop leaders whose thoughtful and stimulating presentations make up this
monograph. I would also like to express my gratitude to the staff of the EMCDDA’s
Department of Drug-demand Reduction — particularly Margareta Nilson, Gregor
Burkhart, Sofia Feteira, Catherine Menier, Philippe Roux and Ulrik Solberg — who
organised the conference so ably and professionally, and to the SVA Travel SA which
arranged the practical and logistical aspects of the conference with such efficiency.
Finally, I would like to single out the efforts of Ulrik Solberg in coordinating the
work of shaping the diverse elements of the second European conference on the
evaluation of drug prevention into the coherent whole that is this monograph.
Georges Estievenart
Executive Director
EMCDDA
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(8) For details of the EDDRA questionnaire, see Chapters 11 and 12.

he partnership between the European Commission and the European
Monitoring Centre for Drugs and Drug Addiction — reflected both in their
joint organisation of the second European conference on the evaluation of
drug prevention and in their mutual commitment to spreading the culture of 
evaluation at EU level — is a crucial one.
The Commission’s October 1999 interim report (9) on three of its Community action
programmes in the field of public health — those targeting AIDS, cancer and drug
dependence — presents the findings of an external evaluation by independent
experts of the activities undertaken by these programmes (10). The report specifically
analyses the consistency, complementarity and effectiveness of the programmes and
assesses the extent to which they have achieved their objectives.
A number of the initiatives set up in the framework of these action programmes have
produced quite impressive results, with many of the multinational networks and
teams that run them providing cost-effective added value to the European
Community as a whole. Yet despite these positive developments, the project reports
often fail to draw a convincing picture of their ability to obtain the necessary exper-
tise and experience from all the EU Member States as well as to disseminate infor-
mation on their activities effectively. The progressive use of electronic-information
channels is, nevertheless, helping to counter this problem.
The projects in the public-health programmes are increasingly emphasising
approaches targeted directly at individuals, and projects with a broad public policy
approach are lacking. Furthermore, links between the drug-related projects and the
Commission’s other public-health programmes appear to be weak. This is particu-
larly problematic given the new competency of the European Commission in the
public-health field following the entry into force on 1 May 1999 of the Treaty of
Amsterdam (11).
The importance and impact of this new treaty cannot be over-emphasised. While
reiterating the importance of the health aspects of the drugs phenomenon, Article
152 (formerly Article 129) on public health recognises that health is a major issue
relevant to a wide cross-section of Community policies and States:
A high level of human health protection shall be ensured in the defini-
tion and implementation of all Community policies and activities. …
The Community shall complement the Member States’ action in reducing
drugs-related health damage, including information and prevention.
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(9) COM(1999) 463 final, 14.10.1999.
(10) Information on the Community action programmes in the field of public health is available at
(http://europa.eu.int/comm/health/index_en.html).
(11) The text of the Treaty of Amsterdam is available on-line (http://europa.eu.int/eurlex/
en/treaties/dat/ams_treaty_en.pdf).
This obligation is unique in introducing a quasi-constitutional requirement for the
Community to take into account the possible health implications of its policy 
measures and actions. Such an obligation would also apply to the Community
action plan for the fight against drugs of which the action programme for the 
prevention of drug dependence forms an integral part.
The European Commission is now considering developing an overall action plan in
the field of public health, and has requested that the action programme for the pre-
vention of drug dependence be extended to 2002 in the meantime.
Issues relating to reducing the demand for drugs, including doping in sports, remain
a key priority for the European Commission. As a result, it is drawing on the recom-
mendations made by the second European conference on the evaluation of drug
prevention as a basis for a formal political proposal stressing the importance of
appropriate evaluation of demand-reduction interventions in Europe.
Alexandre Berlin
Honorary Director of the European Commission representing Dr W. J. Hunter
Directorate-General F, Health and Consumer Protection
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General 
introduction

Margareta Nilson
The second European conference on the evaluation of drug prevention, ‘Evaluation:
a key tool for improving drug prevention’, was both a follow-up to the first European
conference on the evaluation of drug prevention, held in Lisbon in March 1997, and
a unique event in its own right (12). Whereas the first conference had focused on the
scientific aspects of evaluating drug prevention, the second conference concen-
trated rather on the practical and political aspects of evaluation.
Evaluation is an integral part of the European Union Drugs Strategy (2000–04) and
an essential tool of the Community action programme for the prevention of drug
dependence. In this context, the second European conference aimed:
• to demonstrate to both drug-prevention professionals and policy-makers how
evaluation theory and knowledge can be implemented in practice;
• to promote an evaluation culture in Europe with a view to improving drug-
prevention practice; 
• to present practical experiences of the EMCDDA’s evaluation tools — the
Guidelines for the evaluation of drug prevention, the Evaluation instruments
bank (EIB) and the Exchange on drug demand-reduction action (EDDRA) infor-
mation system (13).
The conference was organised into four plenary sessions — with questions or com-
ments after each presentation — and six workshops which were introduced by the
session leader before opening up into a general discussion. While some of the spea-
kers looked back and highlighted the developments that had taken place since the
first evaluation conference, others addressed current and future issues and 
problems.
The EMCDDA: promoting the evaluation of drug prevention
The EMCDDA has implemented a number of initiatives to promote the evaluation
of drug prevention. The most obvious example is its Guidelines for the evaluation of
drug prevention, a manual targeted at programme planners and evaluators which
includes checklists for planning and implementing evaluation as well as a series of
practical examples.
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(12) The papers presented at the first European conference are available in Evaluating drug prevention in
the European Union, Scientific Monograph No 2, Lisbon, EMCDDA, 1998. 
(13) For more on the Guidelines for the evaluation of drug prevention, see Chapters 5 and 6. For more on
the Evaluation instruments bank, see Chapter 6. For more on the EDDRA system, see Chapters 11
and 12.
The second example of the EMCDDA’s promotion of evaluation is its scientific
monograph, Evaluating drug prevention in the European Union, which contains the
presentations from the first European conference on the evaluation of drug preven-
tion. The contributions range from studies of different phases of the evaluation pro-
cess to epidemiological and cost-effectiveness issues.
The EMCDDA’s two on-line databases — EDDRA and the EIB — provide informa-
tion, respectively, on European drug demand-reduction activities that include an
evaluation component, and on the tools used in such evaluations. EDDRA has been
accessible on-line since 1998 (14), and a prototype of the EIB was demonstrated for
the first time to the participants at the second conference on the evaluation of drug
prevention. The Evaluation instruments bank will be accessible via the EMCDDA
website during 2000.
Evaluating drug prevention has also been covered in EMCDDA publications such as
New trends in synthetic drugs in the European Union, Outreach work among drug
users in Europe and in the Centre’s Annual reports on the state of the drugs problem
in the European Union (15).
Purpose of the monograph
This volume is both a complement to the EMCDDA’s second scientific monograph,
Evaluating drug prevention in the European Union, and represents a significant 
step forward in promoting cooperation in the continuous effort to improve drug-
prevention strategies and their evaluation in Europe.
A common question in drug prevention is ‘what works?’, and the chapters in this
monograph, each from its own specific angle, attempt to address this central ques-
tion. While the views expressed do not lead to a definitive or unambiguous answer,
they do facilitate a better understanding of this complex field.
This monograph should not, however, be viewed as yet another attempt at EU
harmonisation but, on the contrary, as a forum in which different players share
their experiences and adapt their knowledge to different national contexts. Nor
should this volume be seen as a definitive and final outcome of the second evalua-
tion conference, but rather as one result of the process of improving drug preven-
tion and its evaluation which will encourage and stimulate others in a ‘ripple’ effect
for some time to come. The EMCDDA sees itself very much as a mediator in such
efforts.
18
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(14) The EDDRA information system is available at (http://www.emcdda.org/databases/databases_
eddra.shtml). 
(15) New trends in synthetic drugs in the European Union, Insights No 1, Lisbon, EMCDDA, 1997;
Outreach work among drug users in Europe, Insights No 2, Lisbon, EMCDDA, 1999; Annual report
on the state of the drugs problem in the European Union, Lisbon, EMCDDA, 1995, 1997, 1998,
1999. 
Structure of the monograph
The monograph is divided into four parts. The first three parts follow the structure of
the conference, while the fourth part presents the recommendations adopted at the
end of the conference and the evaluation of the meeting itself.
• Part 1, ‘Recent progress in evaluation’, describes new developments in evalua-
tion practice and how assessing programmes has helped to improve drug-
prevention practice.
• Part 2, ‘Improving drug-prevention practice’, provides examples of actions which
have led to better drug-prevention practice and describes the instruments and
tools involved in the process.
• Part 3, ‘Improving evaluation practice’, analyses the obstacles that might impede
or weaken the evaluation process, such as communication problems between
evaluators and researchers, on the one hand, and policy-makers, on the other, or
relations between the central, regional and local levels of government.
• Part 4, ‘Recommendations and evaluation’, concludes the monograph and
includes the recommendations agreed by the conference participants. Given that
one of the principal aims of the meeting was to promote evaluation through
concrete examples, both the event itself and the individual workshop sessions
were subject to a formal assessment. The findings of these evaluations are
presented in this final section.
While this monograph can be read consecutively from beginning to end, the chap-
ters can equally be referred to individually. It is hoped that the information 
it contains will be both useful and stimulating for decision-makers and drug-
prevention professionals alike.
19
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Recent progress 
in evaluation Par
t 
I

Introduction
n Chapter 1, Jacques A. Bury explains why evaluation is so important. He
explores its role, characteristics and utility, justifying its place as an indispens-
able element of drug prevention. The author examines the potential confronta-
tion between political agendas and evaluation results and presents the criteria that
future drug-prevention assessments will have to meet in order to overcome such
obstacles.
Mark Morgan examines some of the factors associated with unsuccessful outcomes
of drug-prevention programmes, as highlighted by recent research. Among the
issues he discusses in Chapter 2 are the significance of cultural factors in designing
drug-prevention interventions, the value of fear-arousal messages and the long-term
effects of programmes that were not always evident at the time they were evaluated.
In Chapter 3, Tom Bucke explores how evaluation has successfully helped to shape
drug-prevention practice by examining three recent case studies from the United
Kingdom. These examples cover drug education in schools, prevention initiatives
targeted at groups vulnerable to drug use, and drug prevention in the criminal-
justice system.
Manuel Araujo Gallego takes the example of the Galician plan on drugs in Chapter 4
to highlight the impact of evaluation on regional drug-prevention policies. He 
examines how needs assessment can guide the equitable allocation of resources for
drug prevention and describes the evaluation systems used by the plan on drugs. He
concludes that for drug-prevention professionals, evaluation is the best way of
improving both practice and policy and not an excuse for reducing budgets.
23
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Chapter 1
Evaluation: a key tool for improvement?
Jacques A. Bury
Whether or not evaluation is a key tool for improving drug prevention depends
above all on the relationship between evaluation and the policies underlying specific
prevention programmes.
Programme policies
The policies behind drug-prevention programmes vary depending on the way these
programmes are devised and implemented. The policy is therefore determined by
decision-making processes at different levels and how these processes take into
account evaluation findings. In this context, it should be acknowledged that the
administrative culture is not the most open to evaluating its practices.
In addition, the cultural differences between EU Member States — particularly be-
tween northern and southern Europe — cannot be ignored and indeed were expli-
citly recognised during a European symposium on evaluation in health education
organised by the Collège Rhône-Alpes d’éducation pour la santé (CRAES) in
Bordeaux in 1986. While these cultural differences may be becoming less marked,
they do still remain — in EU parlance, there is ‘convergence’, but not ‘harmonisa-
tion’.
Inspections and audits do not generally facilitate constructive dialogue for impro-
ving services. Instead, these practices are often associated with negative conse-
quences such as staff changes or budgetary cuts. As a result, teams tend to hide the
weak points of their programmes, thus preventing them from being addressed and
improved.
What is evaluation?
Any human activity is evaluated — ‘I breathe, therefore I evaluate’ — and drug-
prevention programmes are no exception. These assessments, however, generally
remain anecdotal or implicit and thus may hamper more official evaluations, par-
ticularly in the way these are requested and interpreted. To some evaluators, the
most important aspect of the process is, therefore, to make previously implicit 
judgments explicit.
A formal evaluation can be represented as the result of a decision made by X for
official reasons Y and unofficial reasons Z. This co-existence of official and unoffi-
cial motives explains why many evaluators attach so much importance to clarifying
the reason for the evaluation request as the preliminary stage of the process. An 
evaluation may, for example, be carried out in a bid to improve a specific pro-
gramme, to justify it or prior to its cancellation. The assessment may be purely a for-
mality and its findings never used, or may be requested after the basic programme
decisions have already been taken.
In this chapter, evaluation is discussed in terms of its potential for improving drug-
prevention programmes rather than from other perspectives, such as its role in
increasing knowledge (evaluation research), controlling expenditure (auditing) or
ensuring the smooth running of services (inspection). While there are literally hun-
dreds of definitions of the term, each highlighting a particular aspect, the following
interpretation reflects the ‘utilitarian’ purpose of evaluation: ‘Evaluation is a process
by which useful information for making helpful decisions is defined, obtained, 
analysed and provided’.
In this context, it is important to understand the mechanisms that influence what
changes, if any, are made to a programme as a result of its evaluation. This involves
identifying the respective roles played by the decision-makers (political or adminis-
trative), the drug-prevention professionals (who are paid by the programmes) and
the target audience (which may provide direct feedback to the programme team or
indirect feedback via public opinion or the media).
A recent report (Conseil Scientifique de l’Evaluation, 1996) illustrates that policies,
as well as the programmes created to implement them, are always ‘theoretical struc-
tures in the sense that they involve an a priori representation of the measures imple-
mented, the attitude of the parties involved, the sequence of mechanisms for action
and the resulting effects’. In reality, things never go according to plan. The parties
involved in a drug-prevention programme may be forced to make unexpected deci-
sions, either because practice never corresponds exactly to theory or because of the
influence of personal ethics or interests.
It is generally accepted that evaluation should assess as objectively as possible the
effects of a policy or programme, the ways in which it operates and the extent to
which it achieves its objectives. ‘As objectively as possible’ implies both a certain
distance — at least from those directly involved in the evaluation — and rigorous
methods for carrying out and clarifying the specific approach taken.
The initial objectives of the evaluation are often reinterpreted or reformulated during
the process. The inevitable difference between the official reasons for the evaluation
and those interpreted by the person who commissioned it should not be underesti-
mated. The official objectives are set out in a policy document, yet the original idea
on which this document is based is almost always subject to selective, ad hoc and
possibly inconsistent changes during the approval process. The official objectives
are then in turn reinterpreted by the sponsor, who may have different ideas from the
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person who initiated the programme, who has himself changed since it was first
devised, and so on.
Evaluation standards, elements and criteria
According to the Petit guide de l’évaluation des politiques publiques (Conseil
Scientifique de l’Evaluation, 1996), successful evaluations fulfil many functions,
including:
• a ‘code-of-practice’ role in providing a sense of accountability and demonstrat-
ing the need for transparency;
• a management role at micro level;
• a decision-making role at macro level; 
• a didactic and motivational role for the parties directly involved.
Many standards have influenced evaluation practice, among them those of the Joint
Committee on Standards for Educational Evaluation founded in 1975 in the United
States (16). This committee has defined 30 norms which can be grouped into four
categories:
• criteria of usefulness to guarantee that an evaluation meets the needs of its bene-
ficiaries;
• feasibility criteria to ensure that an evaluation is realistic and cost-effective;
• code-of-practice criteria to demonstrate that an evaluation is conducted within
the law, with respect for professional ethics and takes into account the well-
being of those involved in the evaluation process, as well as those affected by its
results; 
• criteria of accuracy to guarantee that an evaluation uses information that is tech-
nically appropriate to the subject studied.
Evaluation also has political and technical aspects: politically, it provides the basis
for informed decision-making or ‘evidence-based public health’; technically, it can
help to improve the effectiveness of drug-prevention programmes — hence the
advantage, if not actually the obligation, for evaluators to study previous reports on
all, or part, of the programme. The importance of this fundamental aspect is often
underestimated.
Evaluation does not, however, provide the ‘truth’ about a programme, but is just one
interpretation among many. The existence of different assessments of the same 
programme allows evaluators to gauge whether or not the institution managing the
programme is able or willing to take into account the results of previous evaluations.
It also allows the institution to reinforce particular recommendations by repeating
them in the report. More generally, repeated evaluations can help to draw up guide-
lines for health-prevention and health-promotion initiatives. In this way, a significant
reservoir of knowledge can be gradually built up, mainly through meta-analyses.
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(16)   For more on the Joint Committee, see (http://www.eval.org/EvaluationDocuments/standards.html).
For evaluation research, and each individual evaluation, to be of value, its inevitable
limitations must be clarified. The Conseil Scientifique de l’Evaluation (1996) states
that the assessment process itself must be transparent:
As well as the demand for a full and rigorous statement of the methods
used, this criterion includes the idea that the evaluation must contain
an explanation of its approach and limitations. These are: its position
in relation to other possible evaluations of the same subject; a remin-
der of issues to which it has not, or has not fully, responded; anticipa-
tion of possible objections, and so on. This attempt to think clearly and
reflectively is even more necessary given that evaluations are generally
imperfect, deliberately vague about certain issues and the results they
achieve do not all have the same scope or strength.
The evaluation programme or system adopted must balance the need for rigorous
methods with the constraints — particularly in terms of time and resources — im-
posed by the given situation. As a rough guide, the evaluation budget should be 
between 2 and 15 % of the overall programme budget, depending on the time and
resources available. The more innovative or visible the programme, the more
thorough the evaluation must be. One of the most common ways of sabotaging an
evaluation is to deliberately under-budget it.
‘Time’ here refers both to the time required to carry out the evaluation and to the
time available on the sponsor’s decision-making timetable. Since the two often
conflict, this aspect should be negotiated. It is never easy to harmonise the evalua-
tion timescale with the shelf-life of a policy. In an ideal system, the most important
political decisions should be subject to a concomitant ex ante evaluation and an ex
post appraisal of the objectives and methods. In practice, the consequences of an
evaluation are often indirect and take a long time to appear. Experience tends to
prove that the accumulated stock of studies and evaluations on a given issue, when
this exists, is a permanent source that can be mobilised at any time, and for years,
in informing decisions. However, the funds available tend to be scarce.
The case of the Cochrane Collaboration for evidence-based medicine is an inspiring
example of such mechanisms, despite the arguable limitations of its methods. The
Copenhagen-based European Observatory on Health Care Systems is another, as is
the work carried out by the International Union for Health Promotion and Education
(IUHPE, 1999a, 1999b) with help from the European Commission (17). The European
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) also contributes signi-
ficantly to this structure, as does the European Commission’s excellent guide to eva-
luation methods (European Commission, 1997).
Commissioning an evaluation inevitably requires terms of reference and/or a call for
tender. It is clearly essential for the sponsors of the evaluation to know what they are
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(17) For more information on the Cochrane Collaboration, see (http://hiru.mcmaster.ca/cochrane/). 
For more information on the European Observatory on Health Care Systems, see (http://www.
observatory.dk). For more information on the IUHPE, see (http://www.iuhpe.nyu.edu/).
requesting and they must thus have a realistic idea of what is desirable and possible
given both the objectives and the constraints. The sponsor’s knowledge in assessing
the quality-to-price ratio of the tenders received is at least variable, not to say unpre-
dictable. A consultant is seldom approached at this level, and yet a short feasibility
study of the evaluation to help in planning its mandate and the terms of reference,
as well as information on the budget required, would often help all those involved.
A distinction is generally made between policy evaluation and programme evalua-
tion. The former is wider, both in terms of the field covered and the time required,
and involves systematically assessing the programmes which are used to implement
that policy. Evaluating overall programmes is more targeted and more easily under-
stood by all actors, and must include a way of appraising the individual projects
within the programme. The time required for the preliminary analysis, the collection
of information and its assessment is one of the main differences between policy and
programme evaluation; the effects on the evaluation budget is another.
A further distinction is also usually made between evaluating processes — 
continuing evaluation — and evaluating results — final evaluation. These can be
categorised as either ex ante or a priori evaluation and ex post or a posteriori 
evaluation. Ex ante or a priori evaluation involves a long-term feasibility study and
review of the impact of a particular measure. Where the measure involves a series of
projects, the a priori evaluation is often associated with a process for selecting the best
projects. In addition, if the evaluation results are made available to the managing
body, they can also directly help to improve current or future projects. Ex post or a
posteriori evaluation aims to provide retrospective information on a policy which
has realised its full potential and become routine or on a completed programme. It
is therefore a continuing, concomitant or ‘as-you-go’ evaluation.
It is perhaps more productive, however, to consider evaluation in terms of mecha-
nistic and systematic approaches. The mechanistic approach explores the extent to
which specific objectives are achieved, while the systematic approach considers the
programme in the context of its environment. This method attempts to understand
how the programme operates, the factors that facilitate it and those that render it
more complicated, as well as identifying any unexpected effects — particularly over
and above the specific objectives — and any limitations in its field of coverage.
How should the managing body respond if the programme’s mechanisms do not
cover the planned field in its entirety? For example, are health-promotion projects
included in drug-prevention programmes or not?
Linked to the mechanistic–systematic distinction is the distinction between the
quantitative and qualitative schools of thought, which, in turn, is related to the
concepts of objectivity and subjectivity. Supporters of the quantitative approach
argue that what cannot be measured is not worth evaluating, whereas those who
defend the qualitative approach argue that if it can be measured, it is probably of
no interest (Chronbach, 1977; Davidson 1980). In fact, the multiplicity of informa-
tion sources and the diversity of approaches introduces ‘inter-subjectivity’, which is
perhaps the best form of relevant objectivity. But the diversity of evaluators also
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raises the issue of their technical reliability and of the greater risks of one of them
failing (this risk is estimated at 10 %).
Internal and external evaluations
From the arguments in favour of an external evaluator, Nadeau (1981) cites:
• greater objectivity;
• ability to include evaluation criteria concerning the basic organisational prem-
ises;
• the possibility of acting as a mediator if internal disputes arise;
• a better protected status; 
• greater ease in avoiding undesirable tasks which are not part of the evaluation.
From the arguments in favour of an internal evaluator, he cites:
• greater ability to develop detailed knowledge of the organisation and its pro-
grammes; 
• a better position from which to carry out the continuing evaluation.
Most of the parties involved in evaluation increasingly accept the benefits of a func-
tional relationship between an internal and external assessor. This will become
increasingly natural as quality-assurance practices develop within training institu-
tions, because the person responsible for these practices will often actually be the
designated partner of the external evaluator.
In reality, however, the position of the internal assessor may be very delicate. The
wider the gap between the unofficial and official reasons for the evaluation request,
the more critical the position of the internal assessor, who is often as aware of the
unofficial motives as of the official ones.
In the context of European drug-prevention programmes, an essential element for
evaluation is one of the general objectives of all these initiatives, and also one of the
criteria for selecting the individual projects within them: added Community value
and its related issue of subsidiarity. These factors should also be among the criteria
for choosing evaluators, both in terms of their knowledge of public health in the EU
Member States and of European institutions.
What should guide both sponsors and evaluators is how useful the evaluation will
be for improving the drug-prevention programme. It is essential that the sponsor in
the formal sense, as well as the parties directly concerned — whether the main
actors or the more remote decision-makers — can, in the end, adapt the results of
the evaluation to drug-prevention practice. To do this, a certain number of condi-
tions must be fulfilled. These include negotiating the evaluation contract as far as
possible in consultation with all parties concerned, and undertaking to distribute the
evaluation report immediately to everyone, even if this means accompanying it with
a comment from the official sponsor specifying his own position. A not inconside-
rable factor is the tone of the report, which often reflects the general atmosphere in
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which the evaluation has taken place. Clear criticism can be expressed by using
measured, unemotional language.
Two factors, therefore, seem particularly important.
• The first is the evaluation process itself: the way in which the contract is nego-
tiated and the interviews conducted with the parties involved, including the
stance or code of ethics the assessor adopts.
• The second concerns the evaluation report, which, for many, is what finally
remains of the evaluation. While answering the questions raised by the sponsor,
the report must also include the points made along the way by all parties. It must
above all be relevant to decision-making.
The evaluation report is a method of communication, not an academic thesis for the
assessors nor a profitable investment for the sponsors. It is thus important to produce
several versions of the same evaluation results targeted at the different audiences,
whether decision-makers, drug-prevention professionals or the general population.
Formulating recommendations is a major component of the report and these must
be supported by legitimate, comprehensible and credible arguments. It would,
however, be dangerous if all the recommendations were systematically applied,
since this would probably indicate that they had not been sufficiently considered.
Conversely, it would be worrying if no recommendation were implemented. While
it is unusual for evaluators to be formally associated with the decision-making resul-
ting from their report, this would perhaps be the most effective solution if the majo-
rity of the recommendations were applied and if they were all consistent.
Conclusions
In conclusion, the following points should be borne in mind when planning and
carrying out evaluations:
• results that arrive too late are useless;
• results that cannot be understood by the parties concerned are useless;
• results that cover minor, factual aspects are at best ineffectual, and at worst used
improperly;
• (almost) everything depends on people: this is what tends to be evaluated the
least, and taken into account even less.
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Evaluation and drug-prevention research:
implications of unsuccessful outcomes for
programme design
Mark Morgan
Over the past few years, increasing concerns have been raised about the need to
design more effective programmes to combat drug use in Europe. The 1995
European schools project on alcohol and other drugs (ESPAD) study has demon-
strated that, while differences exist between countries both in terms of the sub-
stances used and the age of onset of drug use, each of the countries and regions sur-
veyed cited problems with either legal or illegal substances (Hibell et al., 1997) (18).
The study also revealed a strong association between drug problems and crime, as
well as a decline in gender differences in drug use, with use by girls tending to
‘catch up’ with boys in several countries (Hibell et al., 1997).
At the same time, the literature on the evaluation of drug-prevention efforts has fre-
quently suggested that such programmes are either only moderately successful or
downright failures (Brown and Kreft, 1998). Programmes may fail because:
• they are not properly implemented;
• the measures they adopt are too weak to change the target behaviour or attitude;
• there is no clear rationale for the intervention; 
• they do not take into account the factors that underpin initiation to drug use.
This chapter examines some of the factors associated with unsuccessful outcomes
of drug-prevention programmes that have emerged in recent research studies.
Particular attention is paid to the importance of cultural factors in programme 
design, the value of messages focusing on risk, and the long-term effects of pro-
grammes which were not evident at the time of their evaluation.
The reason for examining these issues is twofold. First, despite the growing interest
in drug-prevention programmes in Europe, the majority of evaluation studies come
from the United States (Foxcroft, Lister-Sharp and Lowe, 1997), thus linking the
accumulated wisdom to a specific cultural and economic context. Second, it is the
author’s conviction that drug-prevention efforts can be improved by broadening the
(18) The countries or regions surveyed were Croatia, Cyprus, Czech Republic, Denmark, England,
Estonia, Faeroe Islands, Finland, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Northern
Ireland, Norway, Poland, Portugal, Scotland, Slovakia, Slovenia, Sweden, Turkey, Ukraine and Wales.
frame of reference behind such programmes to socio-psychological models of
influence and behavioural change.
Cultural-specific drug-prevention programmes
Many contemporary approaches to drug prevention are based on the assumption that
young people may overestimate the level of social acceptance that exists for 
substance-use behaviour. It is thought that correcting such misperceptions reduces
substance use because normative influences have a powerful impact on behaviour
(Graham, Marks and Hansen, 1991). This raises the related issue of whether the fre-
quency of alcohol and other drug use is, in fact, overestimated. The literature includes
a phenomenon called the ‘false consensus effect’ — the belief by users of a particu-
lar drug that use by others is more frequent than it actually is. Conversely, those who
are not themselves frequent users tend to see themselves as quite unique, thus leading
to a general overestimation of actual use. This phenomenon has also been referred to
as ‘pluralistic ignorance’ in some publications (Prentice and Miller, 1993).
The ESPAD study questioned more than 50 000 16-year-old students from 26 coun-
tries and regions. One of the survey questions required them to estimate the 
frequency of substance use by their friends.
In 20 countries, the frequency of smoking was overestimated. Interestingly, the six
countries in which there was no such distortion — Denmark, Faeroe Islands,
Finland, Iceland, Norway and Sweden — are both culturally and geographically 
linked. In these countries, there was either no substantial overestimation, or the 
percentage of young people who said that ‘most or all’ of their friends smoked was
actually less than the percentage who had themselves reported smoking during the
previous month.
The ESPAD study demonstrated even greater distortion in reports of drunkenness. In
20 of the 25 countries for which data were available, the percentage who reported
drunkenness amongst ‘most or all’ of their friends was greater than the actual num-
ber who admitted such behaviour. More significantly, the countries where this effect
was not evident were the same Nordic States where no major misrepresentation was
evident in the case of smoking, with the exception of the Faeroe Islands.
There are a number of possible explanations for this interesting pattern. It may be
that adolescents in most countries except the Nordic States underestimate their own
substance use, or that such use may be more secretive and therefore less visible in
Nordic countries. However, without further investigation, such interpretations are
merely speculative.
The ESPAD findings have clear implications for the design of drug-prevention 
programmes and specifically for those that attempt to influence behaviour through
norm correction. The study shows that while widespread overestimation of sub-
stance use is common, it is by no means universal. This raises the issue of whether
a programme designed to correct misperceptions can be effective in cultures where
no such misperception actually exists.
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Fear-arousal messages
As has been proved by a long tradition in psychology, fear-arousal messages 
change behaviour. The basic assumption is that assimilating knowledge about the
negative consequences of substance use reduces favourable attitudes towards it, which
in turn decreases the likelihood of actual use. In particular, if the dangerous conse-
quences of a given behaviour were to be spelled out graphically, then young people
would avoid the behaviour in question. This view has led in certain circumstances,
especially in the intervention programmes of the 1970s, to educators believing that
exaggerating the consequences of drug use can be justified if it prevents young people
from experimenting with drugs.
Table 1: Perceived risk of substance use
Country/region 20+ 5+ drinks Occasional Regular Occasional Regular
cigarettes at marijuana marijuana ecstasy ecstasy 
daily weekends use use use use
Croatia 57 44 55 82 59 79
Cyprus 63 71 53 87 51 —
Czech Republic 75 39 37 78 47 80
Denmark 70 13 21 71 36 69
England 55 20 23 44 53 78
Estonia 71 38 44 78 29 55
Faeroe Islands 83 31 40 85 52 82
Finland 68 30 49 91 60 89
Hungary 77 55 62 89 60 86
Iceland 74 37 42 89 86 53
Ireland 61 16 19 57 45 81
Italy 63 33 49 83 58 85
Latvia 68 52 56 82 55 79
Lithuania 74 54 63 76 57 74
Malta 53 40 60 61 59 79
Northern Ireland 66 23 36 61 59 85
Norway 56 29 36 87 39 85
Poland 84 46 64 93 65 93
Portugal 69 53 67 89 69 90
Scotland 60 20 14 32 53 78
Slovakia 68 45 52 87 56 85
Slovenia 49 40 48 79 47 79
Sweden 65 45 52 92 58 91
Turkey 75 62 76 89 74 —
Ukraine 46 58 61 80 60 76
Wales 69 12 23 47 53 82
NB:
The figures shown are the percentage of respondents who believed that the behaviour in ques-
tion was a ‘great risk’.
‘—’ indicates data not available.
Source: Hibell et al., 1997.
However, there is now more than adequate evidence to refute this approach. In the
ESPAD study, the issue of risk was addressed in two ways. First, the survey obtained
information on the extent to which young people thought that substance use was
indeed a serious danger. Second, these data were analysed across countries to see
whether there was a correlation between the level of risk perception and the extent
of reported substance use.
Table 1 above shows the percentage of respondents who believed that a certain substance-
use behaviour was a ‘great risk’. Each of the areas covered by the survey — heavy
smoking, heavy drinking, occasional and regular use of cannabis and ecstasy — is of
particular interest, for example in illustrating the success of campaigns to convince
young people of the dangers of these behaviours.
Two points are especially noteworthy. First, a substantial minority in each country
did not perceive that smoking 20 or more cigarettes daily was a ‘great’ risk, but
thought it involved a ‘slight’, ‘moderate’ or ‘no’ risk. Thus, despite the extensive
information campaigns conducted over the past decades, a great many young
Europeans do not believe that heavy smoking is dangerous. In Ireland, Norway,
Sweden and the UK (England, Northern Ireland, Scotland and Wales), where there
have been sustained and intense anti-smoking campaigns, between one-third and
two-fifths of young people were not convinced that smoking over 20 cigarettes a day
was a great risk.
The second point concerns the differences in risk perception associated with occa-
sional substance use (once or twice) and regular use. In every country, substantially
more respondents thought that regular cannabis use was more dangerous than 
occasional use. This suggests that the critical feature in the perception of risk is not
simply the substance, but its frequency of use. A broadly similar pattern was found
in relation to ecstasy.
Also significant is the correlation between risk perception and actual drug use. In
countries where a higher proportion of young people view use of a certain sub-
stance as risky, is its use relatively lower? The ESPAD study demonstrates that the
association between risk perception and reported substance use depends on both
the substance and the level of use involved. Thus, in the case of smoking, the 
correlation with lifetime smoking is neither substantial nor significant. These results
imply that even if young people accept that smoking is dangerous, they may still
take up the habit.
Two important findings emerge regarding risk perception and smoking. First, a sub-
stantial number of young Europeans do not accept that smoking is a ‘great risk’.
Second, in those countries where relatively more young people accept that smoking
does pose a great risk, the prevalence of smoking is just as great (or even greater)
than in countries where the risk perception is lower.
The association between perceived risk and prevalence is, however, much stronger
and more negative in the case of both alcohol and illicit drugs. For alcohol, the cor-
relations are negative but modest in relation to lifetime prevalence of drinking or
previous-month drinking, but are stronger in relation to heavy drinking (actually
being drunk). This reflects the fact that the risk measure used focuses on heavy drink-
36
Recent progress in evaluation
ing (five or more drinks) (19). Thus, it would seem that in those countries where young
people accept that heavy drinking poses risks, they are less likely to get drunk.
In the ESPAD study, the perception of the risks posed by illicit substances was 
closely related to low levels of use. This was true for all four measures of risk (occa-
sional and regular use of cannabis and occasional and regular use of ecstasy). Thus,
perceived risk seems to have a quite different effect on actual use of cigarettes, alco-
hol and illicit substances: risk perception appears to play a negligible part in cig-
arette smoking, a significant part in heavy drinking and drunkenness and a major
part in all aspects of drug use. While the ESPAD data do not allow firm conclusions
to be extrapolated, it may not be coincidental that the risks of cigarette smoking are
long term while those associated with heavy drinking and drug use also involve
short-term hazards, such as personal injury (20).
Breadth of programme and outcome effectiveness
How appropriate is it to target one or several substances, or indeed to incorporate
drug use into a comprehensive health-education programme? It would seem reason-
able for drug-prevention programmes to target several substances at once. In addi-
tion, the rationale behind a particular drug-prevention programme may make it logi-
cal to incorporate several substances rather than a single one. A further practical
reason is the clear limit to the number of discrete, special-purpose drug-prevention
programmes that any system of delivery can accommodate before becoming redun-
dant and unwieldy.
Some of the most promising evidence of the widespread effects of drug-prevention
programmes comes from studies with schoolchildren. Frankel (1998) suggests that
intensive drug-prevention intervention with pre-school children in early-childhood
programmes could help decrease their drug use in adolescence. The long-term
effects could be related to the degree to which parents are involved in drug-
prevention interventions with their children.
In addition, it has been found that preventing poor academic performance among
schoolchildren itself has a powerful effect on reducing substance misuse several
years later. While early-childhood interventions such as Head Start — which was
implemented throughout the United States in the 1960s — were designed to en-
hance school performance rather than to improve social behaviour or to prevent
substance use at a later stage, such benefits have been demonstrated, possibly as a
result of improved school performance and family relations. Programmes designed
to enhance pupils’ achievement in school have been shown to produce a range of
social and personal effects which decreased anti-social behaviour in adolescence
and beyond. Childhood programmes aimed at improving school performance are
thus a viable way of decreasing juvenile delinquency (Lerner and Galambos, 1998).
37
Chapter 2
(19) Here, a drink is defined as a glass of wine, a bottle of beer, a small measure of spirits or a mixed
drink.
(20) For further discussion of the ESPAD survey results, see Morgan et al. (1999). 
There are at least two explanations for this remarkable finding. One view suggests
that cognitive development, including academic achievement, leads to greater suc-
cess in — and commitment to — school and consequently to lower rates of delin-
quency. The HIGH SCOPE project implemented in several parts of the United States
in the late 1960s in particular supports this hypothesis. Young children from dis-
advantaged backgrounds who participated in this essentially cognitively oriented
programme demonstrated substantially lower rates of delinquency at age 15 than
non-participants (31 % compared to 51 %), and this difference remained stable until
young adulthood (Lerner and Galambos, 1998).
Another explanation relates to the family. There is evidence that early-childhood
drug-prevention programmes improve family functioning, especially parenting skills
and relations between the family and the school. Improved family functioning leads
to more nurturing parenting which in turn reduces the risk of anti-social behaviour.
For example, children who participated in a programme with both a school and a
home component over five years had a much lower rate of delinquency than a
control group in a 10-year follow-up (6 % compared to 22 % — Lerner and
Galambos, 1998).
While most explanations of the link between intervention and preventing delin-
quency have to date been couched in terms of either ‘cognitive advantage’ or
‘family support’, additional factors are also likely to be involved. Positive effects on
young people’s self-concept, on their motivation or on their social development may
provide crucial links between participating in a drug-prevention programme and its
observed effects.
These findings have very significant implications for drug-prevention policies by
providing a link with other initiatives in areas that are generally not considered to
be relevant to substance use. They also present an opportunity for integrating research
on substance-use prevention into research on other social issues, including edu-
cational disadvantage and poor school performance.
Conclusions
There is considerable evidence that drug-prevention programmes designed for use
in all societies and cultures are likely to be difficult to develop and implement. The
evidence of cultural influences on risk factors make this an important area for fur-
ther study. The effect of gender and age differences may have a similar effect and
equally require further investigation.
The data considered in this chapter, both from the ESPAD study and from other
sources, indicate that emphasising the risks and dangers of substance use is of limit-
ed value as fear-arousal messages are not believed or, if they are, their capacity to
influence behaviour is weak.
Similarly, how appropriate is it for drug-prevention programmes to target a single (or
several) substances, and might it be better to broaden school drug-prevention pro-
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grammes in other ways? Particularly interesting is the long-term value of efforts to
prevent academic failure among schoolchildren, which have been shown also to
affect social behaviour and subsequent drug use during adolescence.
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Chapter 3
Evaluation and drug-prevention practice:
recent progress
Tom Bucke
In the middle of difficulty lies opportunity. (Albert Einstein)
Evaluation has not always had an easy relationship with drug policy and practice.
Funds for drug-prevention evaluation have either not consistently been available or
have not always been sufficient, and the effectiveness of various practices and poli-
cies have thus remained either unknown or unclear. Even when rigorous evaluations
have been conducted, their findings (whether positive or negative) have at times
been ignored by both policy-makers and practitioners. In addition, evaluators have
been guilty of not producing policy- or practitioner-relevant findings or of not ade-
quately communicating these findings to their audiences.
While acknowledging these problems, this chapter focuses on three case studies
where evaluation has successfully helped to shape drug-prevention practice.
Drawing on developments in the United Kingdom since the first European con-
ference on the evaluation of drug prevention in 1997, these examples cover three
very different areas of intervention:
• drug education in schools;
• ‘vulnerable groups’; 
• the criminal-justice system.
Each of the interventions cited below took place in the context of the UK
Government’s 10-year plan targeting drug misuse (‘Tackling drugs to build a better
Britain’, 1998). This plan set key performance targets for reducing drug use and led
to extra funding for drug-related law enforcement, treatment and prevention. This,
and other, government initiatives dealing with health, housing and educational
inequalities place a high value on ‘evidence-based practice’ derived from rigorous
evaluation. As a result, funders are increasingly looking at activities in the drug-
prevention field and asking: are they effective?
Case study one: drug prevention and education
The first case study concerns primary drug prevention in schools. A significant
amount of evaluation data is now available on what is effective in this area. For
example, drug education has traditionally placed strong emphasis on providing
young people with information on patterns of drug consumption, pharmacology,
methods of using drugs and so on. This approach may also involve more emotive
means, such as fear-arousal strategies that dramatise the negative effects of drug use
and frighten young people into remaining abstinent. A central assumption under-
pinning these approaches is that if young people are informed about the dangers of
drugs they will make a rational decision to avoid them.
Despite the widespread adoption of this approach, evaluations have demonstrated
that providing information on drugs does not, by itself, have a significant impact on
young peoples’ drug use (Ellickson 1993; Dielman, 1994). This is not to say that pro-
viding information in drug education is pointless, but that to have a sustained
impact on drug consumption, information and programmes that address young
peoples’ attitudes need to be coupled with psychological approaches. One of the
most promising current psychological approaches in drug education is ‘life-skills
training’ which seeks to develop generic, personal self-management and social
skills. The aptitudes typically developed by this training include:
• decision-making and problem-solving;
• cognitive faculties for resisting interpersonal and media influences;
• capabilities for enhancing self-esteem;
• coping strategies for dealing with stress and anxiety;
• general social skills (complimenting, conversation and forming new friendships); 
• general assertive techniques (including requests and refusals).
These generic skills are taught and applied to situations relating to tobacco, alcohol
and drug use, although they could equally be applied to other areas, such as sexual
behaviour and juvenile delinquency.
Life skills and ‘Project Charlie’
The main evidence for life-skills training comes from North America and Australia
(Wragg, 1990; Botvin et al. 1995) and shows significantly lower levels of cannabis,
tobacco and alcohol use among young people who receive the training than among
those who do not. Despite the existence of these studies, however, drug-educational
practice in the UK for most of the 1990s remained uninformed by this evidence and
continued to be variable in coverage, quality and approach. An exception was a life-
skills programme called Project Charlie, initiated in 1992 in a deprived part of East
London among a group of 5–11-year-olds (21). These children were assessed four
years after the start of the project and compared to a control group who had not par-
ticipated in the programme (Hurry and Lloyd, 1997).
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(21) Project Charlie — Chemical Abuse Resolution Lies in Education — was originally developed in the
US to promote abstinence among schoolchildren, delay the onset of first experimentation with drugs,
limit the amount, frequency and situations in which drug use occurs, and inhibit the further devel-
opment of drug use.
The results of the evaluation showed that compared to the control pupils the Project
Charlie children:
• were more resistant to peer pressure;
• exhibited more negative attitudes to drugs; 
• were less likely to have used tobacco and illicit drugs.
While the Project Charlie evaluation was a modest study with a small sample size,
the findings re-emerged in 1997 when the UK’s 10-year drug strategy was being for-
mulated. Senior policy-makers were looking for evidence of ‘what worked’ in drug
education and the Project Charlie evaluation had a strong influence on their think-
ing. As a result, the UK’s new drug strategy states that ‘prevention should start early,
with broad life-skills approaches’ from ages 5 to 11. All schools in the UK are now
expected to establish ‘integrated, sustained and comprehensive programmes invol-
ving life-skills approaches’ by 2002 (UK Anti-drugs Coordinator, 1999). Drug-
prevention programmes outside schools involving young people and their parents
are also to include life-skills approaches. Promoting life skills in school drug edu-
cation, however, has implications for both funding and teacher training. New edu-
cational materials will need to be created or existing ones rewritten and the extent
to which teachers apply the method across the UK monitored. One of the major
lessons here is the opportunistic nature of research evaluation. The Project Charlie
evaluation demonstrates how positive research findings, if they emerge at the right
time for the right audience, can have a major impact on policy and practice.
Case study two: drug prevention and ‘vulnerable groups’
The second case study concerns groups ‘vulnerable’ to problem drug use (22). Such
users typically consume large amounts of heroin, crack or amphetamines, usually
as part of a pattern of ‘poly’ drug use (23). Over recent years, research has led to the
growing realisation that some young people are more likely to develop serious drug
problems than others (Lloyd, 1998; Lloyd and Griffiths, 1998). To put it another way,
those people who have serious drug problems often exhibit common life expe-
riences, including dysfunctional family backgrounds and troubled school careers.
As a result, vulnerable or high-risk groups tend to include those excluded from
school, truants, children in care, young offenders, the young homeless and children
of drug-misusing parents.
The growing awareness of vulnerability to problem drug use has occurred at a time
of increasing interest across Europe in issues of social exclusion and marginalisation
and how social disadvantage influences drug consumption among young people.
43
Chapter 3
(22) Problem drug use involves dependence, regular excessive use, or use that causes serious health
issues. A distinction should be made between problem and casual or recreational drug users. For a
more detailed definition of problem drug use, see Advisory Council on the Misuse of Drugs (1982,
1988).
(23) ‘Poly’ drug use is a pattern of consumption that involves a number of licit and/or illicit drugs. Polydrug
users would include a stimulant user who regularly smokes heroin in order to ease the after effects
of using crack cocaine.
This perspective creates exciting possibilities for drug-prevention practice. If vulner-
able young people can be identified at an early stage, then drug-prevention and
harm-reduction activities could be more effectively targeted. This issue also raises a
number of questions for practitioners, such as how to identify and access vulnerable
groups and what prevention interventions should be delivered. Even if these ques-
tions can be answered, working with vulnerable young people is likely to be a
challenging experience. While some groups may be physically accessible, their
experiences and backgrounds may render them chaotic, inattentive and suspicious
of authority.
Working with excluded schoolchildren
Griffiths et al. (1999) have addressed work with vulnerable young people in the UK
by focusing on those expelled or excluded from school who have been grouped
together in ‘pupil referral units’ (24). Because there is very little evidence on which
approaches actually work with vulnerable groups, and in particular with excluded
schoolchildren, the project workers had to design their own drug-prevention pro-
gramme. This programme involved three elements.
• Drug education was delivered by outside facilitators in sessions that sought to
ensure that the young people had a sound knowledge base for taking decisions
on substance use. Topics covered included types of drugs, their effects and dan-
gers, and drugs and the law.
• Life-skills training was provided through a specially developed course delivered
by outside facilitators. This course sought to assist the young people in dealing
with difficult situations and problems, and to enhance their communication
skills and interaction with others.
• Diversionary activities of a vocational and educational nature were delivered
throughout the programme. The nature of these activities was at the discretion of
the individual pupil referral units.
Evaluation of this initiative began in 1997 and shows how research can shape and
improve a drug-prevention intervention. For example, first-year research findings
described how the diversionary element of the programme had been oversold. Not
all units were providing these pursuits, and when they did these were not the inten-
sive training or skill-based activities that had been originally planned. As a result of
the evaluation, the package was modified and these shortcomings addressed.
Second-year research findings showed that the programme was well received by the
young participants. The results specifically found that:
• just under one third stated that the course had actually changed their attitudes to
drugs; 
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(24) Pupil referral units are specialised centres where young people continue their education after being
permanently excluded from a number of schools. The units are locally based and run either by the
local education authority or by a voluntary agency. The young people who attend these units tend to
be aged 11 to 16.
• just over one third stated that they would be less likely to take drugs after attend-
ing the course.
While these are comparatively weak indicators of success (25), an evaluation report
on the third year will present further findings on the outcome and impact of the pro-
gramme on drug use. This report will be published in the latter half of 2000.
Case study three: drug prevention and the criminal-justice system
The third example of the impact of evaluation on drug-prevention practice concerns
the increasing involvement of the criminal justice system in engaging problem drug
users who are often extensively involved in crime to support their drug consump-
tion.
The police and the courts are among the agencies that have the most contact with
problem drug users. But while the criminal-justice system can apprehend and pro-
secute this population, there is little evidence that conviction and punishment do
anything to reduce their substance use. By contrast, there is quite good evidence
that properly funded and appropriately designed interventions by drug agencies can
substantially reduce drug use and drug-related crime (Hough, 1996).
In the UK, this has led to various strategies to identify problem drug users in
the criminal-justice system and refer them to specialised services for treatment.
While these strategies do not fit neatly into traditional notions of drug prevention,
when linked to treatment their objectives are to reduce drug use, drug-related harm
and drug-related crime.
Problem drug users and ‘arrest referral schemes’
One strategy that has recently been evaluated involves ‘arrest referral schemes’.
These schemes focus on people entering the criminal-justice system after arrest
when they are in police custody. ‘Arrest’ means a break in offending, and in this
context offers drug users a chance to reflect on their behaviour, in the context of
possible prosecution and conviction.
Different types of arrest referral schemes have been evaluated with samples of arrest-
ees monitored on referral to treatment agencies (Edmunds et al., 1998). Two of the
main findings from the evaluation are described below.
Types of arrest referral scheme
Initially, a large number of arrest referral schemes were based on the ‘information
model’ where police officers provide details of local drug agencies and treatment
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(25) Interventions that have successfully changed young peoples’ attitudes and intentions towards drug
use have not always been successful in changing their actual behaviour (Moshowitz, 1989). 
services to all arrestees on a ‘take-it-or-leave-it’ basis. While these schemes are
cheap to establish, they have very poor take-up rates.
A more effective approach in terms of participation by arrestees is the ‘proactive
model’. Under this model, drug workers cooperate closely with the police and often
directly approach arrestees in custody, providing an assessment either on site or at
a later meeting. In some cases, the police may screen or target arrestees for the drug
worker, although the worker is always responsible for providing information about
drug services and encouraging the user to seek advice.
Impact of arrest referral schemes
Those passing through these schemes tend to be white male opiate users in their late
twenties or early thirties. They have a high weekly expenditure on drugs which they
finance through shoplifting, burglary, selling drugs and a variety of other illegal and
legal means. The evaluation found that three-quarters of those seen by drug workers
were referred to drug services and half entered a treatment programme. Interviews
up to 18 months after the first contact with the arrest referral scheme found that the
participants’ expenditure on drugs had fallen from GBP 375 per week (EUR 225) to
GBP 70 (EUR 42). The greatest differences were reported among opiate and stimu-
lant users. Corresponding decreases were found in levels of offending to finance
drug use, while in terms of harm reduction, the prevalence and frequency of inject-
ing had fallen.
The effect of the arrest referral evaluation on policy and practice has been enor-
mous. The UK Government is currently looking at ways of reducing the impact of
crime and drug misuse, and arrest referral schemes are seen as having the potential
to make a real impact on these areas. The findings of the evaluation have led to GBP
20 million (EUR 12 million) being set aside to develop arrest referral schemes in
every police station across the UK by 2002. This means a massive increase in the
number of drug workers based in the criminal-justice system and the significant re-
focusing of UK drug-prevention practice. If these new arrest referral schemes suc-
ceed in engaging the numbers expected, drug agencies will have to expand to meet
the numbers of new clients being referred to them. Part of the GBP 20 million 
will therefore be used to finance the extra drug services required to deal with the
criminal-justice referrals.
Referral schemes are currently being evaluated in other parts of the criminal-justice
system, including those attached to prisons, courts and ‘community sentences’. If
these schemes prove successful, they may lead to increased emphasis being placed
on criminal justice in drug-prevention practice.
Conclusions
The importance of evaluation in drug prevention is increasing, reflecting a wider
trend in social policy over the 1990s from ‘inputs’ to ‘outputs’. In the past, policy-
makers and practitioners addressed a particular social issue or problem by stating
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how much money had been spent, how many new posts had been created, or how
much time had been given to it (inputs). This position is becoming increasingly hard
to sustain. Instead, policy-makers and practitioners are now expected to provide evi-
dence of what has been achieved by the money they have spent, the posts they have
created and the time they have allocated (outputs). As a result of this change, 
policy-makers are increasingly looking to evaluators for assistance (26).
Three common themes run through the case studies outlined above. The first is that
the impact of evaluation on drug-prevention practice may depend on timing. In
other words, providing policy-makers with evidence of effectiveness when they
need it can have a major effect on practice. The lessons here for evaluators include
recognising the opportunities available to them to make an impact on practice, and
marketing evidence of effectiveness in drug prevention in the most appropriate
ways.
The second idea is that evaluations do not have to be large and resource-intensive
to make an impact on practice. The Project Charlie evaluation was modest in size
and budget but, because it confirmed international findings in a UK setting, its
influence has been very significant. Taking examples of effective drug-prevention
practice from the international literature and applying them to a specific country is
one way of influencing practice. Again, a crucial element here is to recognise and
seize opportunities when they arise.
The third theme is that negative evaluation findings can be just as valuable as posi-
tive ones. In each of the case studies outlined above, evaluation has highlighted
approaches that did not work or were not very effective. Instead of being interpreted
as ‘prevention does not work’, these results have led to drug-prevention practitioners
developing more effective approaches and more effective evaluation practice.
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Evaluation and drug-prevention policy: 
the Galician plan on drugs
Manuel Araujo Gallego
Advances in the development of images in the mind and advances in
knowledge are measured much better by the history of questions than
that of answers. Thus, in the final instance, a brain that thinks, thinks
of the centre of the world alone. And though thought may not start with
a question, it does end with an answer. For this reason, be more wary
of answers. For answering represents a process of adaptation, while
posing questions is an act of rebellion. (Jorge Wagensberg)
A brief description of Galicia
Galicia is one of the 17 autonomous communities of the Spanish State, located in
the north-west of the Iberian peninsula. It covers an area of 29 575 km2, bordering
the Cantabrian Sea to the north, the Atlantic Ocean to the west, Portugal to the
south and the autonomous communities of Asturias and Castilla-León to the east.
Galicia’s population of over 2.7 million has a density of 93 inhabitants per km2,
higher than that of Spain as a whole (78 per km2), but lower than that of the
European Union (116 per km2). 49 % of all the population centres in Spain are
located in Galicia, although the region’s inhabitants are distributed unequally, with
a greater density on the coastal fringe than inland. The birth rate in Galicia is nega-
tive — minus 1.2 per 1 000 inhabitants, compared with 1.4 per 1 000 in Spain and
3.0 per 1 000 across the EU. Life expectancy at birth is 74.2 years for men and 81.5
for women, higher than life expectancy either in Spain or across the European
Union.
21.7 % of Galicia’s economically active population work in agriculture and fishing
(compared to 8.6 % in Spain and 5.0 % across the EU), 27.8 % in industry (29.4 %
in Spain and 29.8 % across the EU) and 50.4 % in the service sector (62.0 % in
Spain and 65.1 % across the EU). From 1994 to 1996, gross domestic product per
inhabitant was EUR 8 946, compared with EUR 11 278 in Spain and EUR 17 377
across the EU. Galicia has 17.3 % unemployment, compared with 18.8 % in Spain
and 10.2 % in the EU (27).
(27) 1998 data.
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(28) No 2/1996 of 8 May 1996.
The importance of evaluation in Galicia
Evaluation is one of the guiding principles of the Plan de Galicia sobre drogas
1997–2000 (Galician plan on drugs (GPD) — Consellería de Sanidade e Servicios
Sociais, 2000a), approved by the government of Galicia on 23 January 1997 and by
the parliament of Galicia on 27 June 1997. Research and evaluation of the plan itself
are also governed by this strategic objective. Given the concept’s status as a guiding
principle, the requirement to undertake evaluation affects all the programmes car-
ried out in the various areas of competence of the GPD — whether drug prevention,
assistance to drug users, rehabilitation or training drug workers.
This mandate to evaluate has its origins in the Lei de Galicia sobre drogas (28)
(Galician law on drugs (GLD) — Consellería de Sanidade e Servicios Sociais, 1996).
This regulation covers many areas of drug demand reduction — from preventing
drug consumption (including reducing the availability of alcohol and tobacco) to
the budgetary commitments of public administrations to fund such activities — and
states that evaluation systems are a compulsory minimum requirement of the plan
on drugs. The GLD also refers explicitly to the concept in the articles that establish
criteria for planning and managing demand-reduction activities in Galicia.
Reflecting the importance accorded to evaluation in Galicia, a drug monitoring
centre, the Observatoria de Galicia sobre Drogas, was created in 1996 specifically
to evaluate both the extent of the drug problem in the region and the initiatives
introduced to combat it.
In line with the approach of the World Health Organisation, evaluation is under-
stood here as a systematic means of acquiring empirical knowledge and using the
lessons learned to change or improve a programme in order to facilitate more in-
formed planning and decision-making.
Evaluation as a guide for allocating resources
Evaluation is not a new concept in Galicia, even though particular attention has
only been focused on this task since 1994. In 1988, the first regional epidemiologi-
cal study into drug use (EDIS, 1988) produced an epidemiological risk index or
‘priority’ index to help ensure the equitable distribution of resources for drug pre-
vention within Galicia. Since then, four similar studies have been carried out, each
with it own risk index (EDIS, 1992, 1994, 1996, 2000).
The three priority regions for drug prevention in Galicia include the following health
areas:
• La Coruña, Santiago and Vigo (highest priority);
• El Ferrol, Lugo, Orense and Pontevedra (medium priority); 
• Cervo, Monforte, O Barco and O Salnés (lowest priority).
These three regions have remained unchanged since the first report was produced
in 1988 except for small internal variations, notably in the second region (29).
Table 1: Priority regions for drug prevention
Region 1988 1992 1994 1996 1998 
PI PO PI PO PI PO PI PO PI PO
Highest
priority
La Coruña 1.987 2 1.952 2 1.985 2 1.986 2 2.346 1
Santiago 1.556 3 1.752 3 1.723 3 1.723 3 2.067 3
Vigo 2.034 1 2.149 1 2.275 1 2.086 1 2.252 2
Medium
priority
El Ferrol 0.835 5 0.574 5 0.648 4 0.730 7 0.486 6
Lugo 0.392 7 0.558 6 0.645 5 0.740 6 0.740 5
Orense 0.395 6 0.356 7 0.588 6 0.941 4 0.941 4
Pontevedra 1.243 4 0.651 4 0.533 7 0.762 5 0.457 7
Lowest
priority
Cervo 0.027 9 0.057 9 0.138 9 0.110 9 0.083 9
Monforte 0.312 8 0.240 8 0.072 11 0.096 10 0.072 10
O Barco (a) — — — — 0.076 10 0.061 11 0.030 11
O Salnés (a) — — — — 0.168 8 0.216 8 0.120 8
NB:
PI = priority index or risk index.
PO = priority order of the regions according to the risk index.
(a) The health regions of O Barco and O Salnés did not exist in 1988 and 1992.
Prioritising the areas where drug-prevention programmes are most needed allows
the available resources to be distributed across Galicia based on an accurate assess-
ment of needs.
Table 2 below compares the risk index from the 1998 study (EDIS, 2000) with the
funding allocated to drug-prevention, assistance and social-rehabilitation pro-
grammes in the 11 health areas.
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(29) Prior to the 1994 report, the health areas of O Barco and O Salnés did not exist as such. The coun-
cils of which they are now constituted then formed part of Pontevedra and Monforte.
Table 2: Comparison of epidemiological priority and financial resources allocated
Epidemiological Health area Financial resources allocated (b) Financial
priority (a) priority
EUR % of total 
budget
1 La Coruña 1 430 377 17.2 2
2 Vigo 1 949 812 23.5 1
3 Santiago 1 135 384 13.7 3
4 Orense 523 719 6.3 6
5 Lugo 523 150 6.3 7
6 El Ferrol 988 605 11.9 4
7 Pontevedra 740 232 8.9 5
8 O Salnés 455 321 5.5 8
9 Cervo 237 078 2.9 10
10 Monforte 251 454 3.0 9
11 O Barco 76 184 0.9 11
NB:
(a) Based on EDIS (2000).
(b) 1988 to 1999.
Evaluation systems
The Galician plan on drugs includes two specific evaluation systems: the Sistema de
evaluación asistencial (Assistance evaluation system — SEA); and the Sistema de
evaluación de programas de prevención e incorporación social (Prevention and
social rehabilitation programmes evaluation system — SEPI).
The SEA has been operational since 1 January 1994 and provides information about
drug users in treatment and the help they receive in the care system. The SEA
analyses data at four levels from:
• the care system;
• each treatment programme within the care system as a whole;
• the individual treatment centres; 
• each programme within each treatment centre.
Information on the various treatment programmes — especially drug-free, 
methadone-maintenance and naltrexone-maintenance programmes — is featured in
the SEA manual (Consellería de Sanidade e Servicios Sociais, 1994). The SEA uses
three indicators — time in treatment, reasons for leaving the programme and the
activities undertaken — and the results of these indicators for each treatment centre
are used to set the annual quantitative and qualitative objectives to be achieved by
the centre and to allocate its budget.
Work on the second evaluation system, the SEPI, began in 1996 and its manual
(Conselleria de Sanidade e Servicios Sociais, 2000b) and tools have now been
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finalised. The system was created to assess individual drug-prevention programmes,
as well as the general objectives of the region’s drug-prevention and rehabilitation
policy as a whole. In this context, the SEPI was structured as an operational tool to
help ensure coherence both within individual drug-prevention programmes and
between the various related initiatives undertaken throughout Galicia.
The system’s overall objectives are:
• to collect information on drug-prevention programmes and how the GPD is inte-
grated into social structures;
• to facilitate the analysis and development of these programmes and the decision-
making relating to them, as well as of procedures and planning in the drug-
prevention field as a whole; 
• to enable more complex types of evaluation to be carried out in the long term
once the system of prioritising each area’s drug-prevention needs has been fully
established through regular information collection.
It should be emphasised that not only the individual programmes, but also the over-
all field of drug prevention itself is subject to evaluation. The field itself is seen in
this context as a ‘metaprogramme’ encompassing the individual initiatives carried
out by the voluntary associations and local councils that form part of the GPD net-
work. As a result, when assessing the value and viability of individual programmes,
it is not only their design that is analysed, but also how well their implementation,
objectives and scope match the requirements and priorities set out in the plan on
drugs.
The SEPI collects information at two crucial stages: when the programme is de-
signed; and when the final reports and results are produced. A series of tools or pro-
tocols allows drug-prevention information to be gathered in a standardised fashion
adapted to each specific setting, whether the community, the education system, the
family, the workplace or youth settings.
Evaluating the individual programmes
The criteria for evaluating individual programmes are based on three factors. The
first is the suitability of the programmes, which is assessed in relation to the prio-
rities set out in the GPD.
The second factor is the clarity of the design, which examines the programme’s char-
acteristics and internal consistency at the outset, as well as analysing the relation-
ship between the programme’s underlying motive, objectives and activities. It seems
obvious that a well-designed programme is more likely to tackle practical problems
successfully and will allow the relation between the actions undertaken and the
objectives achieved to be identified. The SEPI studies all programmes via a protocol
known as the programme presentation document. This document provides a stand-
ard format in which the teams involved can present their programmes, and also
serves as a reference guide during the planning process. The programme presenta-
tion document provides the following basic information:
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• a justification of the chosen means of intervention by analysing the situation and
the alternative options available;
• a description of the programme’s characteristics and methodology;
• a description of the target population and context;
• a description of the programme’s general and specific objectives;
• a description of the activities planned;
• a programme schedule;
• the human resources available;
• the material resources available;
• how the programme will be coordinated; 
• the programme budget.
The third factor is the analysis of the programme’s implementation once it has been
carried out. This investigation examines the relationship between the initial objec-
tives and the final outcomes to assess the extent to which the initial goals have been
achieved. Such an analysis is necessary since, during the implementation of a pro-
gramme, changes are often made to the original plan. A standard form has also been
drawn up to facilitate this task.
Evaluating the metaprogramme
The data obtained at the individual programme level are then analysed to identify
trends and developments in the drug-prevention field as a whole. The SEPI provides
a set of indicators obtained from the data in the programme presentation forms and
in the implementation report. From this information, collected both at the outset and
on completion of the programme, a comparison can be drawn between forecasts
and achievements.
Phases of the SEPI
The three main phases of the evaluation system are presented in Table 3.
Table 3: Phases of the SEPI
Phase Objective Tools Outcome
1 annual analysis of drug- — programme presentation analysis and   
prevention programmes document evaluation of
— evaluation plan for drug-prevention
programme design and programmes
planning
2 description of initial — charts and calculation analysis and 
situation and procedure sheets evaluation of initial
situation
3 final annual evaluation — implementation reports evaluation of final 
of drug-prevention for each programme situation
programmes and — charts monitoring initial 
metaprogramme and final situation
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Indicators
The indicators used by the system can be grouped into four types:
• indicators of scope, which refer to the field targeted by each programme and
activity in terms of location and population as well as of scale;
• indicators of activity, which describe the different actions according to the
following categories:
— awareness-raising and information;
— training, including courses, seminars, conferences and discussion groups;
— leisure and free time;
— sport;
— vocational workshops, for example on computing or gardening; 
— coordination meetings among drug professionals, organisations and associa-
tions and local authorities;
• personnel or performance indicators, which assess the abilities of the profes-
sionals and volunteers who implement the programmes; 
• cost indicators, which examine the programme budget.
These indicators can also be classified according to the following programme 
criteria:
• all drug-prevention programmes (the equivalent of the metaprogramme level);
• the fields into which the programmes are grouped, such as community, school,
family, youth;
• the classification given to the activities undertaken, as described above; 
• geographical areas, whether health areas, provinces or Galicia as a whole.
Which of the available measures is most useful for planning and evaluating drug-
prevention initiatives is not yet clear. Combining the indicator types (scope, activi-
ty, performance and cost) and the programme criteria (metaprogramme, fields,
classification of activities and geographical area) could lead to a very high number
of instruments which, in practice, would render the evaluation process completely
inoperable. Instead, a limited number of indicators are needed offering a powerful
enough tool to allow the tasks undertaken to be accurately assessed.
Tables 4 and 5 below present data from 1999 for some possible indicators.
Table 4 shows that:
• 38 % of all local councils in Galicia (119 out of 315) run drug-prevention and
social-rehabilitation programmes;
• the potential target population of these programmes throughout Galicia is 68 %,
although only 18 % actually take part in them;
• the cost per head of the metaprogramme for the user population is EUR 3.32, but
is higher in the geographically smaller and less densely populated provinces,
such as Lugo and Orense; 
• the greater proliferation of these programmes in Pontevedra and La Coruña cor-
responds to the greater prevalence of drug use in these provinces.
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Table 4: Drug-prevention and social-rehabilitation programmes by province and
population
Province Local councils Programmes Population Cost per head
(in EUR)
No (a) % (b) No % (c) potential clients (d) potential clients
clients (d) clients
La Coruña (e) 39 41 92 38 69 22 0.81 2.53
Lugo (f) 24 36 27 11 59 9 0.70 4.81
Orense (g) 30 33 28 12 59 12 0.77 3.74
Pontevedra (h) 26 42 95 39 74 20 0.75 2.82
All Galicia 119 38 242 100 68 18 0.89 3.32
NB:
(a) Number of local councils per province that run drug-prevention and social-rehabilitation 
programmes.
(b) Number of local councils per province that run drug-prevention and social-rehabilitation
programmes as a percentage of all the local councils in that province.
(c) Number of drug-prevention and social-rehabilitation programmes per province as a percentage
of the total number of such programmes in Galicia.
(d) (Potential) clients as a percentage of the total population.
(e) La Coruña includes the health areas of El Ferrol, La Coruña and Santiago.
(f) Lugo includes the health areas of Cervo, Lugo and Monforte.
(g) Orense includes the health areas of O Barco and Orense.
(h) Pontevedra includes the health areas of O Salnés, Pontevedra and Vigo.
Table 5 presents the geographical distribution of the 242 drug-prevention pro-
grammes by their field of action as percentages of the total number of drug-
prevention programmes in each province.
The table shows that the greatest number of drug-prevention programmes in Galicia
focus on information and training (21.5 %), schools (20.7 %), the family (19 %) and
young people (17.3 %). Information and training initiatives include teacher training,
school programmes cover all educational levels up to university, the family projects
include educating parents and families, and youth initiatives are dominated by the
‘Cinema and health’ programme. The situation portrayed in Table 5 reflects the
priorities laid down in the Galician plan on drugs which emphasises schools, the
family and young people as targets for drug prevention.
Table 6 illustrates the regional distribution of school drug-prevention programmes
which use specially designed teaching materials.
Drug-prevention programmes are implemented in 31 % of all public and private
schools in Galicia. Out of the total number of participating schools, 88 % are in the
public sector (representing 32 % of all public schools) and 12 % in the private sec-
tor (representing 23 % of all private schools). The programme reaches a total of 
101 952 pupils — 23 % of all schoolchildren in Galicia — and 4 912 teachers —
14 % of the total teaching staff.
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Table 5: Geographical distribution of drug-prevention programmes by field of action
Province Field of action
school family community youth information legal and social work
and social rehabi-
training assistance litation
La Coruña 20.6 17.4 4.3 17.4 19.6 4.3 13.0 2.2
Lugo 22.2 18.5 0 18.5 25.9 3.7 11.1 0
Orense 21.4 21.4 0 17.8 21.4 3.6 14.3 0
Pontevedra 20.0 20.0 4.3 16.8 22.1 2.1 13.7 1.0
All Galicia 20.7 19.0 3.3 17.3 21.5 3.3 13.2 1.2
NB:
All figures are percentages of the total number of drug-prevention programmes in each province.
Table 6: Regional distribution of school drug-prevention programmes
Province No of schools No of drug-prevention % of schools that run
programmes drug-prevention
programmes
La Coruña 786 202 26
Lugo 225 93 41
Orense 198 48 24
Pontevedra 681 234 34
All Galicia 1 890 577 31
NB:
Data are for the 1998 to 1999 school year.
Problems with evaluation systems
Problems and difficulties will always arise in the design and implementation of any
evaluation system. These obstacles must be faced and resolved if that system is to
succeed in promoting rational decision-making and in facilitating the planning of
drug-prevention programmes. While a list of potential problems would be practi-
cally endless since new difficulties constantly appear, the following are among the
most common obstacles encountered in evaluation:
• uncertainty surrounding the concept of drug prevention itself;
• the heterogeneity of the institutions taking part;
• the need for an inter-sectorial aspect to the evaluation; 
• difficulties among the teams who provide information to the evaluation and to
the planners and politicians who base their decisions on the evaluation results.
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The GPD, the GLD and the framework document on prevention (Comisión asesora,
1993) all provide a fairly clearly defined notion of drug prevention, setting out the
highest-priority fields and programmes. While this has reduced the level of uncer-
tainty surrounding the concept of drug prevention, homogeneity cannot be fully
assumed at the outset because the projects are only gradually adapted to the
contents of these documents.
The heterogeneity of the institutions involved is linked to the existence of various
voluntary associations and local councils, as well as to internal differences within
each of these groups. To establish a single system of evaluation, common elements
have to be identified. At the same time, however, it is crucial that the different
approaches of the various bodies are taken into account, given that the GPD seeks to
be an integrating force and that the problem of drug addiction demands action from
many different angles. This heterogeneity does not affect the evaluation of programme
designs, which must fulfil certain common criteria, but it does affect other types of
assessment relating to the programme’s requirements, justification and results.
Integrating all sectors of the community and all agencies active within it — one of
the goals of the GPD — is a complex task since it presupposes the involvement of
a wide range of social agencies, government departments and other bodies. In such
a context, consensus becomes an essential requirement for planning in order to
ensure that the different views are taken into account and the various resources
available brought into play. Thus, evaluation must consider the programme’s 
potential for achieving this multi-sectorial integration.
Systematic evaluation processes inevitably interfere with the normal working prac-
tices of the teams involved, and inappropriate intervention risks creating excessive
levels of bureaucracy, diverting the attention of the professionals from actually
implementing the drug-prevention programme. Thus, it is vital that evaluation sys-
tems are instituted with care and that the teams involved understand their purpose
and utility, as well as the benefits they can gain from the methods used and the
results obtained.
Providing new tools and systems with which the teams have to work, obtaining
information, inputting data into databases and analysing them all take up time and
disrupt working patterns. New capacities often have to be introduced to deal with
these additional tasks and extra elements have to be juggled, including decisions
relating to the treatment and analysis of data. Introducing new working practices
means incorporating new routines, and that alone requires some effort. In addition,
the optimal performance of these systems is evident only after they have been
operational for several years.
Conclusions
It is vital that the professional teams that undertake evaluations understand fully
what it is hoped the process will achieve, and this is particularly true during imple-
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mentation. Neither false expectations nor misunderstandings should be created.
Evaluation is not a magic solution; it is simply a means of making the decision-
making process more rational and a tool for increasing knowledge about a pheno-
menon — in this case drug use — and how to influence it.
A large proportion of what has been said in relation to ‘frontline’ professional teams
also applies to planners and politicians, especially concerning evaluation as a
‘magic solution’. Just as some professionals think that poor evaluation results may
lead to the loss of their jobs, certain planners and politicians may be tempted to use
those same results as an excuse for reducing the budgets of less productive pro-
grammes.
Clearly if a programme is not working satisfactorily — that is, if it is incapable of
meeting its objectives — there is no sense in it continuing and using human or
material resources. However, a decision to cancel a programme can only be taken
after detailed examination of why it is not achieving its objectives. In other words,
for drug-prevention professionals, evaluation is the best way of improving the effec-
tiveness and efficiency of programmes and not an acceptable excuse for reducing
budgets. The evaluation process, and the technology at its disposal, however, also
have their limitations. For this reason, evaluation processes must be applied with
modesty and honesty, but also with firmness.
References
Comisión asesora para el desarrollo del programa de prevención del consumo de drogas
(1993), Prevención en drogodependencias. Documento-marco, Colección Drogodepen-
dencias 10, Santiago de Compostela, Consellería de Sanidade, Xunta de Galicia.
Consellería de Sanidade e Servicios Sociais (2000a), Plan de Galicia sobre drogas
1997–2000, Colección Drogodependencias 22, second edition, Santiago de Compostela,
Consellería de Sanidade, Xunta de Galicia.
Consellería de Sanidade e Servicios Sociais (2000b), Manual del Sistema para la evaluación
de los programas de prevención e incorporación social, Santiago de Compostela, Consellería
de Sanidade, Xunta de Galicia.
Consellería de Sanidade e Servicios Sociais (1996), Lei de Galicia sobre drogas, Colección
Drogodependencias 20, Santiago de Compostela, Consellería de Sanidade, Xunta de Galicia.
Consellería de Sanidade e Servicios Sociais (1994), Sistema de evaluación asistencial (SEA),
Santiago de Compostela, Consellería de Sanidade, Xunta de Galicia.
Equipo de Investigación Sociológica (EDIS) (2000), O consumo de drogas en Galicia V,
Colección Drogodependencias 23, Santiago de Compostela, Consellería de Sanidade, Xunta
de Galicia.
EDIS (1996), O consumo de drogas en Galicia IV, Colección Drogodependencias 21,
Santiago de Compostela, Consellería de Sanidade, Xunta de Galicia.
EDIS (1994), O consumo de drogas en Galicia III, Colección Drogodependencias 18,
Santiago de Compostela, Consellería de Sanidade, Xunta de Galicia.
59
Chapter 4
EDIS (1992), O consumo de drogas en Galicia II, Colección Drogodependencias 11, Santiago
de Compostela, Consellería de Sanidade, Xunta de Galicia.
EDIS (1988), O consumo de drogas en Galicia I, Colección Drogodependencias 1, Santiago
de Compostela, Consellería de Sanidade, Xunta de Galicia
Further reading
Amigo Quintana, M., et al. (1995), Materiais Didácticos para a prevención do consumo de
drogas, Programa de Educación para a Saúde na Escola, Santiago de Compostela, Consellería
de Sanidade e Servicios Sociais, Xunta de Galicia, and Consellería de Educación e
Ordenación Universitaria.
Wagensberg, J. (1994), Ideas sobre la complejidad del mundo. Colección metatemas,
Barcelona, Tusquets editores.
60
Recent progress in evaluation
Improving 
drug-prevention
practice PaR
T
II

63
Introduction
n Chapter 5, Christoph Kröger examines how the EMCDDA’s Guidelines for the
evaluation of drug prevention have been both distributed and implemented at
European level. He describes the quantitative (number of guidelines distributed
per country) and qualitative (interviews with users) methods used to evaluate the
manual’s impact, and the settings in which the guidelines have been most com-
monly applied.
Gregor Burkhart continues this theme in Chapter 6, explaining how different EU
Member States have adapted the guidelines to their national contexts and highlight-
ing two case studies, one from France and one from Italy. He then describes other
EMCDDA initiatives to promote the evaluation of drug prevention, including the
Exchange on drug demand-reduction action (EDDRA) information system and the
Evaluation instruments bank. The author concludes by identifying how such tools
could be further developed to better serve the needs of European drug-prevention
professionals.
In Chapter 7, Krzysztof Ostaszewski and his colleagues demonstrate how a US
primary-prevention programme aimed at reducing drinking among schoolchildren
was modified for use in Polish schools. The authors explain how the US material was
adapted to a different cultural context, and describe the initial pilot study as well as
the design, procedure and results of an outcome evaluation of the programme. The
chapter concludes with the lessons learned from this innovative experience.
Amador Calafat examines drug-prevention initiatives targeted specifically at recre-
ational drug users in Chapter 8. He identifies the characteristics and significance of
this relatively new phenomenon and describes the forms of prevention that have
grown up in Europe in response to it. The author then suggests concrete ways of
raising awareness of the specific problems associated with recreational drug use and
of improving both preventive interventions themselves and their evaluation.
I

Chapter 5
Implementing the EMCDDA Guidelines for
the evaluation of drug prevention
Christoph Kröger
In 1996, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
began to promote the evaluation of drug-prevention interventions. One of the
Centre’s strategies to demonstrate the importance of such assessments was to develop,
test and distribute guidelines for the evaluation of drug prevention.
The guidelines were drafted by the German national focal point of the Reitox net-
work, the Institut für Therapieforschung (IFT), Munich, with the assistance of drug-
prevention and evaluation experts from other European Member States and from the
National Institute on Drug Abuse (NIDA) in the United States. A draft version of the
guidelines was tested in a feasibility phase in 1997 with the participation of 20 pro-
jects from 13 EU countries. The final version of the guidelines was then translated
into all 11 official EU languages and distributed as a working document in both
paper and electronic format. In autumn 1998, the Guidelines for the evaluation of
drug prevention were published in English (EMCDDA, 1998).
The EMCDDA contracted the Centro de Estudios sobre la Promoción de la Salud
(CEPS), Madrid, and the IFT to monitor and evaluate the distribution and imple-
mentation of the guidelines from August 1998 to May 1999 and to obtain feedback
from recipients about how they were planning to use the manual. The national focal
points of the Reitox network and other national partner organisations were asked to
distribute the guidelines free of charge and to record to whom they were sent. A flyer
providing information on the manual’s aim and content and an order form were 
produced to be distributed as and when it was deemed appropriate. A feedback
sheet was also developed and attached to the guidelines which the recipients were
asked to complete and return to a national address.
Almost 1 200 copies of the guidelines were distributed by the EMCDDA, its 
national partners, CEPS and the IFT between April and December 1998 (see Table 1
below).
Table 1 shows that a maximum of 263 and a minimum of two copies were distrib-
uted per country. These figures should, however, be interpreted with caution since
they are unlikely to reflect the actual numbers of copies circulated in a specific
country, but only those recorded by the national partners. Paper and electronic
copies may well have been made and distributed without the knowledge of the
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national partners. It should also be borne in mind that some institutions were unable
to document their dissemination very accurately because of a high workload and/or
other priorities.
During the nine-month period, almost 500 completed feedback sheets were re-
ceived. Table 2 below shows that most recipients intended to use the guidelines for
drug-prevention work in schools and the community.
The feedback sheets did not, however, give information on how the recipients
actually used the guidelines. Instead, telephone interviews were conducted with a
randomly selected sample of 25 of the 69 German recipients who returned the feed-
back sheet. All recipients had received the guidelines about 12 months prior to the
interview. The semi-structured interview included the following questions:
• Did you receive the guidelines?
• Did you read the guidelines?
• Did you apply the guidelines?
The sample was also asked for detailed (qualitative) feedback and to rate different
aspects of the guidelines.
Figure 1 below shows the main results of the interviews. Three of those interviewed
(12 %) did not remember the guidelines, although a feedback sheet with their names
had been received. Six interviewees (24 %) remembered ordering and receiving the
guidelines, but had not yet read them. The majority of the recipients (64 %) said that
they had read at least parts of the guidelines and about 28 % had also used the
guidelines in their work.
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Table 1: Number of copies of the guidelines distributed, April to December 1998
Country No of copies
Belgium 84
Denmark 263
Germany 173
Greece 38
Spain 132
France 22
Ireland 32
Italy 51
Luxembourg 8
Netherlands 9
Austria 41
Portugal 86
Finland 32
Sweden 2
United Kingdom 205
Non-EU 7
Total 1 185
These figures may appear disappointing at first glance, but could have been ex-
pected given that the copies of the guidelines were given away for free. This may
well have encouraged people to order them without really intending to use them.
Extrapolating cautiously from these figures, it can be assumed that about 600 people
in the EU Member States were not only interested in, but also read, the guidelines,
and this should be seen as an encouraging first result. The readiness of the target
group to apply the guidelines in planning drug-prevention evaluations appears to be
at an intermediate phase. Using a model of eight stages of readiness, this phase can
be characterised as ‘pre-planning’ or ‘preparation’. The eight stages of readiness are:
• no awareness;
• denial;
• vague awareness;
• pre-planning;
• preparation;
• initiation;
• standardisation; 
• professionalisation.
Drug-prevention practitioners in Europe clearly have more than just a vague aware-
ness of the guidelines and the need for evaluation measures in their field. While they
appear interested and motivated to engage in evaluation, they are not yet at the
stages of standardisation or professionalisation.
Conclusions
Implementation of the Guidelines for the evaluation of drug prevention is a long-term
process that is still at an early stage, but first results should encourage their further
distribution. This future dissemination relies, however, on personal and institutional
engagement which in turn depends on how important this task is considered as well,
inevitably, as the resources available. Both the motivation of the institutions respon-
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Table 2: Drug-prevention field in which the guidelines were intended for use
Drug-prevention field No of respondents % of respondents
School programme 112 23.1
Community programme 102 21.1
Recreational youth setting 67 13.8
Early-childhood intervention 55 11.4
Mass-media campaign 42 8.7
Outreach work 31 6.4
Telephone help-line 16 3.3
Other 59 12.2
Total 484 100.0
sible for the distribution (in the first instance the Reitox national focal points) and
their capacity to undertake this task need to be enhanced. This could be achieved by
identifying national ‘key persons’ and encouraging them to distribute the guidelines.
More active advertising in newsletters or at conferences is also necessary.
While the Guidelines for the evaluation of drug prevention clearly cannot, and
should not, substitute personal communication and training, they do already play 
an important role in promoting both the concept and practice of evaluation in the
drug-prevention field.
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12 %
24 %
36 %
Did not remember the
guidelines
Read the guidelines, but
did not use them
Read the guidelines and
used them
Did not read the
guidelines
28 %
Figure 1: Results of telephone interviews with 25 German recipients of the guidelines
Chapter 6
EMCDDA tools for evaluating drug
prevention 
Gregor Burkhart
The first tool developed by the European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) to promote the evaluation of drug prevention was the
Guidelines for the evaluation of drug prevention (EMCDDA, 1998). In monitoring
and evaluating how the guidelines were received by drug-prevention professionals
in Europe (30), the EMCDDA obtained valuable information about the manual’s utili-
ty, together with indications of areas for further development and new issues to be
addressed.
In a second phase, some EU Member States have gone further than simply distribu-
ting the guidelines and collecting feedback, and have adapted them to their specific
national contexts. These national interpretations have both broadened the original
scope of the manual and provided further inspiration for improving evaluation 
practice. Two examples of national adaptations, one from France and one from Italy,
are described below and demonstrate the types of initiative currently under way in
the EU to develop new tools to support the evaluation of drug prevention.
France
The French adaptation of the EMCDDA guidelines added information about the
organisational and management aspects of evaluation to ensure that all available
background information would be accessible to drug-prevention project managers
in France. This initiative reflects the growing evaluation culture in France which is a
priority of the Mission interministérielle de lutte contre la drogue et la toxicomanie
(MILDT, 1999).
Among the innovative aspects of the French version of the manual is the emphasis
it places on project management and decision-making. In this context, project
management includes:
• forecasting;
• monitoring the implementation of the programme and assessing the relevance of
its individual components; 
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(30)  This process is described in detail in Chapter 5.
• adapting the project design to new developments and integrating new elements
as required.
Decision-making involves:
• endorsing and justifying activities;
• reusing a successful approach in other settings; 
• allocating budgets.
The French version of the guidelines asks key questions such as:
• Why undertake the evaluation?
• Who is the evaluation for?
• How should it be managed?
• What can be evaluated?
The practical evaluation questions, however, are very close to those in the original
EMCDDA version, although illustrative examples are taken from a French evaluation
study (Choquet and Lagadic, 1997).
Italy
In Italy, a working group of experts from Ancona, Bergamo, Ferrara, Modena, Rome,
Turin and Urbino has adapted the guidelines to the specific needs of Italian drug-
prevention practice. The EMCDDA version was considered too focused on drug
abuse as the object of prevention programmes whereas most Italian initiatives were
more concerned with social interaction, well-being and more general aspects of
health promotion.
This view illustrates a persistent misconception regarding the EMCDDA’s guidelines
which, as a universal pan-European tool, intentionally do not refer to the specific
concepts, theories, strategies or intermediate objectives found in the literature which
could be used to tackle the problem of drug abuse. Instead, the manual aims to be
neither context- nor culture-specific.
Identifying the most suitable theoretical and strategic framework for a drug-
prevention programme in whatever country or region is the task of the programme
leader. There is an apparent need among practitioners for more explicit statements
and support in formulating the intermediate objectives (such as enhancing social
competence and life skills) and final goals (preventing drug use or abuse) of speci-
fic programmes. While the EMCDDA’s evaluation guidelines leave this task to the
programme leaders, the Italian version includes explicit advice for formulating 
programme objectives. In referring to a concrete set of theories and strategies, 
the Italian adaptation is more explanatory than the EMCDDA original, albeit also
more limited in scope.
The Italian guidelines include flow-chart-like sequences of questions for several
topics, for example:
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objectives?  indicators?  how? (instruments)  when? (planning)  who?
(actors and target group)
These questions are based on those used to collect national data on drug demand-
reduction programmes for inclusion in the EMCDDA’s Exchange on drug demand-
reduction action (EDDRA) information system, and the logical sequence of these
questions underlines the importance of internal coherence in evaluation and pro-
gramme description (31). These questions could be further developed to create an
interactive electronic tool that would ask relevant questions for evaluation in the
right sequence depending on the specific context and stage of a particular 
programme. Such an electronic tool could also integrate the EDDRA questionnaire
— which would both adapt it more effectively to the working practices of the
programme teams and facilitate its completion — as well as basic definitions of
evaluation concepts.
Another interesting feature of the Italian adaptation is the use of socio-demographic
mapping to show changes in relationships between groups and neighbourhoods.
This information can facilitate the more effective allocation of resources, needs
assessment and evaluation.
COST A-6: Evaluation of action against drug abuse in Europe
The publication Evaluation research in regard to primary prevention of drug abuse
(Springer and Uhl, 1998) of the Evaluation of action against drug abuse in Europe
(COST A-6) working group reiterates the need for a clear definition of evaluation
concepts. In the words of Springer and Uhl, ‘everything nowadays is evaluation’.
The EMCDDA guidelines, however, are based on a more ‘common-sense’ than
scientific understanding of the concept of evaluation, and it may now be necessary
to redress this by classifying the types of evaluation referred to according to the
more scientific COST A-6 definition. The work of this group has also highlighted the
need to include ethical considerations on evaluation in future versions of the
EMCDDA guidelines.
Evaluation and EDDRA training
To distribute the EMCDDA guidelines and to expect drug-prevention practitioners to
use them is, however, insufficient. Programme leaders need training in applying
even minimal evaluation standards in order to accept that evaluations do not have
to be carried out at expert level. Above all, practitioners need to be able to see the
concrete benefits of evaluation. These benefits include being part of a network of
information exchange and making their programmes publicly accessible via systems
such as EDDRA, thus gaining greater visibility for their work.
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(31)  The EDDRA information system is discussed in greater detail in Chapters 11 and 12.
As a result, the EMCDDA is jointly organising with the Reitox national focal points
training seminars in the EU Member States. These seminars are designed to promote
evaluation practice among both professionals and regional decision-makers, and to
enhance the skills necessary for working with the EDDRA system and for com-
pleting the EDDRA questionnaire. These workshops will also be a valuable source
of feedback and suggestions from the field and will further strengthen the link be-
tween the EMCDDA and demand-reduction practice at EU level.
Evaluation instruments bank
The Guidelines for the evaluation of drug prevention and the EDDRA information
system are not the only EMCDDA tools devised to promote evaluation. The
Evaluation instruments bank (EIB) is a database of tools for assessing both drug-
prevention and treatment initiatives (32). All the instruments for evaluating drug-
prevention programmes contained in the bank are freely downloadable. Some of the
tools for evaluating treatment, however, are protected by copyright and, while they
cannot be freely downloaded, are all fully indexed and described with clear indi-
cations of where they can be obtained.
The bank contains over 150 prevention and treatment evaluation instruments to-
gether with three search mechanisms allowing for the rapid identification of the
most suitable tools for the user’s needs. The tools are presented according to the
structure of the EMCDDA’s evaluation guidelines, with a selection of instruments
provided for each phase of a drug-prevention programme from planning to summa-
tive evaluation. The instruments included are those that have been found to be of
most value and are most frequently cited in drug-prevention literature. The criteria
used in the selection were:
• evidence of reliability and validity;
• ease of understanding;
• adaptability; 
• grounding in current practice.
In creating the EIB, over 1 600 scientific and grey-literature publications were re-
viewed, more than 200 experts and practitioners responsible for developing
treatment-evaluation tools were contacted, while the prevention instruments included
in the bank and the rationale for their selection were analysed by a group of 12 experts
from across the EU. Over 250 treatment-evaluation tools were reviewed and their
scientific quality evaluated, and around 100 have been included in the bank.
Information is provided on the content, utility, scientific quality, accessibility, copy-
right, cost and source of each tool. All the treatment instruments accessible in the
EIB are original, and their references have been published in the scientific 
literature. The bank includes summaries of more than 900 studies with links to 
specific instruments, and full bibliographies and references are available for all the
tools and studies included.
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(32)  The EIB will be available on-line via the EMCDDA website during 2000. 
As a next step, the EMCDDA will add a mailing list for a direct-discussion forum of
interested professionals to encourage feedback and proposals for the inclusion of
more instruments or for their translation into other European languages. While the
EIB currently only contains instruments in English, the database was designed to
allow tools to be uploaded and accessed in several different languages. The
EMCDDA would welcome any translations of current or new instruments in
languages other than English.
Conclusions
The EMCDDA’s existing tools for promoting the evaluation of drug prevention could
be further developed in several ways.
Based on the Italian flow-chart idea, an integrated electronic version of the
Guidelines for the evaluation of drug prevention could be developed with additional
interactive features. This version would take the form of a computer programme that
would ask relevant questions for evaluation in the right sequence according to the
specific needs of an individual project. Such a tool could also include the EDDRA
questionnaire and basic definitions of common concepts in evaluation, plus the
EMCDDA’s forthcoming guidelines for the evaluation of outreach work (33).
Integrating these elements into a single interactive instrument would enable practi-
tioners to identify more effectively those aspects of evaluation relevant to their
specific situation.
Another significant contribution the EMCDDA could make in this area would be to
use its central position in the Reitox network to create a pool of evaluation expe-
riences, ideas, methods and theories. Information on the most common European
approaches and strategies for drug prevention already held by the EMCDDA — in
large part through the EDDRA system — could then be channelled back to
European demand-reduction professionals.
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(33)  The EMCDDA’s guidelines for the evaluation of outreach work will be available in 2001.

Chapter 7
Evaluating innovative drug-prevention
programmes: lessons learned
Krzysztof Ostaszewski, Krzysztof Bobrowski, Anna Borucka,
Katarzyna Okulicz-Kozaryn, Agnieszka Pisarska
Research has demonstrated that involving parents and peer leaders in drug-
prevention initiatives targeted at young people may be a valuable approach since
both parental and peer behaviour have been shown to influence the health-related
choices made by adolescents. Parental involvement in drug-prevention initiatives
may improve parent–child communication about substance use (Williams et al.,
1995a; Toomey et al., 1997; Williams and Perry, 1998; Williams et al., 1999), and
may also influence young people’s choice of non-drug-using friends (Rohrbach et
al., 1995). Similarly, it has been shown that involving peer leaders in drug-
prevention initiatives may improve their effectiveness (Schaps et al., 1981; Tobler,
1986; Klepp et al., 1986; Perry et al., 1989; Botvin et al., 1990; Komro et al., 1994;
Perry et al., 1996).
In Poland, a number of new drug-prevention initiatives involving parents or peer
leaders have been implemented over the past decade. However, low parental parti-
cipation and logistical problems with using peer leaders, such as the extra burden
this adds to their school timetable, can be serious obstacles. In this context, a two-
year research project was launched by the Institute of Psychiatry and Neurology in
Warsaw to adapt and evaluate an innovative US primary-prevention programme for
fifth-grade schoolchildren, involving both parents and peer leaders, with a view to
replicating it in Polish schools as a component of local-community drug-prevention
action. The US programme, the Slick Tracy Home Team Program, was developed
and evaluated by a team from the University of Minnesota as part of Project
Northland (Perry et al., 1993; Williams et al., 1995a; Perry at al., 1996). The project
was recommended to the Institute of Psychiatry and Neurology by the US National
Institute on Alcohol Abuse and Alcoholism.
The Slick Tracy Home Team Program aims to prevent under-age drinking and consists
of five teacher- and peer-led sessions combined with parent–child activities to be
undertaken at home. Four booklets, one to be worked through each week, provide
information on under-age drinking, alcohol advertising and modelling, peer pressure
and the consequences of alcohol consumption. The activities in the booklets are de-
signed to facilitate parent–child communication about alcohol and other substance
use and to establish effective family rules to deal with under-age drinking. Elected peer 
75
leaders, trained by their teachers, introduce each booklet to their classmates and
encourage them to participate in the activities with their parents. Pupils receive small
incentives, such as sweets or pens, to encourage their active participation. At the end
of the programme, a family evening is organised at which pupils present posters to
their parents. The entire programme requires about 10 weeks to complete.
The Polish version of the US programme, Program Domowych Detektywów
(Ostaszewski et al., 1998), is the result of:
• adapting the US teaching material to the Polish context;
• a pilot study focusing on cross-cultural adaptation of the programme; 
• an outcome evaluation.
Evaluation of the programme consisted of a pilot study held in the 1997/98 school
year, and an outcome study held in 1998 to 1999. Routine implementation of the
programme began in the 1999/2000 school year and included producing materials,
promoting the initiative and teacher training. The project followed to some extent
the six-phase model of the process leading to the implementation of drug-
prevention programmes (Uhl, 1998). These six phases are:
• basic research;
• prevention research;
• concept;
• development;
• testing; 
• routine implementation.
Pilot study, 1997 to 1998
The pilot study (n = 90) used a combination of qualitative and quantitative methods,
including observing classroom activities, analysing programme documentation,
focus-group interviews with teachers, telephone interviews with randomly selected
parents and pre- and post-test self-report questionnaires for students. The results of
the pilot study showed that the programme functioned well in Polish schools
(Ostaszewski et al., 1998). This is borne out by the positive opinions expressed by
all groups involved in the programme — teachers, students and parents — and by
direct observations.
Essential aspects of the pilot study were:
• high rates of parental participation in the programme (about 80 % of parents
took part in one or more activities);
• high quality of the programme delivery (including adequate peer-leader
involvement) which resulted in good student engagement in the programme;
• positive feedback from teachers; 
• positive feedback from both pupils and parents concerning the programme as a
whole as well as its individual elements.
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However, the evaluation also identified two problem areas: the poor participation 
of children at risk of low academic achievement; and some limitations in teacher–
parent cooperation. Of the six students (7 %) who did not participate in the home
activities, all experienced problems at school. According to the teachers, the low
participation of these pupils was associated with alcohol-related problems in their
families. It is estimated that in Poland between 2 and 4 % of children live with an
alcohol-dependent parent and an additional 14 % of children have at least one
parent who regularly abuses alcohol (Sieroslawski, 1997). The pilot study helped
identify that during the programme some children at risk would need special atten-
tion or individual care from their teachers.
The second problem concerned teacher–parent cooperation. It was quite a new exper-
ience for teachers to share responsibility for delivering the programme with parents
and, as a result, the teachers questioned whether the parents actually undertook the
booklet activities with their children and if they really read the materials designed for
them. The teachers felt that they should have greater control over what their pupils
were taught during the programme. This opinion reflects a more general problem in
the Polish school system — the low level of cooperation between schools and parents
and the lack of partnership between them. As a result of the pilot study, the following
modifications were made to improve teacher–parent cooperation:
• a leaflet was produced aimed specifically at parents;
• new content was added to the teacher manual to explain in more detail the 
specific roles of parents, teachers and peer leaders in the programme;
• several new presentations were included to stimulate parental participation in
the family evening; 
• it was recommended that teachers obtain parental consent before the start of the
programme.
Teacher training was adapted to give precise advice on how to work with pupils
whose parents did not participate in the booklet activities.
Outcome evaluation, 1998 to 1999
Design and subjects
The second phase of the evaluation focused on immediate outcomes and adopted a
quasi-experimental design. The quality of the programme delivery was also controlled.
The study sample (n = 440) consisted of fifth-grade pupils in 10 primary schools from
Mokotów, a district of Warsaw. The school authorities agreed to participate in the pro-
gramme and accepted random assignment to either the intervention or reference
group. Five schools were assigned to the intervention group (n = 231) and five to the
reference group (n = 209), which took part in the programme the following term.
The outcome evaluation was based on a self-report questionnaire. Pupils were
assessed in their classrooms by trained staff at pre-test (September 1998) and at post-
test (December 1998). Of the students monitored at post-test, 11 % dropped out
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leaving 393 (89 % of the original sample), and there were no differences in attrition
rates between the intervention and reference groups. Eleven students (five from the
intervention and six from the reference groups) were removed from the analysis
because of inconsistent responses to at least three different questions. Thus the final
study sample in the outcome analysis consisted of 382 students — 203 in the inter-
vention and 179 in the reference group — or 87 % of the original study sample.
There were no baseline differences between the groups in terms of the age of the
pupils (the average age in both groups was 11.5 years at pre-test) or their family
composition (86 % in the intervention group and 85 % in the reference group lived
with two parents). Although the gender composition differed between the groups
(54 % of the intervention group were boys compared to 48 % in the reference
group), this variation did not reach statistical significance.
Scales of measurement
The main variables of interest were:
• alcohol use;
• intention to use alcohol;
• peer norms;
• parent-child communication about the consequences of drinking and smoking;
• perceived resistance skills; 
• alcohol-related knowledge.
Of the six scales used to measure these variables, four (alcohol use, intention to
drink, peer norms and resistance skills) met the statistical criteria for sufficient relia-
bility and validity (Ostaszewski et al., 1999). The scale concerning parent-child
communication demonstrated high internal consistency (alpha — 0.79), but some
limited support for the construct validity. Although the alcohol-related knowledge
scale did not perform well, either in reliability or construct-validity analyses, it was
not excluded as there was no better multiple construct to measure the relevant
knowledge. Scales were scored by adding the points for each individual item, with
equal weights given to them.
Table 1 shows the characteristic of the six scales, examples of the individual items,
and the internal coefficients and main source for each scale. Frequency of cigarette
smoking and demographic variables were measured by single items.
Procedure
The Program Domowych Detektywów was implemented in the five intervention
schools as part of the curriculum between October and December 1998. Teachers
and school coordinators were given relevant materials and trained by programme
staff in two four-hour sessions, and parental consent to the use of the programme in
each school was obtained before the programme began. Peer leaders were elected
by their classmates and trained by their teachers, and ‘rewards’ were given to parti-
cipating pupils on completion of the first two booklets. The family evening parties
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were organised by teachers and school coordinators and parents were also actively
involved in three schools. Each student who completed a presentation received a
special diploma, and sweets, cakes and refreshments were also available. Teachers
and school coordinators received a small amount of funding towards the cost of the
evening from Warsaw school authorities.
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Table 1: Characteristics of the six scales used in the study
Scale Items or examples of items Alpha Main source of the 
coefficient scale or items
Alcohol use Q: ‘How often have you drunk Adapted from Johnston
(four items) (a) alcohol: in your lifetime, in the last 0.74 et al. (1993), Williams et
year, in the last month, in the al. (1995b)
last week?’
A: ‘never’, ‘once’, ‘twice’, 
‘three or more times’
Intention to Q: ‘How likely is it that you will Adapted from Johnston
use alcohol drink alcohol: in your lifetime, 0.70 et al. (1993), Williams
(three items) in the next year, in the next month?’ et al. (1995b)
A: five, ranging from ‘I would not 
drink’ to ‘I would drink’
Peer norms Q: ‘Does your best friend drink Adapted from Williams
(six items) alcohol?’ 0.63 et al. (1995b)
A: ‘yes’, ‘no’
Q: ‘How many of your friends 
smoked cigarettes last month?’
A: four, ranging from ‘none’ to 
‘more than half’
Parent-child Q: ‘Do your parents talk to you Adapted from Williams
communi- about the problems drinking 0.79 et al. (1995a)
cation (three alcohol can cause young people?’
items) A: ‘yes’, ‘no’ 
Perceived Q: ‘How sure are you that could Adapted from Williams
resistance say “no” if you were offered 0.74 et al. (1995b)
skills alcohol in the following situations:
(five items) at a friend’s house?...’
A: five, ranging from ‘I could say 
“no”’ to ‘I could not say “no”’
Alcohol-re- Q: ‘Alcohol gives people energy’, Adapted from Williams
lated know- ‘Beer, alcohol and wine advertise- 0.40 et al. (1995a)
ledge ments try to get people my age to
(five items) think it’s cool to drink’
A: ‘yes’, ‘no’, ‘don’t know’
NB:
(a) Alcohol use  = more than one sip of beer, wine, vodka or champagne.
Results of the process evaluation
The process evaluation was based on a combination of qualitative and quantitative
methods:
• post-test questionnaires for students (n = 226) and parents (n = 158);
• two group interviews with teachers (n = 10); 
• analyses of programme documentation.
The evaluation found that the programme had been fully implemented in all inter-
vention schools. According to self-report data from both students and parents, over
90 % of the students participated in the booklet activities, most frequently with their
mothers. Similar rates were identified from the teachers’ classroom records. Girls,
pupils in two-parent families and ‘good’ students were significantly more likely to
complete more booklets. The rate of participation in the family evening was also
high, with 74 % of students attending, 56 % with at least one parent.
Teachers were given two alternative methods of selecting peer leaders in the classroom:
election from a whole group of students; or election from small, pre-selected groups.
Although most of the choices were based on student popularity, group interviews with
teachers established that the procedure differed from class to class. Some teachers
modified the recommended method in different ways, while others tried to influence
the selection. In a few classes, the election caused some competition between candi-
dates, but according to the teachers this was only a marginal problem. Furthermore,
there were no significant differences in satisfaction rates between peer leaders and
participating students, which suggested that peer leaders were accepted in their new
roles. In addition, being a leader was perceived by students as an honour. In the tea-
chers’ opinions, the trained peer leaders were very motivated and fully engaged in the
programme activities. Although they experienced some difficulties with discipline in
activities with small groups, they generally performed their tasks well or very well.
The process evaluation also identified some significant differences in the quality of
the programme delivery. Students from three classes reported significantly lower rates
of participation in the activities and much lower rates of satisfaction (see Table 2).
Analyses of documentation and interviews with teachers confirmed that in these
three classes there had been some defects in the programme implementation —
such as shortening the classroom activities and poor preparation of the family eve-
ning — as well as inadequate cooperation between the school staff involved in the
programme, insufficient parental acceptance of the programme and lack of
commitment by the school authority. In this context, it was concluded that quality
of programme delivery might be an important aspect of routine implementation.
Results of the outcome evaluation
Pre-test equivalence
There were no significant baseline differences between the intervention and refe-
rence groups in all alcohol-use and smoking items (see Table 3). A high percentage
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of 11-year-olds reporting alcohol use in their lifetime and the previous year was pro-
bably caused by including champagne in the list of alcoholic beverages. Some chil-
dren may, for example, have reported alcohol use after having more than a sip of their
parents’ champagne during a New Year’s Eve party. There were no significant discre-
pancies at pre-test in other outcome variables. Only one difference was identified —
parents of pupils in the intervention group used alcohol more frequently at home: 
p < 0.05. This variable — besides gender — was controlled in the outcome analyses.
Outcomes
Analyses of the differences between the intervention and reference groups were
tested using multiple analysis of variance (Manova) with an individual subject as the
unit of analysis. In the first step, differences in alcohol use were analysed and in the
second step the other five scales were analysed together. Comparison of the varia-
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Table 2: Programme participation and satisfaction rates in the intervention group
Seven classes Three classes Chi- p
(n = 172) (n = 59) square
% participation in three 94 64 33.5 p< 0.001
or four booklets (a)
% participation in the family  65 24 24.6 p< 0.001
evening (student plus parents) (b)
% of highly or very highly  75 37 23.6 p< 0.001
satisfied students (b)
NB:
(a) Identified from teachers’ classroom records.
(b) Identified from students’ self-report questionnaires.
p = level of significance.
Table 3: Alcohol and cigarette use in the intervention and reference groups at pre-test
% Intervention % Reference Chi- p
group group square
(n = 203) (n = 179)
Alcohol use (a) 
Lifetime  68.1 61.3 1.79 n.s.
Last year 41.9 37.8 0.63 n.s.
Last month 12.0 10.1 0.35 n.s.
Last week 6.3 3.6 1.37 n.s.
Cigarette smoking (b) 21.2 17.4 0.86 n.s.
NB:
(a) Alcohol use  = more than one sip of beer, wine, vodka or champagne.
(b) Any use of cigarettes.
n.s.  = not significant.
p = level of significance.
tions using the six main scales suggested a significant reduction in alcohol use 
(p < 0.02) and intention to drink (p < 0.03) among students in the intervention
group. The programme was also effective in increasing pupils’ knowledge about the
consequences of alcohol drinking (p < 0.001) and parent–child communication
about the effects of both alcohol and cigarette use (p < 0.03). There were no signi-
ficant divergences on two scales concerning peer norms and resistance skills (see
Table 4). In addition, the results based on a single item suggested a reduction in the
frequency of cigarette smoking (f = 4.09; p < 0.05) among the intervention group.
Because of the significant defects in programme delivery in three classes, additional
analyses were conducted to check whether these problems might have produced nega-
tive side effects. Results of these additional analyses suggested that in one of the classes
undesirable side effects could have occurred in teacher–parent cooperation.
Lessons learned
Evaluation demonstrated that administering the prevention programme via booklets
from classrooms to families is a very effective way of involving parents in drug-
prevention activities aimed at children aged 11 to 12. With 80 to 90 % of parents
participating in one or more parent–child activity, this method is much more effec-
tive than more traditional ones, such as training in parenting skills or workshop activ-
ities organised in schools (Ferrer-Perez, 1994). However, in Poland, cooperation
between schools and parents is a very sensitive component of the programme and
should be carefully planned. The majority of parents should consent to the use of
the programme before it begins which entails making available accurate information
about the programme content, organisation and expected results. In addition, pupils
whose parents do not participate in home activities require individual care and, if
necessary, a ‘parent substitute’ from the school staff.
Using elected and trained peer leaders in the classroom activities was both feasible
and well received by teachers and pupils alike, suggesting that peer leadership
based to some extent on popularity is accepted among this age group in Polish
schools. These results were similar to US experiences with elected and trained peer
leaders of the same age in health-promotion programmes (Klepp et Al., 1986).
However, cooperation between peer leaders and teachers is a fairly new idea in
Polish schools, and teachers tend to have their own opinion about the ability of their
students to play such a role. This probably explains why some teachers wanted more
influence on the selection of peer leaders. Problems of competition between candi-
dates reported by some teachers could no doubt be reduced by using a selection
procedure in which pupils would not be told beforehand that they were selecting
peer leaders. This procedure should be better explained during teacher training.
The study also emphasised the role of qualitative evaluation methods during the
cross-cultural adaptation of a drug-prevention programme and the assessment of its
effectiveness. For example, group interviews with teachers allowed the programme
staff to understand the barriers in school–parent cooperation which was crucial for
developing adequate solutions.
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Conclusions
Although positive evaluation results mean that use of the programme in local-
community alcohol-prevention initiatives can be recommended, defects in routine
implementation may impair its effectiveness or even cause undesirable side effects.
To ensure the quality of the programme delivery, teacher training is needed as well
as simple evaluation standards to be used during routine implementation.
According to the process evaluation results, the following aspects of programme
implementation should be monitored:
• rates of parent–child booklet activities (with an expected 80 to 90 % of students
working with parents on three to four booklets);
• rates of parental participation in the family evening event (with an expected 
50 to 60 % of parents attending); 
• rates of student satisfaction (with over 60 % of pupils being highly or very high-
ly satisfied).
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Table 4: Comparison of students in the intervention and reference groups on six main scales
Scale Conditions Mean df F-statistics p
Intervention   Reference
n = 174 n = 151
Alcohol use pre-test 2.56 2.09 1 5.54 p < 0.02
(0–2) post-test 2.94 3.07 323 +
n = 168 n = 156
Intention to use pre-test 2.33 2.06 1 5.28 p < 0.03
alcohol (0–12) post-test 2.77 3.17 322 +
Peer norms (0–18) pre-test 1.23 1.03 1 2.78 n.s.
post-test 1.71 2.14 322 +
Parent–child com- pre-test 1.99 2.24 1 4.99 p < 0.03
munication (0–3) post-test 2.32 2.30 322 +
Perceived resis- pre-test 1.43 1.82 1 0.09 n.s.
tance skills (0–20) post-test 2.05 2.56 322 +
Alcohol-related pre-test 2.85 2.92 1 25.20 p < 0.0001
knowledge (0–5) post-test 3.51 2.91 322 +
Cumulative effect s = 1 6.81 p < 0.001
for the five scales m = 11/2 +
n = 158
NB:
Numbers in parentheses indicate the range of values for each scale.
+  = changes in expected direction.
df  = degree of freedom.
p  = level of significance.
n.s.  = not significant.
Most drug-prevention studies have to deal with common methodological problems
concerning statistical analyses, measurement procedures, comparability of groups
and attrition rates (National Institute on Alcohol Abuse and Alcoholism, 1997).
While several of these problems seem to have been adequately addressed in the
Polish study, some important limitations need to be mentioned here. The most 
significant constraints were the lack of any delay between the end of the interven-
tion and follow-up, the relatively small sample and the problem of units of analysis.
The statistical methods used in the individual-level prevention studies require the
same units to be assigned to experimental conditions as are used in the analyses. In
the Polish study, this was not possible because of the small sample. As a result, a
school was used as a unit of randomisation and an individual as a unit of statistical
analysis. It is worth noting that almost all of these problems were caused by serious
limitations in funding.
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Chapter 8
Reviewing the prevention of
recreational drug use 
Amador Calafat
Characteristics and significance of recreational drug use
Over the last decade, recreational drug use has become one of the most widespread
forms of drug consumption and a major concern in Europe. At the same time, other
more traditional forms of drug use — such as heroin use — have become more
contained. Although recreational or weekend drug consumption mainly involves
alcohol and tobacco, other illicit substances are also widely taken, especially can-
nabis. Cannabis use has become very prevalent in much of Europe, irrespective of
its legal position in the individual Member States, and is followed in popularity by
ecstasy, amphetamines and cocaine.
The rise in use of certain drugs in recreational settings has coincided with the rapid
expansion of what might be called ‘recreational culture’ throughout western Europe.
Characteristic of this culture is the significant increase in the range of entertainments
the leisure industry offers to young people, not only in terms of the number of enter-
tainment venues and activities, but also of the much greater availability of time.
‘House’ and other dance music is one of the defining styles of this development, and
the importance of ‘raves’ in shaping this recreational culture — albeit not to the
same extent in all countries — cannot be ignored.
To address drug use so closely linked to a cultural movement requires understand-
ing and action at different levels and from different perspectives. In the recreational
context, these include:
• considering the entire recreational scene as a dangerous form of drug promotion
and urging campaigns to modify it and restrict its further expansion;
• accepting that alcohol and drug consumption is an established fact in recreational
environments which it is futile to try to restrict, and that the most urgently needed
and effective approach is to provide accurate information to help reduce problem
consumption and its associated behaviour among current consumers; 
• understanding that the recreational scene is a specific culture, which has posi-
tive effects on young people’s self-expression, social skills and maturity, but one
that has to be studied in order to understand the many factors involved.
Although alcohol, tobacco and cannabis are still the most widely used substances
in Europe, ecstasy is more typical than any other drug of this new era of recreational
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use. Ecstasy refers not only to one specific chemical compound — 3,4-methylene-
dioxy-N-methylamphetamine (MDMA) — but also to other related substances that
are consumed under this generic name. Ecstasy has become a symbol of some of
the most distinctive values of this recreational culture, including a certain type of
music and dancing and a way of establishing relationships.
The rapid spread of ecstasy has been enhanced by the properties attributed to it. It
was perceived at the end of the 1980s and early 1990s as being a relatively or com-
pletely harmless drug, encouraging contact between people at an affordable price,
although it was also acknowledged to be incompatible with the use of other sub-
stances, especially alcohol. For many people, including some professionals in the
drugs field, the apparent absence of side effects associated with ecstasy and the pos-
sibility of avoiding them by taking certain preventive steps (drinking water, resting
from time to time and not mixing ecstasy with other substances) created the illusion
that, used intelligently, the drug could be consumed without ill effects. All that was
necessary, then, was to provide young people with sufficient information to ensure
that they took the necessary precautions. If on-site testing could also demonstrate
that the tablets used were not adulterated — a preventive measure already intro-
duced in some European countries — where was the risk? Yet clinical and epidemio-
logical facts, ethnographic studies and tests carried out on both animals and human
beings have shown that ecstasy is not such a harmless drug after all.
The Sonar project, undertaken by the Institut de Recherches Européen sur les
Facteurs de Risque chez l’Enfant et l’Adolescent (Irefrea) with the financial support
of the European Commission, has, since 1996, been studying the issues and pro-
blems associated with drug use by young people in recreational environments. The
study is being carried out in towns and cities in nine European countries (34). To date,
the Sonar project has identified the diversity of forms of drug consumption in urban
areas, the various subgroups involved, differences between Member States and the
cultural characteristics associated with drug use. It has also provided information on
some forms of risk behaviour and risk perception. These data (Calafat et al., 1998,
1999) can help to focus preventive policies more effectively as well as pointing the
way for future studies (35).
Some of the conclusions of the Irefrea study (Calafat et al., 1998) were obtained
from a sample of 1 627 young people who habitually participate in weekend recrea-
tional activities in five European cities (36). Approximately half of these young people
served as a control group to increase the validity of the findings. According to this
research, ecstasy users:
• are more likely to be multiple substance users than other young people who go
out at night (control group);
• are more likely to indulge in abusive consumption (for example, get drunk more
frequently);
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(34)  Germany, Greece, Spain, France, Italy, Netherlands, Austria, Portugal and the UK.
(35)  These reports can be downloaded from (http://www.irefrea.org).
(36)  Coimbra, Modena, Nice, Palma de Mallorca and Utrecht.
• are not marginalised individuals, but do exhibit certain differences from the
control group, such as being more likely to be sensation seekers or to exhibit
behaviour symptomatic of greater social deviance, such as petty theft or fighting;
• tend not to consider ecstasy use as particularly risky and to have a more positive
view of its effects;
• are less interested in prevention; 
• have a greater interest in dance culture.
The fact that ecstasy users are less interested in preventive issues is important since
understanding their attitude towards prevention will help to target preventive activi-
ties more effectively and provide a clearer understanding of what they can be expec-
ted to achieve. A key factor for ecstasy users’ lack of interest in prevention is that
they want to experience the drug’s effects, which they view favourably, and they
therefore underestimate its possible risks. For example, in Coimbra — and similar
figures are found in other cities — 26 % of non-users believe that ecstasy is addic-
tive, compared to 1 % of users. In Utrecht — and, again, similar figures are found
in other cities — the unpredictable effects of ecstasy are a cause of concern to 
38 % of non-users, but to only 17 % of users. If, for example, the young people of
Palma de Mallorca are asked how important it is for them to know the chemical
composition of the ‘ecstasy’ they use, 33 % attach no importance at all to it, 55 %
say that they would be interested but that they use the tablets without any
problems, and only 11 % say that if they did not know the composition of the tablet
they would ‘prefer’ not to take it.
This ‘anti-preventive’ attitude is not surprising since the very concept of leisure time
involves a certain disregard for rules and an indulgence in risk behaviour. Of the
sample of 2 700 young people questioned during 1998 (Calafat et al., 1999), 60.8%
reported being drunk at least once a month. In so doing, they accepted a high level
of risk, demonstrated by the fact that 43 % had driven under the influence of alco-
hol and 30 % under the influence of another drug. Of those who had driven under
the influence of alcohol, 13.7 % had been fined for doing so, 13.4 % had been
involved in road accidents and 6 % had been arrested.
Yet experiencing problems associated with drug use is often not sufficient reason to
give them up, and among the same sample 29 % admitted having continued to use
a particular drug despite encountering problems with it. In most cases, the drug that
caused the majority of problems was alcohol (36.9 %), followed by cannabis
(19.9%) and ecstasy (14.0 %). Ultimately, it would appear that being a user auto-
matically reduces receptiveness towards prevention. This attitude is influenced by
many different elements, including the fact that initial experiences of a drug are rela-
tively easy to handle, or that being a user makes it necessary to create an intellec-
tual mechanism to justify such behaviour, not forgetting the fact that the existence
of risks may actually be regarded as a positive factor by the user.
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Preventing recreational drug use
At present, preventing recreational drug use is a relatively new and underdeveloped
field, and one which presents many challenges, both theoretical and practical. The
deep concern generated in Europe over the past 15 years by the scale of the recrea-
tional phenomenon and the appearance of substances such as ecstasy in this
context has made finding an appropriate preventive approach to these forms of drug
use and the circumstances in which they arise a matter of urgency.
Traditionally, drug-prevention programmes have focused mainly on schools, and an
extensive body of experience exists, with a number of programmes already evalu-
ated. However, these programmes, which require relatively stable and definable
conditions since they involve a specific group (for example, pupils of the same age
sharing part of their timetable), cannot necessarily be adopted in broader settings.
Instead, preventing recreational drug use requires a full understanding of a very
potent, highly developed and ever-changing youth culture, within which drugs have
an important place and are often seen as powerful symbols. Community prevention,
although it has been less studied, may come closer to providing the methods and
instruments needed for preventing recreational drug use. Be that as it may, the past
successes, failures and evaluations of drug prevention must not be overlooked.
Nevertheless, the form of prevention that has rather unexpectedly developed to
contain the problems associated with recreational drug use has little in common with
more traditional drug-prevention approaches. Various factors have influenced the
type of initiative that has been growing up in many European cities and countries.
One important phenomenon has been the popularity of ecstasy, the social factors
associated with its use (such as the popularity of dance and ‘house’ music, the belief
that it is a modern and ‘safe’ drug) and the initial lack of awareness of its harmful
effects, together with the belief that the few problems that had been identified and
accepted could easily be controlled by taking certain precautions. An associated issue
is the recent success of damage-limitation policies in the field of treatment, which has
prompted thoughts of a similar approach in the area of recreational drug use.
‘Damage-limitation’ prevention is based on the assumption that a large proportion
of the problems associated with recreational drug use could be controlled if the per-
son concerned was aware of them and took the appropriate preventive steps (for
example, drinking plenty of water or resting from time to time). The preventive
activity would thus involve providing the user with the necessary information to
make the right decisions. From this angle, the problem would not be the drug
consumption itself — regarded as inevitable in any case, and an established social
fact — but ignorance of what action to take to deal with its consequences.
This transposition of the principles of damage limitation used in drug treatment to
the prevention field, however, is not without its problems. Damage limitation in
treatment is aimed at individuals who are deeply involved in drug use, whose lives
are powerfully conditioned by it, and who have very limited ability to make deci-
sions about their own lives. Any expectation that they would abandon or greatly
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reduce their consumption of the drugs on which they are dependent is, in many
cases, illusory. The circumstances and characteristics of young people in recrea-
tional environments are very far from this stereotype. This target group represents a
wide spectrum of young people with a generally high level of control over broad
areas of their lives who use drugs to varying degrees, from abstinence to dependence.
Introducing elements of risk reduction into the preventive measures targeted at these
young people seems to be the most appropriate approach. It is consistent with a
value system in which individual responsibility for actions is increasingly more
important than a paternalistic approach. However, it seems neither very logical nor
consistent with the evidence to rely on this approach as the main, or in some cases
only, drug-prevention strategy. The capacity of these users to manage the risks they
are taking, as well as their interest in avoiding the problems associated with such
drug use, has tended to be overestimated. As a result, campaigns have generally
involved distributing information leaflets, attractively presented and in tune with
youth culture, in the hope that young people will learn to use certain specific drugs
in a less dangerous way.
In practice, this has been the most frequent type of preventive measure for recrea-
tional drug use. A recent review of current preventive programmes in European
recreational settings (Burkhart, 1999) notes that the majority of such initiatives are
based on providing information and that, contrary to what they supposedly claim,
most of the people at whom these programmes are targeted are abstainers or occa-
sional rather than frequent users. This whole range of measures has therefore been
implemented without proper evaluation and without taking into account the failure
— as far back as the 1960s — of school drug-prevention initiatives based solely on
information.
Those responsible for these programmes have even taken a belligerent attitude
towards more ‘traditional’ prevention approaches, regarding them as ineffectual and
not reaching the heart of the problem. They view recreational drug use by young
people as an established fact about which nothing can be done. In their view, pre-
ventive efforts should not attempt to influence trends, but should confine themselves
to ensuring that recreational consumption does not become a problem for the indivi-
dual or the group. As a result, there have been no serious evaluations of the effects of
these campaigns —- which are directed at consumers — on non- or occasional users.
While the experiences and views of practitioners in the field are clearly important
in planning drug-prevention policies, such professionals may be biased in their
statements, especially regarding ideological aspects. There can be no doubt that, in
the drugs field, where many different views co-exist, ideological perspectives are
significant. This, of course, is no bad thing, provided that it remains possible, in
discussions or in the approaches adopted, to differentiate between facts for which
some empirical basis exists and personal beliefs.
A good illustration of how such confusion can occur is found in a recent study
which examined the drug-prevention strategies preferred by 1 200 Spanish primary-
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and secondary-school teachers (Mejías et al., 1999). Encouraging self-esteem, re-
sponsibility and independence was favoured by 50 %. A very close second was value
clarification (45 %), while the least popular strategy was training in social skills
(16%). A review of 58 longitudinal studies of the aetiology of drug use (Petraitis et
al., 1998) shows that 11 out of 12 studies find no relationship between low self-
esteem and continuing drug use, nor between anxiety or depression and drug use.
While low self-esteem is perhaps more a consequence than a cause of substance
abuse, nine studies did find a relationship between future drug use and extroversion,
assertiveness, lack of inhibition and sensation seeking, while only two did not. What
can have occurred to produce such a misunderstanding? The assumption is that
teachers defend the educational ideal, which does not necessarily coincide — and,
as this study clearly shows, does not in fact coincide — with the objectives of drug
prevention.
Why are teachers so unenthusiastic about interactive programmes that teach social
skills when in practice these are often the only ones that actually have preventive
effects (Tobler, 1997)? After all, the most effective initiatives are those that attempt
to motivate young people actively instead of making them passive receptacles for
information. Various reasons can be posited for the teachers’ response, including
ignorance, the greater complexity involved in implementing interactive pro-
grammes, or the fact that such programmes require training or skills that the teachers
may not be able to provide. The basic reason, however, is that teachers have greater
confidence in programmes which are more in tune with their educational beliefs. If
drug-prevention in schools 30 years ago demonstrated the serious limitations of
information provision as a method, even when aimed at a fairly receptive popula-
tion which pupils are by definition, how can current approaches based almost
exclusively on providing information — and to young people who have little interest
in drug prevention and in some cases are deeply involved in drug abuse (Calafat et
al., 1998, 1999) — be expected to succeed?
Future action
The range of possible options for action is currently fairly broad, although most of the
drug-prevention programmes that have been proposed in recreational settings have
concentrated on providing information to users or testing the composition of tablets to
avoid adulteration. Instead, action should focus on controlling supply and demand.
Experience of drug prevention shows that establishing coordinated strategies at
different levels increases the potential for success. Among the areas for focus are:
• accessibility to drugs;
• legal or police pressure;
• risk perception;
• risk limitation;
• group (or environmental) expectations and pressure;
• prior experiences with drugs, risks and problems;
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• levels of intelligence, personal abilities and expectations; 
• a culture which supports or justifies young people’s behaviour.
Primary prevention — whether in schools, the family or the community — is not a
thing of the past, but remains very important, especially when young people are being
initiated into recreational practices and high-risk behaviour at a very early age(37).
In addition to primary prevention, the following measures can be implemented:
• self-help and peer-group pressure;
• repressive action;
• providing information on risks to users;
• testing the substances consumed;
• promoting safer dance parties;
• outreach campaigns;
• information campaigns;
• increasing the provision and expertise of emergency services;
• alternative drug-free recreational activities; 
• influencing the recreational scene to promote health advancement.
Some of these measures are already being effectively practised in various EU
Member States. In the Netherlands and the UK, for example, night-club security staff
are given special training, public transport is provided at night, clubs ensure easy
access to contraceptive vending machines and drinking water, and so on.
Control measures, such as observing closing times or complying with legislation on
minors, have been established to a greater or lesser extent in all EU countries,
although in practice the level of tolerance to recreational drug use is quite high.
Some programmes already attempt to deal specifically with the problems of recrea-
tional substance use. In Sweden, a special police division has been formed to iden-
tify and penalise young people whose recreational drug use is problematic.
Measures to regulate entertainment venues are difficult to enforce in many countries
and cities, particularly given the many vested interests involved, above all in the
leisure industry. A field study undertaken by Irefrea (Calafat et al, 1999) in 1998 in
nine European cities (38) found a generally low police presence in entertainment
districts, while the private security staff employed by the venues themselves were
more prominent.
The search for alternative forms of weekend entertainment to bars and clubs, as has
begun in some Spanish cities such as Gijón, may be an important recourse, pro-
vided that these alternative entertainments are set up on a serious basis and as long-
term projects. It is common in the drug-prevention field to see schemes established
with virtually no continuity. Some self-help and self-motivation initiatives have been
set up — for example in Manchester and some German towns — by the same young
people who are experiencing problems with drug use.
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(37)  For more on drug prevention within the family, see Mendes et al. (1999), available at (http://www.
irefrea.org).
(38)  Athens, Berlin, Coimbra, Manchester, Modena, Nice, Palma de Mallorca, Utrecht and Vienna.
Conclusions
Given the recent rapid growth in recreational drug use, it would appear important
to devote some resources to defining the entertainment and recreational culture.
This is not an easy matter, but it is important to understand that this new phenome-
non involves many other elements than simply the interests of young people, the
most significant of which are the financial interests of the leisure industry itself.
Information leaflets do, of course, have their place within prevention strategies aimed
at recreational drug use, but they will need more clearly defined objectives, content
and target groups, and greater cooperation with other drug-prevention programmes.
The information which such leaflets have supplied hitherto has tended to focus on
advice on how best to confront and solve the problems caused by recreational drug
use which, even in the best-case scenario, is a limited objective. This is because users
in these environments have only a partial interest in preventive measures and, even
when they do show interest, information alone does not appear to influence them to
reduce their drug use. In a study of the reasons for increases and decreases in the use
of various drugs among the US population, undertaken from 1976 to 1996 (Johnston
and O’Malley, 1998), certain factors — such as continuity of studies, participation in
antisocial activities, number of outlets — were found to be reliable predictors of drug
use. The only factor that really explained the historical changes, year by year, how-
ever, was the perceived risk or disapproval of a particular drug.
Recreational drug use is clearly a priority area for preventive action and its impor-
tance can only continue to increase. It is now time to find the most appropriate
approach to this phenomenon.
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n Chapter 9, Pavel Bem sketches the overall development of, and trends in,
drug prevention in central and eastern Europe and draws parallels with de-
velopments in the European Union. The author divides the central and east
European countries into three categories and identifies the specific needs of each of
these groups.
Relations between the ‘research world’ and the ‘political world’, as well as the com-
munication and interaction between them, are the focus of Chapter 10. Susanne
Schardt draws on her own involvement in the European Cities on Drug Policy net-
work and her work in the Drug Policy Coordination Office of the City of Frankfurt
and gives advice on how best to transmit scientific research findings to politicians
and decision-makers.
In Chapter 11, Teresa Salvador-Llivina examines the rationale and objectives behind
the EMCDDA’s Exchange on drug demand-reduction action (EDDRA) information
system. She traces its background, describing the various stages involved in
developing and testing the prototype, and presents the key recommendations from
the feasibility phase.
Philippe Roux continues the story of EDDRA in Chapter 12 by highlighting the sys-
tem’s current status. He describes the processes of information gathering, quality
control and maintenance of the system, as well as the roles of the various partners
involved. The author demonstrates both the technical and scientific challenges inhe-
rent in the EDDRA project, and examines areas for future development.
In Chapter 13, Sabine Haas discusses how best to convey the importance of 
evaluation, as well as the practical skills required, to drug-prevention practitioners.
Reporting on experiences in Austria, she highlights the need for clearly defined
objectives in planning evaluation, and describes the methods used to develop prac-
tical expertise. She concludes by proposing concrete ways of supporting the imple-
mentation of evaluation at European level.
Taking the work of the Réseau SécuCités-Drogues network as a starting point, Joana
Judice focuses on drug prevention in local communities in Chapter 14. Using
examples of drug-prevention projects targeting young people in Barcelona and
Saint-Herblain, she describes the context in which these programmes were created,
the evaluation of the initiatives and the obstacles this evaluation revealed. The
author concludes by outlining the characteristics of good practice at local level,
while also highlighting the importance of adequate funding.
In Chapter 15, Alfred Uhl explores the limits and constraints of evaluation studies in
general. He outlines a number of common problems, including imprecise termin-
ology and inadequate methodologies, and suggests ways of overcoming them, while
also underlining that there are no easy or definitive solutions to such problems.
Instead, concerted action is required to improve the quality of both drug 
prevention and evaluation in Europe.
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Evaluating drug prevention in central
and eastern Europe
Pavel Bem
The 1990s were a period of dramatic social, political and economic changes in cen-
tral and eastern Europe. In the wake of these developments, many central and east
European countries (CEECs) were confronted by unprecedented growth in illicit
drug use, especially among adolescents and young people. Drug-related crime and
new threats to public health — including those posed by intravenous drug use, the
spread of HIV/AIDS and hepatitis B and C — have been the inevitable conse-
quences of this emerging social phenomenon.
Many of the CEECs are attempting to tackle these problems with no national drug
demand-reduction policies, with no established drug-prevention and treatment sys-
tem and with serious limits to the public-health resources available to them. As a
result, all these countries must maximise the effectiveness of the resources used and
the interventions implemented. The need for cost-effective primary-prevention re-
sponses, as well as treatment and rehabilitation, is becoming a crucial issue for both
national drug demand-reduction strategies and local public-health policy planning.
Since the early 1990s, a great number of preventive and treatment interventions have
been initiated in almost all the countries of the region. In some cases, the need was so
urgent that the programmes were established with no prior evidence of their effec-
tiveness. However, research has demonstrated that maintaining such programmes
without adequate knowledge of whether or not their approach is effective is funda-
mentally problematic and may even be counterproductive. Empirical evidence of the
value or cost-effectiveness of individual drug demand-reduction programmes, as well
as of national demand-reduction strategies, is thus essential for policy planning.
Current status of drug-prevention evaluation
In reviewing the current status of drug-prevention evaluation research and practice
in central and eastern Europe it is clear that, although the importance of evaluation
research is widely recognised throughout the region, it is not sufficiently imple-
mented in practice in most CEECs.
Central and eastern Europe is a very heterogeneous region which is defined more
from a geopolitical than from an economic, social or public-health perspective. In
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addition, the level of drug abuse varies greatly from country to country, despite
some commonly reported regional trends. The current level of development in drug
demand reduction, the extent of the services available, as well as the institutional
and human capacities involved in the field, differ even more dramatically. Thus, in
assessing the current status of drug-prevention evaluation in the region, major,
sometimes even extreme, variations are apparent.
A significant amount of documentation and information about drug demand reduc-
tion in the CEECs has been collected since systematic and comprehensive interna-
tional assistance became available in the 1990s, for example from the EU Phare
multi-beneficiary drugs programme, from the Pompidou Group of the Council of
Europe or from the World Health Organisation. In the context of the Phare project
on drug information systems (DIS) and the Phare project on technical assistance to
drug demand reduction (39), the Phare Programme Coordination Unit (PCU) in Riga
has generated comprehensive reports on each CEEC describing the status of various
aspects of drug demand reduction as well as the specific needs of each country
(National Reports, 1998; Summary Reports, 1999).
The Phare multi-beneficiary drugs programme has assessed the status of evaluation
in the partner countries by asking its network of drug demand-reduction coordina-
tors the following questions (40).
• Does your country carry out evaluation and drug-prevention research?
• Do evaluation and drug-prevention practice take place in your country?
• Does your country have an evaluation and drug-prevention policy?
• Is your country familiar with the EMCDDA Guidelines for the evaluation of drug
prevention (EMCDDA, 1998)? (41)
• Is your country familiar with the EMCDDA’s Exchange on drug demand-
reduction action (EDDRA) information system? (42)
• What are the drug-prevention evaluation needs of your country?
From the results of this assessment, the CEECs can be grouped into three main
clusters.
• Countries in which drug demand reduction is well developed, based on:
– existing and operational demand-reduction strategies;
– a wide range of available drug-prevention and treatment services;
– guaranteed permanent national and local funding; 
– minimum quality-assurance instruments in place.
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(39) Information on the Phare multi-beneficiary drugs programme is available at (http://www.fad.
phare.org/). Information on the Phare project on drug information systems is available at (http://www.
fad.phare.org/dis/). Information on the Phare project on technical assistance to drug demand reduc-
tion is available at (http://www.fad.phare.org/ddr/).
(40) The Phare partner countries are Albania, Bosnia-Herzegovina, Bulgaria, Czech Republic, Estonia,
Former Yugoslav Republic of Macedonia (FYROM), Hungary, Latvia, Lithuania, Poland, Romania,
Slovakia and Slovenia. 
(41) For more information on the Guidelines for the evaluation of drug prevention, see Chapters 5 and 6.
(42) For more information on the EDDRA information system, see Chapters 11 and 12.
• Countries in which drug demand reduction is fairly well developed, based on:
– existing, but not fully operational demand-reduction strategies;
– available, but limited drug-prevention and treatment services;
– some, but insufficient, national or local funding; 
– no quality-assurance instruments in place.
• Countries in which drug demand reduction is less well developed, based on:
– no national demand-reduction strategy;
– no or very limited demand-reduction services available;
– no or very limited national demand-reduction funding; 
– no quality-assurance instruments in place.
Evaluation and drug-prevention research
The countries in the first group reported experience of evaluation and drug-
prevention research, with Poland the most advanced in this context. In the Czech
Republic, a study conducted in 1998 to evaluate the effectiveness of major primary-
prevention programmes suggested that interactive and comprehensive drug-
prevention projects were the most efficient. Research carried out in Slovenia from
1995 to 1997 evaluated over 80 primary-prevention school-based projects. Drug-
prevention and evaluation studies have also been undertaken in Hungary and Slovakia.
The countries in clusters 2 and 3 had not carried out any evaluation or drug-
prevention research.
Drug-prevention evaluation practice
In the Czech Republic, Hungary, Poland and Slovenia, evaluation is becoming an
integral component of drug-prevention programmes and an obligatory condition for
receiving government funds. However, even these countries reported that drug-
prevention professionals had limited experience of evaluation practice, especially of
methods and types of evaluation.
Countries in cluster 2 reported limited evaluation experience which is not an inte-
gral part of most of these countries’ drug demand-reduction programmes. Some of
these CEECs stated that international projects, such as the EU Phare project on tech-
nical assistance to drug demand reduction, had provided them with their first oppor-
tunity to introduce aspects of evaluation into drug-prevention practice in a planned
and integrated way.
Countries in cluster 3 have almost no experience of evaluation methodology, and,
where this does exist, it derives purely from international projects.
Evaluation and drug-prevention policy
Cluster 1 countries have an established evaluation policy and evaluation is a manda-
tory component of all programmes that request government (national or local) funds.
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The drug demand-reduction strategies adopted by cluster 1 and 2 countries typically
come under the umbrella of a comprehensive national drug policy. While almost all
existing national drug strategies include some form of evaluation, this can hardly be
interpreted in most cases as a comprehensive or sophisticated enough instrument to
deliver what would be expected from a national drug-strategy evaluation.
Cluster 3 countries have no national evaluation or drug-prevention policy.
EMCDDA Guidelines for the evaluation of drug prevention
All cluster 1, 2 and 3 countries reported basic knowledge of the EMCDDA’s
Guidelines for the evaluation of drug prevention, although practical use of the manual
differs markedly. Most CEECs do not use the guidelines in practice, although Lithuania
has translated the document and distributed it widely throughout the country.
Awareness of EDDRA
All cluster 1, 2 and 3 countries reported basic knowledge of the EDDRA informa-
tion system, although only very few stated that they had derived practical benefits
from its use.
Drug-prevention evaluation needs
All CEECs reported an urgent need to implement drug-prevention evaluation much
more widely. From analyses of the Phare country reports (National Reports, 1998;
Summary Reports, 1999), it can be concluded that both common (regional) and
individual (country-specific) needs in the area of drug-prevention evaluation exist in
central and eastern Europe.
Common needs throughout the region include:
• training demand-reduction professionals and drug-prevention project managers
in evaluation methodology and skills;
• developing and disseminating evaluation manuals and guidelines, which must
be simple, comprehensive and cheap for practical use;
• sharing examples of good practice in successful demand-reduction projects in
EU Member States as well as in the CEECs; 
• training policy-makers in evaluation advocacy.
Country-specific needs include:
• clusters 1 and 2:
– long-term assessment of the outcomes of primary-prevention projects;
– evaluation of community-based drug-prevention programmes;
– evaluation of mass-media campaigns; 
– evaluation of school-based drug-prevention programmes.
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• cluster 3:
– support in designing and implementing national demand-reduction policies; 
– support in funding drug-prevention programmes and evaluation research.
Conclusions
The variations in drug-prevention evaluation status among the individual CEECs are
significant. While some countries are well advanced in this area and are approach-
ing the level of EU Member States, others have very limited experience of
evaluating demand-reduction projects. International programmes, such as the EU
Phare initiatives, have proved in many cases to be pilot instruments and to have
provided many CEECs with their first opportunity to integrate evaluation compo-
nents into their demand-reduction activities.
Facilitating and reinforcing the integration of comprehensive evaluation method-
ology into drug-prevention programmes has been stressed as a priority in almost all
CEECs, with training drug practitioners in evaluation skills the most commonly
accepted method. The diversity of the countries in the region, however, has demon-
strated the need to tailor international assistance to specific national needs. Taking
into account the experience of drug-prevention evaluation in some CEECs, mutual
information exchange between them should be promoted. Applying economic cri-
teria and cost-effectiveness philosophy in drug-demand reduction is clearly another
crucial element in responding to the growing drug problem in the region.
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Communicating research findings
to policy-makers
Susanne Schardt
The good news
Politicians constantly make use of evaluations and statistics, particularly in adopt-
ing, rejecting or legitimising specific political strategies. In order both to examine
and to justify their actions, politicians strongly advocate ongoing evaluation of the
impact of their policies on the public since, at local level in particular, such meas-
ures are directly at the mercy of public opinion.
In the context of drug prevention, comparing local strategies with those implemented
in other local authorities is particularly important, and it is here that a society’s ability
to reach a consensus on, and to provide, an efficient response to public health and
safety issues comes to the fore. Economic aspects, too, have long played a major role
in formulating drug policy. With an increasingly limited budget, local authorities tend
to focus on measures that are both comparatively cheap and that have an immediate
and visible impact. Many so-called ‘harm-reduction’ measures — such as needle-
exchange programmes, ‘users’ rooms (where drugs can be taken under safe and hygie-
nic conditions), or methadone-maintenance programmes — have been implemented
not only because they help the individual drug user, but also because they have a posi-
tive impact on public order and safety and thus benefit the local community as a whole.
The bad news
On the other hand, politicians generally do not have first-hand professional experience
in their particular fields of responsibility and research considerations are not necessarily
the prime determining factors in their decision-making. Instead, their decisions tend to
be based on political (including party political) and economic factors, as well as on
public opinion, which often only reaches politicians indirectly via the media.
Since politicians are often responsible for several different areas, they have little
time to study research reports or to find the answer to pending problems in relevant
scientific publications. Furthermore, analysing research findings has not yet been
institutionalised at local-authority level. Although press-cutting departments have
been set up by local governments to scan the media and pass on relevant informa-
tion to politicians, they generally do not search scientific publications. Therefore, if
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scientific findings are being passed on to the politicians, it is mostly via the media.
It is not, then, surprising that political decisions are much more frequently based on
‘public’ opinion than on scientific evaluation.
The greatly simplified use of research findings and data — for example, via the
Internet — does offer some theoretical advantages in that it enables as much infor-
mation as possible on relevant subjects to be relayed to decision-makers. In prac-
tice, however, local authorities tend to have only limited access to the Internet and
its daily use as a reference tool is not yet sufficiently established. Furthermore, in
most cases, the politicians themselves hardly use this technology at all. Here, too,
the time factor plays a fairly significant role: as every user knows, the Internet can
provide unlimited answers to questions that were never asked; conversely, finding a
precise answer to a specific question can take a very long time.
In addition to most politicians’ lack of professional expertise in their subject, their
limited access to the relevant information available, and the fact that they anyway
have little time to research their subject matter, many local authorities do not have
the opportunity to ‘adapt’ evaluation research to a specific political activity. This is
mostly due to the factors determining political decision-making mentioned above.
Yet evaluation can clearly enhance drug policy. It can be used to examine and,
above all, legitimise political measures, but will only very rarely give rise directly to
new political decisions. This is because the actual implementation of certain meas-
ures is mostly guided by what is politically possible given constraints such as the
balance of power, the need to find a political and social consensus in relevant com-
mittees or public opinion. In terms of priorities, scientific evaluation usually comes
below these political necessities and is at best used to underline what has already
been discussed and decided. Scientific data tend to have the greatest effect when
communicated to politicians in a condensed form and when they refer to problems
pending in the local community. Given that decision-makers are used to reading
press clippings, ‘bringing evaluation to the politicians’ therefore requires a language
and style which has more in common with journalistic principles than with pure
research criteria. Lengthy, in-depth information is unlikely to be read and informa-
tion must be kept ‘straight and simple’. This is a challenge which scientific resear-
chers must meet if their findings are to influence political decisions.
The above considerations are largely based on the author’s own experience of work-
ing in the Drug Policy Coordination Office of the City of Frankfurt and with the
European Cities on Drug Policy (ECDP) network during the past 10 years (43).
Through its role as a drug-policy advisory and clearing body, the ECDP has made it
its job to improve the exchange of information with local government. A recurrent
question is: ’How can I get my message across to my local politician?’
Issues of cost effectiveness, whether or not a political consensus can be found for
certain measures, as well as whether their impact will be visible to the public and
be reflected positively in the media, should all be borne in mind. In so doing, it is
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(43) For more information on the ECDP network, see (http://www.ecdp.net/).
crucial to remember that, at political level, evaluation is used specifically to allow
politicians to examine their own actions as simply and quickly as possible.
A crucial question in implementing as well as evaluating drug policy is whether the
measure can actually change an existing problem. To communicate such a message
effectively to political decision-makers, however, an overview of data is not enough.
Instead, this data must be ‘translated’ into the possible political actions that can be
taken.
Experience gained from the work of the ECDP has shown that the network’s local-
authority members are particularly interested in including more ‘best-practice’
models and in more extensive evaluation of drug-policy measures. The growing
interest in evaluation in Europe makes it possible to compare the strategies of dif-
ferent local authorities and to draw conclusions from the effects of specific political
measures. Furthermore, these methods help to accelerate the sometimes exceed-
ingly laborious and lengthy process of developing drug policies and implementing
them in real terms, since current experience can be used as a point of reference.
It goes without saying, however, that political strategies cannot simply be transferred
from one local authority to the next. What works in one city may not work in
another. Why this is so is clearly a very interesting subject for scientific evaluation,
and one which would also be of great interest to politicians.
Use of EMCDDA products
The European Monitoring Centre for Drugs and Drug Addiction’s Annual report on
the state of the drugs problem in the European Union (EMCDDA, 1995, 1997, 1998,
1999) is an indispensable source of information for the ECDP network and a
valuable reference work for local decision-makers. With the support of the
EMCDDA, the ECDP for the first time distributed a copy of the annual report to the
participants at its eighth International Cities Conference, ‘Common initiatives in
drug policy — an assessment of local drug problems, needs and strategies’, held in
Halle, Germany, in June 1999. Many of the politicians at the conference learned of
the existence of this publication for the first time in this way, and their response was
overwhelmingly positive.
The EMCDDA annual report, however, provides relatively little, if any, locally orien-
ted information. This may be attributable to the fact that the information on which
it is based is delivered by the national focal points of the Reitox network which
include scant local data in their national reports, and sometimes none at all.
Considerably better cooperation with local authorities would be most welcome
here, particularly given that policy-making in Europe appears to be increasingly
developing from the bottom up, giving local authorities a much greater role than
before.
Local authority members of the ECDP almost consistently do not make use of the
Exchange on drug demand-reduction action (EDDRA) information system and this
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is certainly due to the fact that the Internet has been little used in local government
up to now (44). The EDDRA system could, however, play a significant role once the
daily use of the Internet has become established in the public sector to the same
extent that it already appears to have been established among most practitioners
working in the field of drugs, research and medicine, and among most non-
governmental organisations.
Conclusions
In conclusion, the following points can be made. First, it is important to make poli-
ticians aware of the utility, possibilities and limitations of evaluation.
Second, information should be provided to politicians with a specific goal in mind.
It is crucial to circulate available research findings and present them to local govern-
ment politicians on an active and regular basis, and not just to wait for politicians
to make specific enquiries.
A major drawback to the use of research studies in politics is the poor comparabili-
ty of data and the practically non-existent evaluation of overall political strategies,
particularly at local-government level. This applies both to the EMCDDA’s products
and to most other research findings, which, furthermore, tend to be used only very
sporadically or are largely unknown.
A scientifically based assessment of the effects of certain drug strategies would be
desirable, as would the establishment of a set of instruments to facilitate continuous
feedback, both on the part of practitioners working in the drugs field and politicians
responsible for drug policy. In the same way as providing information to politicians,
a proactive approach in requesting feedback would be useful. One way of facilita-
ting this could be to organise a conference similar to the evaluation conference from
which this monograph derives, where local politicians and local civil servants could
speak about their experiences of using scientific findings in their everyday work. By
describing their needs and requirements, some form of continuous and regular
information exchange with local decision-makers could be established. Through
such systematic feedback, actual needs could be evaluated in a meaningful and use-
ful way. It must be remembered, however, that obtaining direct feedback from poli-
ticians is always a long and difficult process. Furthermore, politicians often expect
miracles from evaluation and, given its known limits, all those in the field should try
to meet the policy-makers’ needs in terms of the presentation of the evaluation
results, their accessibility and the politicians’ major concerns about their policy
measures, but also be clear about what evaluation can provide and what it cannot.
The drugs issue is a highly individual one. A policy aimed at people cannot, and
should not, be guided purely by arithmetic or statistics. Many factors are at play
which determine the success or failure of a drugs policy, and not all social processes
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(44) For more details of the EDDRA information system, see Chapters 11 and 12.
can be evaluated or controlled by policies. The same basic rule can apply to re-
search as to a policy: it should be continuously subject to examination and impro-
vements by methods other than purely scientific ones. Yet, on one point, at any rate,
evaluation and politics have something in common: sometimes something just
works, and no one knows why.
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EDDRA: creating a European
information system on drug-demand
reduction
Teresa Salvador-Llivina
Information needs in the field of drug-demand reduction
During the past decades, interest in health and well-being and how to create a more
equitable and fairer society has grown in all European Union Member States. At the
same time, many social problems have emerged at national, regional and local level
as a result of recession, unemployment, social migration and deprivation, and other
socio-economic factors. Evident among these social problems are those relating to
drug abuse, and even while the prevalence of some drugs is declining or stabilising
in most Member States, new substances are constantly entering the market and their
consumption among some social groups is increasing. The limited achievements to
date of drug policies based on supply reduction has led to an awareness of the need
to improve the efficacy of demand-reduction strategies in Europe (Salvador-Llivina
and Ware, 1995).
To reinforce substantially the field of drug-demand reduction, policy-makers, scient-
ists, drug professionals and others involved in this area all need to increase their
understanding of how demand-reduction interventions can help to alleviate current
problems, as well as what constitutes good practice in the field (Alvarez-Vara,
1993). Up-to-date, high-quality information is required on how to implement effec-
tive programmes, how to establish indicators for success and how to develop good
evaluation practice.
Responding to that need requires a tool capable of providing reliable information in
the easiest, cheapest and quickest possible way to facilitate coordination and avoid
duplication of effort (Salvador-Llivina, 1995). To create such a device, the European
drug demand-reduction field must overcome the many obstacles to communication
encountered in this multi-sectorial and complex area. In the context of the EU, this
is not an easy task. Significant cultural diversities are found both among and within
countries regarding the perception of drugs, ways of identifying the causes of drug-
related problems and the measures used to deal with them. In addition, distinct
demand-reduction policies, variations in the scientific and professional background
of the actors involved and the variety of European languages spoken all render com-
munication even more complex.
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One of the main areas of competence of the European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA) is drug-demand reduction. The EMCDDA aims to
improve both the quality and the accessibility of information on demand-reduction
interventions in Europe by collecting and analysing existing data, improving data-
comparison methods and disseminating relevant information (45).
The establishment of a European information system on drug demand-reduction
interventions was one of the priorities of the EMCDDA’s first three-year work pro-
gramme (1995 to 1997). This information system was to be based on a set of prin-
ciples regarding information collection, interpretation and dissemination (Orthne
and Blum, 1989; Buckland, 1991; Avgerou and Cornford, 1993; Anderson and
Aydin, 1997; Heathfield et al., 1997; Carise et al., 1999), and the Centro de Estudios
sobre la Promoción de la Salud (CEPS), Madrid, was contracted to create and test a
prototype system.
Initial aim of the system
The main aim of the information system, now known as the Exchange on drug
demand-reduction action (EDDRA), was to respond to the different information needs
of scientists, policy-makers, decision-makers and practitioners involved in planning
and implementing demand-reduction activities in Europe. This goal had to be reached
by identifying, collecting and disseminating objective and comparable information.
Closely related to this, the system had to integrate both the latest technological tools
for collecting, storing and disseminating data, and high-quality standards regarding the
content of the information gathered (Meyer et al., 1996; Johnson, 1997).
These two elements — latest technology and quality standards — were considered
essential components of an information tool that would provide the services cur-
rently lacking in the European drug demand-reduction field. Furthermore, the sys-
tem had to be cost-effective and user-friendly both for those entering data and for
those searching for information.
Mapping existing needs
The preliminary steps in creating the system included identifying information
sources, defining potential users and assessing their information needs in all the EU
Member States through a detailed analysis of:
• the national reports on drug demand-reduction activities prepared by each
national reference centre of the European Prevention Assessment System (EPAS,
1994) (46);
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(45) The EMCDDA’s mandate is set out in Council Regulation (EEC) No 302/93 of 8 February 1993 (OJ 
L 36, 12.2.1993). 
(46) The EPAS project was funded by the European Commission to map the European drug-prevention
field for the first time.
• the information maps and national reports prepared by the Reitox national focal
points for the EMCDDA (47);
• a report on demand-reduction activities in Europe prepared for the EMCDDA
(Nilson, 1995);
• a study of governmental and professional sources from each EU Member State
(CEPS, 1995);
• a review of drug demand-reduction research in existing bibliographic repertories
such as:
– Index Medicus (descriptors: substance abuse; health promotion; health ser-
vices; school health services);
– Excerpta Medica (descriptors: public health; social medicine and hygiene;
drug dependence; alcohol abuse; health policy and management; occupa-
tional health; industrial medicine); 
– Current Contents (descriptors: social and behavioural sciences; life sciences;
clinical practice).
The data gathered from these sources not only provided a very realistic picture of
the current status of drug-demand reduction in Europe, but also identified the
obstacles to be overcome when establishing an instrument for data collection and
dissemination in the field. The main problem areas included:
• the qualitative nature of most of the information available;
• the great heterogeneity of approaches reflecting cultural, political, professional
and semantic differences across the EU;
• lack of an established evaluation culture in the field;
• lack of previously established national information systems to monitor drug
demand-reduction interventions in most EU States;
• the long time delay between the end of a research project and the publication of
its findings in the scientific literature; 
• the added difficulty posed by the use of more than 11 languages at implementa-
tion.
Objectives of the EDDRA system
Both the information needs and the obstacles identified above had to be addressed
in establishing the EDDRA system. Within this framework, its primary objectives
were identified as follows:
• to provide reliable and comparable information on high-quality and scientifically
backed demand-reduction interventions in the EU;
• to provide continuous, periodic and up-to-date information on ongoing pro-
grammes, especially innovative and collaborative projects;
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(47) An information map is an instrument devised by the EMCDDA to record in a uniform way the sources,
availability, quality and flow of information in the EU Member States. National reports on the drug
situation in each Member State are provided annually to the EMCDDA by the national focal points. 
• to provide regular information on methods of implementing demand-reduction
programmes; 
• to provide information regarding evaluation, such as the outcomes of different
demand-reduction approaches, results of interventions and their impact.
The secondary objectives of EDDRA were:
• to facilitate contact between professionals and teams who could benefit from
each other’s experience in diverse cultural settings;
• to create an educational tool capable of helping practitioners and teams to plan
and report their project logically;
• to promote and facilitate both external and internal programme-evaluation infor-
mation;
• to coordinate efforts with other European or international initiatives to profit from
each other’s work and avoid duplication of effort; 
• to increase the visibility of the EMCDDA and its national focal points among
drug demand-reduction professionals.
The feasibility study: developing and testing the prototype
Objectives of the feasibility study
The main objectives of the feasibility study, carried out in 1996 to 1997, were:
• to develop a tool designed to respond to existing needs;
• to confront and help to overcome current constraints; 
• to test and fine-tune the prototype.
Methodology
The feasibility study was developed using interactive methodology with the invol-
vement of the EMCDDA, CEPS as the coordinating body, the SEMA Group as the
company responsible for creating the system’s electronic architecture and the Reitox
national focal points. Following the results of the initial review of sources described
above, a preliminary proposal for a prototype was drawn up by CEPS, with input
from the other actors involved. A coordination committee of representatives of the
participating organisations was established to monitor the development of the fea-
sibility study. The committee’s tasks were to:
• coordinate aspects related to the system’s implementation;
• introduce the use of EDDRA in each participating country;
• establish the work schedule; 
• identify possible problems and ways of coping with them.
Several meetings were held during this period to review and discuss developments.
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Once the prototype was ready, the feasibility study developed in three phases:
• testing the prototype in a limited number of countries;
• creating the final tools and producing the final outputs; 
• implementing the system in all EU Member States.
Before testing began, several preparatory tasks were undertaken. These included
defining the quality criteria demand-reduction programmes had to meet in order to
be included in the system, completing the final paper and electronic questionnaires
to be used to collect information on the programmes, and identifying which natio-
nal focal points would participate in testing the prototype. The participating focal
points were those of Belgium, Greece, the Netherlands and Sweden.
Defining quality criteria
To be eligible for inclusion, the demand-reduction projects had to demonstrate an
evaluation component. In addition, quality criteria were established at the start of
the feasibility phase for each participating focal point to follow in selecting initia-
tives for inclusion in EDDRA to ensure the accuracy of the information available via
the system. The quality criteria were:
• programme identification (the organisation and contact person, centre or depart-
ment responsible);
• type of programme approach;
• initial situation (the drug-related problems the project aimed to address);
• objectives of the intervention (general and specific);
• basic assumptions or theoretical foundation for the initiative;
• target population;
• status of the target population in relation to illegal drugs;
• substances addressed by the programme;
• programme setting;
• direct expected coverage;
• programme actions;
• number of staff or volunteers involved;
• geographical coverage;
• calendar;
• status of programme in relation to evaluation;
• total or annual programme budget;
• source of funding; 
• programme abstract.
To ensure that each programme accepted for inclusion fulfilled the quality criteria, a
set of attributes, validation rules and integrity constraints were defined for each data-
base field. If the system detected no information in a field defined as a quality crite-
rion, it would reject the project. Furthermore, coherence between stated objectives,
plans for evaluation and the results presented was also established as a requirement.
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The questionnaire
The questionnaire to be completed for each programme had to fulfil the following
criteria:
• be comprehensive while still being concise;
• be straightforward, or at least not too time-consuming, to complete;
• be able to collect as much objective information as possible;
• allow projects to be compared;
• facilitate quick and easy access to information;
• provide different options for retrieving the information; 
• facilitate different types of analysis of the information gathered.
Objectives during the testing phase
In September 1996, testing of the prototype began. The primary objectives were:
• to test the system’s technical and technological structure and functioning;
• to test its capacity to produce objective, reliable and comparable information;
• to ensure its smooth and uniform functioning in the participating countries; 
• to produce the first outcomes.
To meet these objectives, a comprehensive operational structure had to be defined
and established. The operational goals for this trial period were to:
• establish the role of all participants (the EMCDDA, the CEPS coordinating team,
the participating focal points and the SEMA Group);
• produce a pilot version of the information-collection questionnaire;
• set up an advisory committee to assess information needs and monitor the test
phase;
• agree on the definitive name for the system;
• test and adopt the quality criteria;
• clearly define both the procedures and actors involved in standardising the
information-collection process;
• produce the first outcomes of the system as both an electronic database and a
paper manual; 
• produce a final report summarising the implementation, results, obstacles
encountered and proposals made to overcome them.
Outputs of the feasibility study
The feasibility study resulted in the following outputs:
• the EDDRA questionnaire, including eight main areas of information, together
with an operational list of terms produced to facilitate comparability;
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• guidelines to help the national focal points select projects for inclusion, includ-
ing quality criteria, operational definitions of key demand-reduction terms and
specific advice on how to enter projects into the database;
• the EDDRA users’ manual containing a complete glossary of terms used and
practical examples of how to complete each item of the questionnaire;
• an Internet newsgroup to promote the exchange of ideas, problem solving and
so on, particularly regarding viewing projects in the database, modifying and
improving the system’s different applications, and identifying problems or
bugs;
• on-site training seminars at each national focal point to discuss aspects of the
practical implementation of the system such as:
– using the different components;
– navigating through the database;
– applying the quality criteria;
– entering projects into the database;
– entering messages into the newsgroup;
– elaborating strategies to promote the system; 
– deciding on the most suitable method of national information collection and
dissemination; 
• entering programmes in the database.
During the feasibility study, the focal points were required to search, select and pro-
duce information from a least five demand-reduction projects in their country
(including treatment, drug-prevention and/or harm-reduction interventions). By the
end of this period, 112 interventions had been entered, and suggestions to improve
the electronic questionnaire registered.
Recommendations from the feasibility study
By the end of the feasibility study, EDDRA had proved to be a valuable instrument.
It was able to produce objective, reliable and comparable information on drug
demand-reduction activities in Europe, along with standards to promote good and
evaluated practice in the field.
During this phase, the following recommendations were made to improve the func-
tioning of the system.
Content
• The national EDDRA managers should be constantly and widely promoting and
disseminating the quality criteria for inclusion in EDDRA.
• The questionnaire and operational definitions of key terms should be constantly
fine-tuned during the first years of EDDRA’s implementation at European level.
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Technical aspects
• Technical aspects, such as reducing the time taken to upload, download and
save data, must be adequately supported to avoid discouragement and the loss
of working time by the focal points.
• A full-time professional must be appointed to provide constant technical assis-
tance, at least for the first years of implementation.
Organisation
• The person appointed within each focal point to enter the programme informa-
tion into the database should be fully trained in the main characteristics of
EDDRA, and at the same time should have adequate knowledge and understand-
ing of drug demand-reduction interventions in their own country.
• Broad participation should be encouraged, possibly by developing specific
promotion strategies.
• As a key communication tool within the EDDRA project, the newsgroup should
be continued during the general implementation phase.
• EDDRA should facilitate as far as possible broad access to information in each
country. Creating a multilingual approach would substantially contribute to this
aim.
Quality control and standardisation
• Due to the uneven quality of the projects entered by the national focal points,
systematic screening should be undertaken centrally by the EMCDDA to ensure
a basic level of quality and standardisation.
• The EMCDDA should undertake the centralised editing of the English of the pro-
ject descriptions entered into the database.
Conclusions
The EDDRA information system has now grown, both in terms of its size and the
experience gained by the parties involved, to ‘adulthood’ (48). Both positive and
negative aspects identified by the participants in the feasibility phase have already
been addressed by the EMCDDA and the EDDRA national managers based at the
Reitox national focal points. As a next step, full participation in the EDDRA system
by drug professionals from all EU Member States will help to stimulate and further
enhance the quality of demand-reduction interventions in Europe.
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(48) The current status of the EDDRA system is discussed in Chapter 12.
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Chapter 12
EDDRA: current achievements
and future challenges
Philippe Roux
The advent of new technology, in particular the Internet, has heralded a new era in the
dissemination and exchange of information, and the consequences of this information
revolution have yet to be fully assessed. This is particularly true of information on drugs
and drug addiction. From its creation in 1993, the European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA) has committed itself to making full use of the Internet
and other new technologies to disseminate the information it gathers and analyses on
drug use and its consequences. In this context, the EMCDDA not only developed an
electronic network — the European information network on drugs and drug addiction
or Reitox — linking its key partners in each of the EU Member States and the European
Commission, but has also created a public website providing information on all aspects
of the Centre’s activities, products and services, with access to specialised databases and
links to drug-information centres at national, European and international level (49).
It was within this context of technological innovation that the Centre developed its on-
line information system, the Exchange on drug demand-reduction action (EDDRA) (50).
The primary aim of the EDDRA system was to make publicly accessible detailed infor-
mation on the various measures implemented in the 15 EU Member States to reduce
the demand for drugs. The unique aspect of EDDRA is that it includes only those
demand-reduction initiatives that have an evaluation component.
From the outset, the project posed both a technical and a scientific challenge. The
technical challenge was to devise a tool that would allow the greatest exchange of
information between the partners involved, and to create a multilingual database to
permit the quickest, simplest and most efficient navigation by the general public.
The scientific challenge was to find a standard way of collecting data that are diffi-
cult to access in the various Member States.
The context
Before discussing EDDRA in detail, it is important to mention the context in which it
was created and the significance of the EMCDDA in this framework. The EMCDDA
(49) The EMCDDA website is available at (http://www.emcdda.org). 
(50) The EDDRA information system is available at (http://www.emcdda.org/databases/databases_eddra.shtml).
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was established in 1993 to improve knowledge about drugs and drug addiction in
the EU in an attempt to combat the phenomenon.
As a major aspect of its mandate (51), reducing the demand for drugs occupies an
important position among the six priorities of the EMCDDA’s work programme for
1998 to 2000. These six priorities are:
• consolidating and improving information systems in the areas of epidemiology
and demand reduction;
• consolidating and enhancing the Reitox network;
• improving and developing key indicators, methods and evaluation tools;
• improving the quality of the Annual report on the state of the drugs problem in
the European Union (EMCDDA, 1995, 1997, 1998, 1999), the visibility of the
work of the EMCDDA and the Reitox network and the dissemination of the infor-
mation collected and produced by the Centre;
• developing cooperation with international partners, and ensuring synergy with
the European Community action programme for the prevention of drug depen-
dence (52); 
• developing methodologies and tools to facilitate the comparison of the initia-
tives, laws, strategies and policies pursued by the different EU Member States.
The EMCDDA’s efforts to reduce the demand for drugs, combined with those of its
Reitox partners, focus on four main strategies:
• defining terminology to facilitate information exchange at EU level;
• promoting a culture of evaluation in Europe and making available relevant tools
and guidelines to those working in the field;
• providing a chapter on demand reduction in the EMCDDA’s Annual report on the
state of the drugs problem in the European Union; 
• developing the EDDRA information system, as well as other specialised data-
bases and information media.
EDDRA: current status
The EDDRA database emerged from a simple premise: drug-prevention profes-
sionals are more inclined to include evaluation in their project designs when they
are provided with concrete examples.
The EDDRA system currently comprises:
• an EU-wide network of national managers based at the Reitox national focal points;
• a standardised information-gathering tool in the form of a questionnaire;
• specially created software for editing the data collected off-line; 
• a fully searchable database accessible via the EMCDDA website.
(51) See footnote 45. 
(52) See footnote 7.
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In order to reach as wide an audience as possible, a structure to permit the multi-
lingual consultation of the database was developed for the 2000 version of the sys-
tem. To date, texts are available in German, English and French and entries in all 11
official Community languages will be available by the end of 2000. It should be
noted, however, that for obvious budgetary reasons some data are only available in
the original language and in English.
Gathering the information
The EDDRA national managers form the core of the system. Their task is to gather
data on national demand-reduction programmes that fulfil the single criterion of
including a well-documented evaluation component.
While the national managers are the mainstay of the system, its cornerstone is the
standardised questionnaire used to collect relevant information on the individual
programmes. Accompanied by a comprehensive glossary of terms, the question-
naire divides the project information into nine sections:
• identification of the programme and its actors;
• the programme’s background and objectives;
• its main characteristics;
• evaluation of the programme;
• the results of the evaluation;
• the programme budget;
• a programme abstract;
• the project outputs; 
• specific comments.
The questionnaire contains a total of 48 questions, 11 of which have open fields to
allow the national managers to describe the project in detail.
The information flow among the parties involved in the project is managed via a
multilingual editing and messaging software created especially for EDDRA. This
software allows the questionnaire to be edited off-line by the national managers and
the files to be sent directly to the European manager at the EMCDDA by e-mail.
The information circuit can be summarised as follows:
• first, each national manager gathers relevant data on demand-reduction initia-
tives in their country via the EDDRA questionnaire, analyses them, edits them
and sends the edited file via e-mail to the European manager at the EMCDDA;
• second, the European manager re-reads the questionnaires to ensure that all is com-
plete and comprehensible before forwarding the entries to the Translation Centre for
the Bodies of the European Union in Luxembourg for a final linguistic polishing;
• third, the European manager enters the final product into the database where it
becomes accessible to the general public on-line.
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This lengthy process is designed to ensure that the information contained in the
EDDRA system is of the highest possible quality and accuracy. In this context, co-
ordination meetings are regularly organised for all the partners involved to ensure
the overall coherence of the project.
Searching the database
The database includes two search engines that permit:
• a rapid search by pre-defined fields, for example by country, programme ap-
proach, action or target group; 
• an advanced search with eight separate fields that can be combined according
to the user’s needs, thus permitting, for example, a search for all evaluated pro-
jects in France that target heroin users.
Once the search has been submitted, the system provides a list of projects that meet
the selected criterion or criteria together with accompanying abstracts and details of
the relevant contact person. The user may view or download the complete project
description which is presented in a standardised format to facilitate comparison be-
tween projects.
Technical challenges
Given the remarkable speed at which information technology is developing, no
sooner has a computer product been installed than it is already obsolete. Managing
a project that includes a complex information-technology component is, therefore,
not an easy task, and even less so when the project involves partners throughout the
15 EU Member States with varying degrees of mastery of the technologies con-
cerned.
Where information technology is concerned, there are always several alternative
possibilities at any one time, each with its own advantages and limitations, and
‘compromise’ is thus the key word. What is required is a product that can be easily
updated and adapted to changing technologies and that can be used by the widest
possible audience. For databases accessed via the Internet, response time is a
crucial element and the interface and search tools must therefore be designed to
ensure the swiftest possible handling of the user’s request. As a result, when de-
veloping these tools a compromise must be reached between efficiency and precision.
Scientific challenges
EDDRA’s aim to provide information only on European drug demand-reduction
projects that include an evaluation component also poses a twofold scientific
challenge.
The first difficulty concerns the fact that EDDRA was devised to encourage the
development of an evaluation culture in Europe. Since evaluation is virtually un-
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known in the field of drug prevention, very few drug demand-reduction initiatives
in Europe have to date been effectively assessed. It is thus a considerable challenge
to gather and disseminate information that does not actually exist. Yet, rather than
creating deadlock, this potential contradiction is in fact a strong point of the system.
EDDRA is much more than ‘just another database’. Instead, it is the tool of an extre-
mely ambitious project to support the development of a real evaluation culture in
the 15 Member States — hence the criterion that all projects in the system must
include an evaluation component. Yet this evaluation does not have to be complete
for the project to be incorporated into the system. Including projects in EDDRA is a
way of ‘rewarding’ the teams involved for their efforts to evaluate their actions and
a means of encouraging them to continue doing so. For this incentive-based
approach to succeed, the EMCDDA and its partners must ensure that the EDDRA
system is made widely known at EU level, and the national managers are currently
exploring ways of actively promoting EDDRA.
In any event, a balance must also be struck between the quality and quantity of the
projects in the database. EDDRA can be seen, to some degree, as an indicator by
which to observe and quantify the evolution of a European evaluation culture. The
system currently contains about 100 demand-reduction projects, encompassing dif-
ferent approaches and responses to drug addiction, which more or less satisfy the
fundamental eligibility criterion. This figure is expected to increase fourfold by the
end of 2000.
The second scientific challenge relates to the actual editing of the contents. While it
is undoubtedly of real interest to professionals in the field to share their knowledge
on an EU-wide scale, reporting skills are sorely lacking. A large part of the national
managers’ work thus consists of helping local teams to edit and present their projects
effectively. Despite such assistance in completing the questionnaire, a large number
of project descriptions remain incomplete, thus creating a lack of homogeneity
among them notwithstanding the attempts at standardisation described above.
The EMCDDA is supporting the efforts of the national EDDRA managers by organi-
sing joint training schemes with the Reitox national focal points focusing on improv-
ing the reporting and evaluation skills of EU demand-reduction professionals. These
efforts will be continued in 2000, but still remain insufficient given the few finan-
cial resources available and the extent of the task.
Conclusions
Report-writing skills are an essential component of activities in the fields of social
work and public health. They are the starting point for all evaluation protocols and
processes to improve working practices. Enhancing the quality of these reports is
currently the most crucial task facing the national EDDRA managers. This issue
should receive wider recognition and has implications for the topics covered by
both initial and continuing training courses for social-work and health professionals.
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The national EDDRA managers and the EMCDDA have to date dedicated significant
efforts to improving the quality of the data provided by the system. In addition, in
order better to meet the needs of those working in the field, considerable work has
been undertaken to facilitate their access to the different resources and materials
available via the system. These efforts include:
• making the EDDRA manuals available in all 11 Community languages;
• supplying the national managers with a multilingual version of the EDDRA
editing and messaging software; 
• restructuring the database to allow navigation in all Community languages (to be
achieved by the end of 2000) and access to the individual project data in the
original language and in English.
In spite of major budgetary restrictions, the EMCDDA is investigating the possibility
of making the EDDRA database entirely multilingual. All these efforts form a
significant part of the EMCDDA’s contribution to the development of an evaluation
culture in the field of drug-demand reduction in Europe.
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Chapter 13
Promoting evaluation and
enhancing skills
Sabine Haas
Since 1997, the Österreichisches Bundesinstitut für Gesundheitswesen (Austrian
Health Institute — ÖBIG) has been actively promoting evaluation, both in its capa-
city as the Reitox national focal point for Austria and as national coordinating body
for European Drug Prevention Week (EDPW) 1998. This experience has revealed
both the rapidly growing interest in evaluation in Europe — as increasingly reflec-
ted in practical activities — and major deficiencies in the basic knowledge, skills,
framework and conditions required for good evaluation practice.
These deficits are not surprising, given that although evaluation is a scientific
concept, it is primarily local practitioners and politicians who are involved in plan-
ning and implementing measures designed to reduce the demand for drugs. For a
long time, these groups did not consider evaluation to be a necessary element of
demand-reduction programmes and, with limited funding available, adding a
‘scientific’ component was regarded as a ‘luxury’ and not a priority for limited
resources which would be better spent on working directly with the target group.
Moreover, evaluation has often been seen as a task that could not be carried out
effectively with the skills available within the project.
On the other hand, there has been an increasing demand for evaluation as an
‘objective assessment of success’ over the past few years. At the same time, interest
in, and awareness of the need to acquire, the necessary skills have also grown. In
considering the issue of disseminating the knowledge and abilities required for
evaluation, at least three questions arise.
• Who are the target groups?
• What knowledge should be conveyed as a matter of priority?
• How can this be done?
Reaching the target groups: top down and bottom up
A distinction should be made between at least two relevant target groups and, on
the basis of these groups, two different approaches to promoting evaluation. The
‘top-down’ approach is geared to decision-makers and funding bodies and attempts
to convince them of the importance of evaluation. This is relevant for improving the
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framework conditions for evaluation. While evaluation often still fails because of
inadequate resources, it can also be promoted and motivated by means of financial
guidelines. This is illustrated, for example, by the fact that many Austrian facilities
providing help for drug addicts have become involved in evaluation for the first time
in the context of EU programmes, such as the Community action programme for the
prevention of drug dependence (53), and have ‘acquired a taste for it’ in the process.
Although the top-down approach must not be neglected, this chapter focuses above
all on the ‘bottom-up’ approach. This is targeted at drug-prevention experts active at
local level and attempts to convey to them that evaluation is both meaningful and
useful. A secondary aim is to motivate them to evaluate their own projects and to
learn in the process. This method should therefore be directed at the largest possible
number of drug demand-reduction practitioners, and not simply at a restricted group
of those working explicitly on evaluation, scientific reporting or project planning.
For a variety of reasons, it is both necessary and worthwhile to convey background
knowledge and promote a better understanding of evaluation among the widest pos-
sible group of drug practitioners. As the process becomes more comprehensible and
better understood, so the uneasiness that is frequently felt about external evaluation
is reduced. Promoting an understanding of the concept can also increase the level
of identification with all forms of assessment and its results as well as reducing the
level of inhibition about initiating an internal evaluation and about ongoing invol-
vement with it.
Whether internal or external, evaluations require support and input from a number
of parties active in the specific project or programme who are often also involved in
generating the evaluation tools. This input may include documenting current work
and experience or generating questionnaires and tests. The quality of an evaluation
usually depends on the reliability of the data and information obtained at grass-roots
level. The best way of ensuring this quality is for everybody involved to understand
that this ‘additional’ work is both meaningful and necessary.
Defining objectives, presenting projects and planning evaluation
ÖBIG’s experience, both of analysing the national projects for inclusion in the
Exchange on drug demand-reduction action (EDDRA) database and as national
coordinating body for the EDPW 1998, is that, even with the necessary motivation,
implementing evaluation still raises a number of problems.
One fundamental issue — which became apparent both in the context of the
EDDRA system and in project applications for EDPW 1998 — is defining objectives
and the basic assumptions underlying them. Project managers often have difficulty
presenting the principles behind their activities in a pre-set, standardised format.
Nor is it easy to distinguish between the objectives and basic assumptions of a proj-
ect and the methods applied. This probably reflects the different logic of practice-
(53) See footnote 7.
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oriented and scientifically oriented project planning. Measures designed to reduce
the demand for drugs are often planned and conceived on the basis of aspects other
than those required for a ‘scientific’ presentation. For example, projects evolve
according to changing political priorities or deficits detected during practical work.
In this context, the goals pursued are not always specifically and ‘scientifically’
recorded and are rarely operationalised.
An associated and inter-linked problem lies in making the implicit elements of a pro-
ject explicit, both for the project managers themselves and, in due course, for others.
Regarding EDDRA, it often becomes clear from the material available or from personal
discussions that activities are more varied, more extensive and more soundly based
than is apparent from the questionnaire completed by the project managers. The
everyday reality of the project often leads those closely involved to take major aspects
of it for granted and to lose sight of the fact that these same aspects are fundamental.
As a result, they are omitted from the project description. If the project managers work
together to complete or revise the questionnaire, this can be an eye-opener for them
too, shedding new light on their own perception of their project.
Not only do these problems in designing and presenting programmes make it diffi-
cult to describe them consistently and comprehensibly — as required not only by
EDDRA, for example, but also increasingly by other project applications, such as
the Community action programme at EU level or the ‘Healthy Austria Fund’ at
national level — they also create obstacles to evaluation. A clear definition of the
objectives and basic assumptions (both practical and theoretical) involved in a pro-
gramme is essential if goals are to be expressed in operational terms and methods
and tools developed to review their achievement. However, if these aims remain
either un- or ill-defined it becomes more difficult to plan the evaluation, and
planning is both one of the most important and one of the most difficult stages of
any assessment. While it is often not easy to define the methods, tools and indica-
tors by which experiences and ‘successes’ can both be evaluated and implemented
in practice, this is crucial to ensure the quality and usefulness of the data and
information obtained. If the project objectives are made clear from the outset, the
evaluation will be easier to plan.
Methods and tools: materials, training
Experience in Austria to date indicates that evaluation skills must be conveyed in a
manner that is as specific and practice-oriented as possible. This was apparent, for
example, from the first announcements of the EDDRA database in the newsletter
DrugNet Austria (ÖBIG, 1997), which were fairly theoretical and elicited no res-
ponse. Only when the published abstracts of the EDDRA projects were very speci-
fic, clear and practice-oriented were interest and demand triggered. When the
methods and results were described, the evaluation required also became less fright-
ening, as these aspects showed, for example, how an evaluation can be carried out
and what the results can be. This, in turn, often sounded practice-oriented, clear and
comprehensible, rather than scientifically complex.
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While providing guidelines and manuals is an important form of support for evalu-
ation work, it is not sufficient as these materials do not facilitate individual dis-
cussion of specific problems and interaction is limited, even when there is good
educational preparation. However, these tools can represent an important addition
to advanced training interventions, which themselves constitute an appropriate first
step towards conveying the relevant knowledge. ÖBIG offered its first training meas-
ures for Austrian drug-prevention professionals in October 1999. Based on the need
for advanced training and knowledge transfer described above, these seminars fo-
cused on project presentation on the one hand — in particular, defining objectives
and fundamental assumptions based on the EDDRA questionnaire — and basic
information on evaluation — operationalising objectives, defining possible indica-
tors and tools, and so on — on the other. Participation in the one-day events was free.
The training offered was geared primarily to drug practitioners either marginally
involved in evaluation, dealing with evaluation in their everyday working lives, or
merely interested in the topic. In terms of methodology, it was attempted to gear the
training to practice by working with specific case studies provided or suggested by
the participants. A major part of the training consisted of teamwork, which promo-
ted the independent application of what had been learned and facilitated a flexible
response to the specific difficulties that arose. Using the EDDRA information-
collection questionnaire and the EMCDDA Guidelines for the evaluation of drug
prevention (EMCDDA, 1998) helped to bring these materials to life and hence to
make them more easily applicable in practice.
The experience gained during the training events was positive. Austrian drug experts
showed much greater interest than expected in the content and the feedback was
very good. The participants themselves said that the seminars made them feel better
prepared and more strongly motivated to work on evaluation. The training offered
was perceived as a helpful and meaningful measure and further, more detailed train-
ing events — particularly with regard to information on evaluation — were
requested. Follow-up training at a higher level will therefore be provided.
Learning by doing: quality circles, helpdesk, peer exchange
In the long term, however, training will only be effective if it is put into practice.
Learning by doing is the most exciting and also the most sustained way of acquiring
knowledge and experience. However, in the field of drug demand reduction, this
process has not as yet been adequately supported by the expertise and knowledge
available.
At the end of 1999, therefore, as a follow-up to the training seminars mentioned
above, ÖBIG arranged for a ‘quality circle’ on evaluation to be established in the
Vienna area. The idea was to improve the quality of evaluation practice by pro-
viding a forum for discussing specific plans and evaluation projects, and for ex-
changing knowledge relating to theoretical and methodological issues. In this way
the circle would support the principle of ‘learning by doing’. For example, at the
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first meetings, participants discussed the methodological problems of evaluating
drug-prevention measures on the basis of a specific project and general questions
relating to process evaluation.
Drug experts involved in evaluation showed great interest in the idea and it was
agreed that they would meet once a month for three hours to exchange relevant
knowledge and experience. In addition to practitioners working in local drug facili-
ties and projects, a number of scientific experts also attended the meetings. There
was particular interest in discussing issues and problems arising from practical
evaluation work (integration into the everyday life of a project, staff motivation,
methodological options and limitations).
Conclusions
The regional activities described above should now be both supported and supple-
mented at European level. A ‘helpdesk’ based at the EMCDDA could offer support
and advice on very specific issues and problems, suggest possible methods and
tools for evaluation, and draw attention to existing experience. This could be of great
assistance to those involved in planning and implementing evaluations at local
level. It could also help to improve the quality of evaluations as the ‘central’ level
would be more aware of the kinds of questions and problems people were facing
when implementing evaluation at local level. In response, the materials, support
and so on they provide to them could be improved accordingly.
A peer exchange would similarly stimulate the exchange of ideas and experience by
experts involved or interested in evaluation, and would thus also support and pro-
mote a learning process. Furthermore, cooperation and information exchange
extending beyond the individual project and, in particular, across national borders,
could greatly increase motivation for undertaking evaluations. In organising a peer
exchange of this kind, use could be made of the experiences and structures of the
European networks already in existence in the drugs field, such as the Federation of
European Professionals Working in the Field of Drug Abuse (ERIT) or the European
Association of Professionals Working with Drug Dependencies (Itaca) (54).
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The challenge of evaluation 
for local communities
Joana Judice
A large number of European towns, particularly those affected by ‘drug tourism’ and
the organisation of major music festivals, ‘rave’ parties and other similar events, are
questioning the relevance of drug-prevention messages aimed at children and teen-
agers (55). In fact, the emergence in recreational culture of new synthetic drugs such
as ecstasy, use of which is increasingly prevalent among young people, has empha-
sised regional authorities’ feeling of powerlessness in regard to drug prevention,
especially since the prevention programmes established to date do not appear to
have an effect on young people who do not identify with the traditional image of
the drug addict these programmes promote.
In the context of the general task of drug prevention, for which local authorities are
responsible, political decision-makers now acknowledge that it is vital to establish
primary-prevention programmes aimed specifically at children and teenagers.
The growing popularity of synthetic ‘dance’ drugs among the young, and the
increasing use of licit with illicit drugs at an early age, is now forcing a preventive
response from local communities.
The challenge of evaluation for politicians
Evaluation can help policy-makers:
• decide whether an action should be implemented, changed or expanded;
• justify the funds allocated;
• interpret quantifiable data; 
• validate the prevention methods used.
In addition, evaluating the effectiveness of primary drug prevention demonstrates
the extent to which it has helped reduce the number of drug users as well as the
health risks they face. This undertaking may seem impossible given the constantly
(55) This chapter is based on the Réseau SécuCités-Drogues network project that examined the relevance
of drug-prevention messages aimed at children, teenagers and vulnerable groups, particularly in
response to the increasing use of new synthetic drugs (Réseau SécuCités-Drogues, 1999).
shifting drug scene, both in terms of the drugs supply and methods of drug use, an
argument often put forward by those drug-prevention professionals who do not
evaluate their programmes. This position is characteristic of the ‘all-or-nothing’
approach to drug prevention, because while it is difficult to evaluate the impact of
drug prevention in general, it is nevertheless possible to evaluate specific pro-
grammes from different perspectives.
At the preliminary stage of the Réseau SécuCités-Drogues project, school drug-
prevention and/or health-education measures that used different methods were
identified in 15 European towns (56). Two of the resulting evaluations — one of a
project targeting children in Barcelona, Spain, and the other of a project targeting
teenagers in Saint-Herblain, France — are described below.
Evaluation of a drug-prevention project in Barcelona
Reasons for establishing a drug-prevention programme
In Barcelona, a city of 1 508 805 inhabitants, polydrug use is a major problem (57), affec-
ting around 9 000 people. The most commonly used substances are alcohol, tobacco
and tranquillisers, and alcoholism in particular is of great concern to local authorities
and local politicians. Children are frequently confronted by the problem of drug addic-
tion in their own environment and the need to establish an effective drug-prevention pro-
gramme aimed at them was justified by a study on the prevalence of tobacco use among
schoolchildren. In 1989, an intervention based on this study began to take shape.
Strategy used
The first stage was to create a partnership on prevention. The Institut Municipal de la
Salut (Local Authority Institute of Public Health) proposed developing school drug-
prevention programmes in collaboration with external parties, such as teachers and
pupils, health services, associations including youth groups, and social services. These
drug-prevention programmes would form part of a general health-education policy
and be targeted at three main age groups: 8–11-year-olds; 11–13-year-olds; and those
aged 13 and over. The second stage was to establish these programmes in schools.
The PASE programme
One such programme was the Programa de prevenció de l’abús de substàncies
addictives (PASE), a medium-term (12 to 18 months) tobacco-, alcohol- and drug-
prevention programme aimed at children aged 11 to 13. The project, devised by the 
(56) Mons (Belgium); Odense (Denmark); Hamburg, Karlsruhe and Munich (Germany); Barcelona
(Spain); Argenteuil (France); Bologna and Milan (Italy); Vienna (Austria); Loures (Portugal); Belfast,
Nottingham and Sheffield (UK); Oslo (Norway). 
(57) See footnote 23.
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Institut Municipal de la Salut, is managed by the Departament de Promoció de la Salut
(Health Promotion Department) and aims to reduce the incidence of tobacco addic-
tion by 25 %, to reduce the consumption of alcoholic drinks (notably at weekends) by
25 % and to strengthen negative attitudes to substance abuse. A pilot programme was
established during the 1989/90 school year which proved highly successful with both
pupils and teachers. In 1996 to 1997, the programme was implemented in 63 state,
68 co-educational and 10 private schools involving 7 667 pupils.
The programme focuses on helping children to identify social pressures, to with-
stand advertising strategies and peer pressure, to acquire social skills and to clarify
their own values and attitudes to the substances that cause dependence. While the
basic work is geared to preventing smoking, emphasis is placed on the harmful
effects of those substances with which children are familiar and the PASE pro-
gramme also covers the consumption of alcohol and cannabis. The programme
includes 10 activities — covering issues such as dependence and peer pressure —
which are integrated into everyday classroom activities.
Evaluation
Evaluation of the PASE programme assessed both its activities and its effectiveness
using an experimental group and a control group. The two groups attended an infor-
mation session at the start of the programme to increase their awareness of both licit
and illicit drugs, and the experimental group then followed the programme.
The evaluation results showed a difference in attitudes to tobacco among the two
groups, with the control group more tolerant of tobacco advertising. These data were
collected via:
• a questionnaire for teachers;
• a form for monitoring and evaluating activities completed by the teachers
administering the programme; 
• a questionnaire for pupils, distributed at the start of the programme, at the end
of the school year and in the middle of the following school year.
Direct monitoring of the programme by the team that created it was also an impor-
tant source of information, particularly for comparing the original outcome expec-
tations with how the programme actually developed. However, this type of analysis
is subjective and can only complement an external evaluation.
Obstacles to the programme
Evaluation found that the programme is more appropriate for the 11 to 12 age
group. For those aged 12 to 13, it was recommended to use the Decidex (‘You
decide!’) drug-prevention programme which combines different strategies, primarily
focusing on enhancing the skills to decide whether or not to use drugs and relating
drug use with adolescent lifestyles and problems.
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In addition, lack of time was frequently mentioned as a problem for teachers, as was
lack of resources for some schools and the teachers’ impression that they were over-
loaded with work.
Evaluation of a drug-prevention project in Saint-Herblain
Reasons for establishing a drug-prevention programme
After several years of activities for preventing drug addiction, such as annual drug-
information interventions in schools, the local authority of Saint-Herblain, a town of
43 689 inhabitants, was alerted in 1990 by a school head teacher that cannabis was
being sold and used in the school.
Strategy used
The first stage in responding to this problem was to establish a local coalition on pre-
vention. A pilot group, Prévention des toxicomanies (drug addiction prevention),
brought together the various services concerned to develop a common drug-
prevention strategy to be implemented in all schools. It was decided that the evalua-
tion should be carried out externally by the Institut National de la Santé et de la
Recherche Médicale (National Institute for Health and Medical Research — Inserm).
The second stage was to establish the primary-prevention programme in schools.
The primary-prevention programme
The programme was devised by two local-authority departments, the Délégation
Permanente de Prévention et de Sécurité Urbaine (Permanent Delegation for
Prevention and Urban Security — DPPSU) and the Centre Communal de Promotion
de la Santé (Health Promotion Community Centre — CCPS). Its aim was both to
encourage pupils aged 11, 13 and 14 to behave responsibly when confronted with
the problem of drug addiction, and to enable teachers to recognise signs of malaise
among pupils before the symptoms of drug addiction actually appeared, to identify
those in difficulty when faced with these problems and to know what attitude they
should take. In 1992, the programme was implemented among 531 students in four
schools.
The programme consists of:
• a health game (snakes and ladders) to make children aware of the effects of their
behaviour on both their health and their environment (year 6 pupils — 11 years
old);
• a drama forum, to challenge pupils about the risks associated with certain kinds
of drug-related behaviour (year 4 pupils — 13 years old); 
• a lecture by a health professional to inform pupils about the physiological and
mental effects associated with drug-taking (year 3 pupils — 14 years old).
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Evaluation
A team from Inserm evaluated the programme using an experimental group from
Saint-Herblain and a control group from Rezé, a nearby town with a similar social
structure to Saint-Herblain. The evaluation covered how the programme had been
set up and its effects, and involved a quality and gender-based analysis according to
the sex of the pupils.
The initial objectives were:
• to measure the differences between the two groups from the point of view of life-
style and the perceived availability of alcohol, tobacco and drugs;
• to introduce preventive measures targeting young people as well as adults; 
• to gauge young people’s satisfaction with the programme activities, their attitude
to drug prevention and their opinions and attitudes to alcohol, tobacco and
drugs.
Year 3 pupils (aged 14 to 15) were questioned about whether or not they had been
involved throughout the entire four-year programme. Two separate questionnaires
were drawn up, one for the Saint-Herblain pupils and one for the Rezé pupils, and
the experimental group also answered a few additional questions.
The evaluation results suggest that the PASE programme’s drug-prevention measures
changed perceptions to, as well as actual use of, the target substances. The young
people from Saint-Herblain had a more definite opinion on drugs, were more aware
of sales outlets for illicit drugs, used them less and intended to use cannabis less in
the future than the pupils from Rezé. The evaluation also showed that those parties
actively involved in the programme had the young people’s trust.
Obstacles to the programme
Parental involvement in the programme was poor, and although most parents had
been informed about it, only one in 12 actually attended. A large number, however,
discussed the programme with their children at home.
The young people themselves appreciated the programme, but did not believe it was
useful.
Conclusions
The following factors characterise good drug-prevention practice at local level.
• The decision to form a local partnership. The courts and the police may even
need to be included so that the interventions established complement each other
and that the role of all parties is clear, particularly to the target group, in this case
young people.
• Creating an evaluation plan before starting the action.
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• Evaluating the project according to a few, selected criteria. While evaluation is
relative as regards the programme’s long-term impact, it also allows the pro-
grammes to be adapted as necessary, generates concrete, scientific results and
not simply assumptions based on observation, and contributes to a better under-
standing of the theory behind the programmes.
• Providing the necessary means, however modest, to achieve the objectives.
Good practice allows communication about health promotion without focusing
exclusively on the products targeted.
It remains difficult, however, to motivate decision-makers when evaluation results
are not visible until a few years later. This is usually the result of insufficient funds
being allocated by the local authority.
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The limits of evaluation
Alfred Uhl
Green’s Law: ‘Anything is possible if you don’t know what you’re 
talking about!’ (Bloch, 1985)
Societies have always been confronted by the fact that individuals suffer from severe
physical, psychical and social problems, and that these problems usually affect
other individuals as well as society as a whole. Societies are responsible for taking
appropriate measures to combat these problems, but in what specific areas? And
what are ‘appropriate measures’?
At first sight, the answers seem simple. Most people agree that interventions should
begin before problems arise, that the emphasis should be on helping and convinc-
ing individuals rather than coercing them, that the private sphere of individuals and
their basic rights should not be violated and that measures should be as effective
and efficient as possible. In other words, the focus should be on primary prevention,
educational approaches and evaluated measures, and decisions should be based on
real scientific evidence.
Looking more closely, the situation is far more complex. While there are myriad
problems to tackle, resources for drug prevention and evaluation are limited and
priorities therefore have to be set. Very often, what is lacking is a sound empirical
or theoretical basis on which to build strategic decisions. More specific research on
prevention is clearly needed, but some very interesting and important research
questions are beyond economic and/or epistemological feasibility. Those working in
the drug-prevention field are often faced with phenomena that are hard to assess
reliably, with a long latency period between intervention and outcome, low prob-
lem incidence, a large variety of uncontrollable simultaneous influences and
important contextual factors that change rapidly over time and vary from region to
region.
Currently, an increasing demand for drug prevention and evaluation can be ob-
served throughout the European Union. This demand correlates with high expecta-
tions of the feasibility of prevention and evaluation. Many experts are fascinated by
the growing practical importance of their fields, but feel uneasy about the equally
growing gap between rising expectations and what can realistically be achieved.
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This leads to a fundamental dilemma regarding how to proceed which can be
expressed in terms of the following three problematic positions:
• anti-scientism;
• deliberate ignorance of methodology; 
• cynical opportunism.
‘Anti-scientism’ is characterised by a rejection of quantitative science and basic
research logic. This position is essentially irrational and fits nicely into contemporary
alternative and esoteric trends. It is quite popular among those working in the prac-
tical field of drug prevention, who feel threatened by the demand to evaluate, who
are not trained in the basic logic of research methodology and who are aware that
many expensive evaluation projects do not produce conclusive evidence anyway.
The proponents of anti-scientism claim to be in favour of ‘process evaluation’ and
‘qualitative research’, but what they aim at instead is a semantic trick to legitimise all
forms of unsystematic and subjective data collection which are not suitable for assess-
ing the value of certain approaches. It should be stressed that ‘process evaluation’
and ‘qualitative research’ — if properly defined and understood (see, for example,
Uhl, 1998) — are central pillars of research and evaluation, and the present discus-
sion is not intended to place these concepts in a negative light.
Proponents of the second position, ‘deliberate ignorance of methodology‘, place
great emphasis on experimental designs, inference statistics and objectivity, but they
systematically avoid dealing with research limitations, statistical artefacts and
methodology. They are commonly confronted with critics who reject their ‘scienti-
fic’ results based on practical experience and common sense. In this context, some
researchers take the metaphorical expression ‘blindness’ as a synonym for ‘scienti-
fic objectivity’ far too literally.
‘Cynical opportunism’ characterises those researchers and evaluators who realise that
much of what is produced as ‘scientific evidence’ is not conclusive at all, but who
stick to common and widely accepted research strategies for pragmatic reasons
because they simply do not know of a sensible alternative. In some ways, this under-
standable position comes close to fraud, but since virtually every critical researcher
who has been working in the field for some time has to accept that some of his or
her own published work might be classified in this category, even rigorous critics of
the current state of research hesitate to apply such harsh labels. Is this cautious
approach justified? Probably not. Researchers should not let inevitable mistakes of
the past prevent them from naming problems explicitly and learning from them how
to improve their work. If researchers resort uncritically to widely used fashions,
repeat prevailing convictions, create the impression of being able to cope with any
tasks, ignore fundamental uncertainties, deliberately misuse the ambiguity of termi-
nology and neglect basic methodological problems, they can attract more customers
for the time being, but in the long run risk losing the credibility of their profession.
There is definitely an alternative to these three positions. Research can and should
represent an informed and critical effort to find lasting solutions to problems.
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Expressing the inherent uncertainties encountered in daily drug-prevention and
evaluation practice, highlighting weak spots, rejecting tasks that are not feasible
because of economic and/or epistemological restraints, using precise terminology
and facing up to methodological problems may risk disappointing potential cus-
tomers, but will strengthen the profession and help to build a sound foundation for
a good and lasting reputation.
Some practitioners in the field, frustrated by the complexity of the task and tempted
by the need to tender for projects for economic reasons, may sympathise with one
or other of the three problematic positions outlined above, but should rigorously
reject them. Despite the difficulties encountered, there is room for optimism.
Primary drug prevention and its evaluation are challenging tasks, but if the profes-
sion is really understood, despite all its limitations, numerous promising
approaches, sensible options and solutions are available to prevent a lapse into
depression or cynicism.
COST A-6: Evaluation of primary prevention in the field of illicit drugs
In 1992, the European Commission commissioned a project, Evaluation of action
against drug abuse in Europe, within the framework of its Coopération Scientifique
et Technologique (COST) to assess activities related to problems with illicit drugs (58).
At the initial project meeting, the task was split into five sub-tasks, each to be carried
out by an independent working group. When the second working group (WG II),
Evaluation of primary prevention in the field of illicit drugs, first met, two facts
became immediately apparent:
• the list of properly evaluated primary drug-prevention projects in Europe was
rather short; 
• much more work was needed to base such projects on a sound theoretical basis.
WG II felt that the terminology used in drug prevention and evaluation was far too
ambiguous and vague for a systematic discussion, and that some central methodo-
logical problems inherent to the field tended not to be adequately considered or
analysed. As a result, a consensus study on definitions, concepts and problems was
set up using the Delphi method developed by Dalkey and Helmer (1963) and popu-
larised by Lindstone and Turoff (1975). Most concepts referred to in this chapter
were developed in this study, and the final report (Uhl, 1998) is available free of
charge at (http://www.api.or.at/lbisucht.htm).
Ambiguity of central terms and concepts
The inevitable ambiguity and vagueness of language can be — and is commonly
and regularly — used as a powerful tool to mislead others without deceiving them
(58) For more information on COST A-6, see (http://www.infoset.ch/inst/costa6/).
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directly, and to circumvent insoluble problems by reinterpreting central terms. A
rational, consistent and honest dialogue requires precise and unequivocal terminol-
ogy. It does not matter whether words have different meanings as long as all parties
are aware of this and can state precisely which meaning they are using. Logic dic-
tates that definitions are conventions and cannot be true or false. Individuals can-
not, therefore, be prevented from inventing and using different terminologies.
Instead, what can be done is to:
• identify relevant definitions of scientific terms;
• demand that others state to what concepts these terms refer;
• attempt to convince others to drop inadequate formulations; 
• suggest standard terminology.
Everyday versus scientific interpretation
The everyday meaning of ‘prevention’ refers exclusively to actions taken to prevent
something before it occurs.
Scientists, however, usually understand the term ‘prevention’ in a much broader
sense, encompassing ‘primary’, ‘secondary’ and ‘tertiary prevention’, as initially
defined by Caplan (1964). The COST A-6 WG II suggested splitting ‘tertiary preven-
tion’ into type A and type B, thus creating four forms of prevention:
• primary prevention to prevent problem onset;
• secondary prevention to intervene if a problem is likely to occur (prevention in
high-risk groups) and/or if the problem has not yet fully manifested (prevention
of problem manifestation);
• type-A tertiary prevention to deal with fully manifested problems (prevention of
further harm among addicts); 
• type-B tertiary prevention, or quaternary prevention, to prevent problems from
recurring once they have been successfully treated (relapse prevention).
‘Evaluation’ in everyday parlance is the process of determining whether a technique or
strategy is of any value. Central questions include ‘does it work?’ and ‘is it ethically jus-
tifiable?’ Less important are questions such as ‘how does it work?’ or ‘why does it work?’
The scientific definition of evaluation is quite different, and encompasses a hetero-
geneous class of concepts ranging from documentation and description via hypotheses
that generate exploratory research to hypotheses that test confirmatory research.
If ‘prevention’ and ‘evaluation’ are understood according to their everyday meaning,
many promising approaches for reducing social and individual problems are not in
fact ‘prevention’ at all, and evaluation would not be feasible because of economic
and/or epistemological restraints. If both terms are understood in their scientific
sense, however, a wide range of possible interventions can be included and practi-
cally all projects can somehow be evaluated. What is offered may be very different
from what the customers expect, but according to established scientific standards it
is difficult to argue that what is produced is neither prevention nor evaluation.
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Some common scientific classification systems for ‘evaluation’, as well as some
newer concepts developed by the COST A-6 WG II, are described below.
Process, outcome, impact (POI) classification (data dimension)
This popular classification (see Clayton and Cattarello, 1991) is based on the kind
of data collected:
• process evaluation systematically assesses the process during the execution of
the programme;
• outcome evaluation looks at whether or not the programme objectives were met; 
• impact evaluation addresses the question, ‘did any effects occur that were not
explicitly planned?’
Structural, process, outcome (SPO) classification (data dimension)
This classification by Donabedian (1980), developed in the context of quality assur-
ance, is also based on the type of data collected:
• structural data describe the structural conditions of the programme, such as the
place of intervention, the qualifications of the programme team and the charac-
teristics of the target group;
• process data describe the parameters of the programme’s implementation; 
• outcome data describe the effects of the intervention.
Context evaluation (data dimension)
Drug-prevention programmes are developed for certain target groups under
specific historic and cultural conditions (the context). Context variables —
such as attitudes, knowledge, experiences and fashions — vary from culture
to culture and are subject to rapid change. Programmes that are effective
under certain contextual conditions may be ineffective or even counterpro-
ductive under other conditions, and only by monitoring the context closely
can such differences and changes be identified and the necessary adaptations
made.
Formative, summative (FS) classification (state-of-the-programme dimension)
This classification by Scriven (1967) refers to the developmental state of the pro-
gramme being evaluated:
• formative evaluation takes place in the formative phase, while a programme is
still being developed; 
• summative evaluation takes place in the summative phase, after a programme
has been finalised.
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Four-phase model of programme development
The COST A-6 WG II suggested extending Scriven’s FS classification to a four-phase
model of programme development.
• In Phase 1, the ‘concept’ or ‘pre-formative’ phase, the prevention concept itself
is developed. This purely reflective phase precedes the ‘formative phase’, starting
with the intention to develop a new programme and ending with the first preli-
minary draft.
• In Phase 2, the ‘development’ or ‘formative’ phase, the programme is created
based on observation and small-scale trials until a final version with no obvious
shortcomings evolves.
• Phase 3, the ‘testing’ or ‘first summative’ phase, aims to confirm the effectiveness
of the final version, and ideally involves experimental or quasi-experimental
designs. If such a global assessment of effectiveness is not feasible, it is usually
at least possible to test parts of the causal model behind the prevention approach
(partial proof of effectiveness) or to derive effectiveness based on existing
empirical evidence (historic deduction of effectiveness).
• In Phase 4, the ‘routine’ or ‘second summative’ phase, the tested final version is
routinely applied. In this final phase — since effectiveness has already been
established — the main emphasis is on quality assurance.
Descriptive, exploratory, confirmatory (DEC) classification (methodological 
dimension)
A third way to classify evaluation research is as descriptive versus exploratory versus
confirmatory evaluation, a concept related to the kinds of conclusions researchers
may legitimately draw on epistemological grounds (the methodological dimension).
• Descriptive evaluation is a synonym for collecting and recording data, docu-
menting and categorising phenomena and summarising the findings without
directly attempting to formulate new hypotheses and theories.
• Exploratory evaluation goes beyond mere description. Exploratory research
ranges from collecting basic information in rather unexplored scientific areas to
the hypothesis-driven development of new models and theories. There are no
strict rules concerning procedures in exploratory studies. Basically anything with
a chance of providing a greater insight into relevant phenomena is possible and
legitimate, as long as it is made explicitly clear that the results of the exploratory
phase are not final in any sense.
• Confirmatory evaluation is not concerned with discovering new phenomena
and/or formulating new hypotheses, but with proving existing ones.
Confirmatory evaluation uses the principles of probability theory and inductive
statistics to discriminate substantial effects from irrelevant chance effects. If
feasible on epistemological and economic grounds, exploratory results 
should eventually be tested in confirmatory studies.
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Internal, external (IE) classification (evaluator dimension)
In the course of programme development and application, who organises and
directs the evaluation naturally makes a great deal of difference. These tasks can be
carried out by programme developers and/or programme staff (internal evaluation),
or by external experts (external evaluation).
Data, state-of-programme, methodological, evaluator (DSME) classification
The COST A-6 WG II suggested integrating all the classification concepts mentioned
above into a comprehensive, four-dimensional classification, encompassing:
• data dimension:
– structural data;
– process data;
– outcome data (explicitly expected effects);
– impact data (effects not explicitly expected); 
– context data;
• state-of-programme dimension:
– concept phase (pre-formative phase);
– development phase (formative phase);
– testing phase (first summative phase); 
– routine phase (second summative phase);
• methodological dimension:
– descriptive approach;
– exploratory approach; 
– confirmatory approach;
• evaluator dimension:
– internal evaluation; 
– external evaluation.
The DSME classification is quite useful for describing evaluation but, despite inte-
grating most scientifically established concepts to classify evaluation, it is by no
means complete or sufficient.
Several important forms of evaluation — from needs assessment to efficiency eva-
luation — are defined below to complete the picture.
Needs assessment
Central to developing or implementing specific drug-prevention programmes is
assessing whether or not action is required in a specific problem area, and whether
needs are already being adequately met by existing programmes and/or services.
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Ethical evaluation
The personal convictions of the evaluators naturally also have a strong
impact on any evaluation. Evaluators usually judge immediately whether the
techniques and strategies suggested by programme developers and/or used by
the programme staff correspond to their personal values and are ethically
acceptable to them. Ethical evaluation should therefore be made an explicit
topic.
Historical evaluation
A common form of evaluation is expertise based on personal experience and re-
search knowledge. Since this process makes use of existing (historical) data, the
label ‘historical evaluation’ is appropriate.
Methodological evaluation
Methodological evaluation is concerned with whether empirical research is based
on an appropriate epistemological and statistical basis.
Feasibility evaluation
If a programme is probably not feasible under real-life conditions, it makes little
sense to spend time and effort demonstrating its effectiveness. It is possible to iden-
tify lack of feasibility without elaborate and expensive research designs in the for-
mative phase of programme development.
Monitoring unexpected adverse side effects
Monitoring unexpected adverse side effects is a central aspect in every phase of eva-
luation. The number of potential problem areas is almost unlimited and new unde-
sirable outcomes may arise if the contextual conditions change.
Effectiveness evaluation
Effectiveness evaluation aims to prove that pre-defined goals (specific changes in
primary-efficacy variables) can be achieved. If economic or methodological limita-
tions render it impossible to design methodologically adequate experimental or
quasi-experimental studies to provide global proof of effectiveness, it is usually at
least possible to test parts of the causal model behind the prevention approach (par-
tial proof of effectiveness). In some cases, effectiveness can legitimately be derived
from empirically based theory (historical deduction of effectiveness or historical
evaluation). If there is strong evidence that a certain strategy works, it does not have
to be tested repeatedly.
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Quality assurance
The COST A-6 WG II recommended defining quality assurance (QA) as ‘evaluation
of the quality of implementation under routine conditions’, that is, after a pro-
gramme has been implemented. The idea is to ensure that the level of programme
execution does not decline. QA can be organised internally by the programme staff
(quality management or QM) and externally by independent evaluators (quality
control or QC).
Efficiency evaluation
Efficiency evaluation, not to be confused with effectiveness evaluation, includes
cost-effectiveness analyses (CEA) and cost–benefit analyses (CBA). CEA compares
the efficiency of approaches aimed at identical goals, while CBA compares the
value of the benefits obtained from a programme with the costs of implementing it.
Methodological aspects of evaluating drug prevention
Some of the methodological problems encountered in evaluating primary drug pre-
vention can be easily resolved with appropriate strategies and moderate efforts.
Other problems require greater efforts — possibly not justified in many specific
situations — and still others create insurmountable economic and/or epistemologi-
cal research limitations. A few particular methodological problems are addressed
below.
Exploratory research presented as confirmatory
The difference between exploratory and confirmatory research is of fundamental
importance in science. Both forms of research depend heavily on each other and it
is unjustified to consider either approach as having a higher status. Unfortunately,
Popper (1934), while stressing the importance of exploratory research, reserved the
attribute ‘scientific’ for confirmatory research. This caused the fateful perception that
exploratory research is inferior to confirmatory research and tempted many scien-
tists to present exploratory work as confirmatory. Since journals usually restrict the
size of the research articles they carry and often do not really care about the epis-
temological foundations of research, it is not always easy to identify such funda-
mental shortcomings in scientific articles.
Many variables treated as primary-efficacy variables
The dichotomy between primary-efficacy and secondary variables is central to spe-
cifying outcome variables within confirmatory research projects. Under ideal condi-
tions, confirmatory research projects should have only one primary-efficacy
variable. This can be a specific factor or an index generalising over a set of several
variables. If one primary-efficacy variable is not feasible, the nominal significance
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level has to be adjusted to the number of primary-efficacy variables or alpha infla-
tion will jeopardise all significant considerations. This phenomenon is well known
to scientists, but very few care about its practical implications.
Inadequate surrogate variables
The dichotomy between efficacy and surrogate variables is based on the concept of
indirect measurement via causally linked dimensions — a common procedure in
science. Surrogate variables are used to assess phenomena in cases where it is
difficult or impossible to assess efficacy variables directly. Popular synonyms for sur-
rogate variables are ‘intermediate variables’, ‘indicator variables’ or ‘proxy meas-
ures’. The use of surrogate variables is justified, given that causal relationships be-
tween intermediate variables and efficacy variables have been established through
experimental or quasi-experimental research. It is highly questionable, however,
whether the causality assumption is based on correlation only. While causality
implies correlation, the converse is not the case. In practical research, any correla-
tions in line with research expectations are commonly interpreted causally while
implausible correlations are not.
Short-, medium- and long-term effects
In designing prevention programmes, it is the lasting (long-term) effects that are of
primary interest, while short- and medium-term effects may play a role as secon-
dary variables to explain the mechanisms leading from specific actions to the de-
sired outcomes. They may also serve as surrogate variables to assess the ultimate
problem dimension indirectly, but they are definitely not substitutes for essential
long-term effects. Evaluators unable to demonstrate lasting results commonly imply
that short-term outcomes are relevant per se, but this reasoning is not really con-
vincing.
Knowledge, attitudes, personality and life skills as outcome variables
Variables such as knowledge, attitudes, personality and life skills commonly play a
prominent role in evaluating primary-prevention outcomes and many researchers
treat these factors as primary variables to assess effectiveness. Much empirical
research suggests that changes in most of these indicators do not result in relevant
behavioural change or a reduction in the problem.
Non-linear relationships
The assumption that an average reduction in problem indicators reduces the overall
risk of problematic developments in a cohort is widespread but incorrect. Instead,
the relationship between indicators and associated problems is commonly ‘u-
shaped’ rather than linear.
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According to the ‘self-protection/self-medication hypothesis’ (Uhl and Springer,
1996), people with severe psychological, psychical and/or social problems tend
either to avoid alcohol totally (abstainers) or to consume excessive quantities (prob-
lem drinkers). If the average problem level could be successfully reduced through
primary prevention, both the number of abstainers and the number of problem drin-
kers would be expected to fall, resulting in more people consuming alcohol as well
as fewer people with alcohol problems. A similar relationship has been demon-
strated concerning cannabis.
Protective and risk factors
It is common practice in prevention research to look for variables that correlate with
favourable and unfavourable outcomes and to call them ‘protective’ and ‘risk’ fac-
tors. Some of these elements are ‘context variables’ that cannot be changed — such
as gender or ethnic background — while others are ‘intermediate variables’ — such
as attitudes, level of education or skills — that can be influenced to a varying degree
through appropriate interventions.
‘Protective’ and ‘risk’ factors function in three ways:
• as ‘indicators’ to identify high- and low-risk groups, for example to identify target
groups for specific secondary preventive measures;
• as ‘surrogate variables’ to assess indirectly primary-efficacy variables that are
hard or impossible to assess directly; 
• as ‘starting points’ for preventive intervention strategies.
The first of these three, the indicator function, is relatively unproblematic, but the
surrogate variable and starting-point functions assume causality — a highly proble-
matic assumption if based on correlation studies only.
The problem of heterogeneity
A central, implicit assumption behind many statistical procedures is homogeneity of
effects, in other words, the assumption that all subjects react more or less homo-
geneously to interventions under scrutiny. Whenever the homogeneity assumption
is grossly violated, statistical analysis based on this supposition may yield highly
misleading results. An illustrative example is the famous Grand Rapid Study
(Borkenstein et al., 1964), a milestone in traffic research that related the effects of
alcohol consumption to road safety. The data initially seemed to prove that mode-
rate alcohol levels help to reduce traffic accidents. Hurst (1973) re-analysed the
data, controlling for heterogeneity (the different drinking patterns of drivers), and
showed that the published effect was artificial, caused by the fact that abstainers —
who are, of course, always sober — on average cause four times as many accidents
as sober drinkers. In all homogeneous cohorts, the accident risk increased monoto-
nously with higher alcohol levels.
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Variation over time and context
In empirical research, stable causal relationships over time independent of situa-
tional factors (context) are ideal. In drug prevention, this is hardly ever the case.
Specific circumstances and susceptibility to certain preventive approaches vary
greatly from culture to culture, from subculture to subculture and from cohort to
cohort — and all these factors are subject to rapidly changing fashions and
trends.
Generativity
‘Generativity’ describes the common occurrence of small interventions generating
unpredictable effects which evoke further unpredictable effects until an abundance
of unpredictable and non-reproducible consequences have arisen. According to
chaos theory (Steward, 1989), this is a common phenomenon in nature. In some
situations, the magnitude of generativity may far outweigh systematic prevention
effects. Generativity should not be confused with unanticipated systematic effects
that may be included as expected effects in future evaluation.
Power considerations
Programme effects can usually only be realistically proven if:
• problem incidence is high;
• the effects are massive; and/or
• the sample sizes are large.
If a certain issue in a given population, such as the manifestation of problem drug
consumption in the total population, has an incidence of less then 0.1 % per year,
and if a programme reduces this manifestation by 20 % (relative effect), problem
incidence can be expected to fall from 0.1 % to 0.08 % within this year. This is equi-
valent to an absolute effect of 0.02 % or 1 out of 5 000 people. To have an accep-
table chance of proving the intervention outcome requires a total study sample of
more than 360 000. Power considerations are commonly neglected in programme
evaluation and designs with inadequate-sized samples (under-powered designs) are
widespread.
Under-powered designs increase the likelihood of strong publication bias, caused
by the fact that such studies that do not yield statistically significant results are
hardly ever considered for publication, while under-powered studies containing
statistically significant results are readily accepted.
Measurement problems with self-reported consumption
A widespread assessment strategy in drug-prevention evaluation is to use self-
reports, a relatively unreliable source of information. The possible magnitude of
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the bias can be illustrated by a finding from Uhl and Springer (1996) who were
confronted with the fact that almost two-thirds of several age cohorts who had
already admitted illicit drug use decided not to ‘remember’ previous drug use 10
years later.
Dependence of observational units
It is common in drug prevention for the observational units to be sampled in clus-
ters or groups (such as school classes) and treated as independent units, causing an
increased rate of significance by mere chance. In practical research, this problem is
usually solved by simply ignoring it.
Conclusions
Drug prevention and evaluating drug prevention are almost uniformly considered high
public priorities. It is self-evident that actions implemented to prevent problems before
they occur are superior to interventions established once problems have emerged.
Besides, there is a broad consensus that whether or not these interventions produce
the desired results should be assessed to optimise strategies. Actions proposed in this
context should be well described, feasible, ethically justifiable, effective and cost-
efficient, and all this is somehow related to the term ‘evaluation’.
Looking critically at the present state of drug prevention and evaluation, there are
many fundamental problems. The central terminology is extremely heterogeneous
and vague and many people are not aware of this. Sound scientific evidence
concerning which concepts are worth pursuing and which are obsolete is scarce,
and drug-prevention programmes tend to be either inadequately evaluated or not
evaluated at all. In addition, many promising research questions in this field can-
not be tackled because of fundamental economic, technical and epistemological
limitations.
In spite of all this, researchers, drug-prevention specialists and evaluators have the
means to improve drug prevention and evaluation if they have sufficient funds
with which to do so and if the public does not expect miracles. Real progress is
possible if those in the field are more precise in both terminology and concep-
tions, are ready to accept basic methodological limitations rather than ignore
them and are prepared to admit inevitable uncertainties and accept that some
things just cannot be achieved at present. Public pressure to accomplish impos-
sible tasks must be withstood and colleagues who nourish unrealistic expectations
because of calculated insincerity or ignorance criticised.
What is therefore needed is concerted action to improve the quality of both drug
prevention and evaluation. Important milestones in this endeavour in Europe in-
clude the Handbook prevention (Van der Stel, 1998), the work of COST A-6 result-
ing in the publication of Springer and Uhl (1998), the European Monitoring Centre
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for Drugs and Drug Addiction’s Guidelines for the evaluation of drug prevention
(EMCDDA, 1998) and the implementation of the EMCDDA’s Exchange on drug
demand-reduction action (EDDRA) information system (59).
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Recommendations
On the basis of the discussions held during the second European conference on the
evaluation of drug prevention, the organisers proposed a number of recommenda-
tions that were debated, revised and amended during the conference workshops
and approved in the final plenary session. The revised recommendations, which
form the final conference conclusions, were presented as one of the last points of
the programme. The participants expressed the hope that agreeing on these issues
would place the evaluation of drug” prevention higher on the political agenda in
Europe.
Evaluation is recognised as a tool for more cost-effective drug-prevention
strategies
• Needs assessment and evaluation are essential for effective drug prevention and
are an integral part of such programmes and activities at all levels, whether inter-
national, national, regional or local.
• Appropriate means (including financial resources) should be available for deve-
loping and implementing adequate evaluation protocols for all drug-prevention
programmes and projects.
• The need for commonly agreed evaluation quality criteria — such as clear and
coherent objectives, goals, purposes and resources available for the programme
— is recognised. The EMCDDA’s Guidelines for the evaluation of drug preven-
tion and its Evaluation instruments bank should be taken into account in deve-
loping such criteria (60).
• Close cooperation should be established between the authorities (political and
others) and professional bodies dealing with drug prevention in developing any
evaluation procedure.
• The evaluation procedure should be devised in close cooperation with the pro-
gramme designers and implementers as well as with the main players who will
use the evaluation results.
• Key programme personnel should be involved in planning the evaluation and all
stakeholders should receive continuous feedback during the process.
• Evaluation results should be used for developing new and refining existing drug-
prevention programmes and, where appropriate, for selecting which projects
should be implemented in practice.
• Evaluation processes, while entailing a financial cost, should ensure that drug-
prevention programmes and projects are better focused and more efficient.
• Proper needs assessment must be included at the initial stage of any evaluation
and should serve as an instrument for feedback during the evaluation process.
(60) For more on the Guidelines for the evaluation of drug prevention, see Chapters 5 and 6. For more on
the Evaluation instruments bank, see Chapter 6.
• Target groups should be considered the key source of information in the needs
assessment. Taking account of the ethnographic factors in the target groups’
social context (norms, values, lifestyles) is more likely to enhance their accep-
tance of an intervention.
• Mapping is a dynamic and proactive aspect of assessing the needs of target
groups that requires qualitative and innovative methods in addition to traditional
questionnaire surveys.
• Internal evaluation of projects and programmes is essential and should be under-
taken throughout the planning and implementation phases.
• The stakeholders and actors involved in a drug-prevention programme should
establish whether additional, external evaluation is required before the project
or programme is initiated. The external evaluator’s involvement should last at
least for the duration of the project or programme.
• Continuous feedback between programme implementers and evaluators should
be ensured throughout the process.
• Those involved in developing and planning drug-prevention strategies should
receive training in conceptualising, designing and evaluating social interventions
to facilitate the integration of evaluation at the planning stage.
• All those involved in planning and implementing drug-prevention projects
should receive adequate training in evaluation processes and methodology.
• Evaluation training programmes at all levels should be set up. The EMCDDA
could be invited to play an advisory role in this.
• The exchange of knowledge and tools in the field of drug-prevention evaluation
should be reinforced at European level.
• Appropriate exchanges of experience in the field of evaluation methodology
(including practical examples) with international organisations and selected
third countries are to be encouraged.
• Information on evaluation results and research should be compiled at national
and European level and published as a resource for programme planners.
• Mechanisms should be developed to facilitate the dialogue between practi-
tioners and policy-makers on what evaluation findings mean for the further
development of drug-prevention programmes.
• The added value of international guidelines for evaluating drug prevention is
acknowledged. Nevertheless, it is crucial to adapt these to cultural specificities.
• The need for further research into evaluation is recognised and should be en-
couraged, in particular at EU level.
• Special attention should be focused on the evaluation needs and corresponding
training and logistic requirements in the candidate countries for accession to the
European Union (61).
At its meeting on 12 to 14 January 2000, the EMCDDA Management Board sugges-
ted (as had some participants at the conference) that these 24 recommendations be
condensed and given clear headings. Accordingly, and without loss of content, the
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(61) The candidate countries for accession to the European Union are Bulgaria, Cyprus, Czech Republic,
Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia, Slovenia and Turkey.
EMCDDA reduced the 24 recommendations to 15 and introduced the ‘labels’ given below.
• Improve prevention: evaluation processes, while entailing a financial cost,
should ensure that drug-prevention programmes and projects are better focused
and more efficient.
• Means for evaluation: appropriate means (including financial resources) should
be available for developing and implementing adequate evaluation protocols for
all drug-prevention programmes and projects.
• Importance of needs assessment: needs assessment and evaluation are essential
for effective drug prevention and are an integral part of programmes and activi-
ties at all levels, whether international, national, regional or local. Proper needs
assessment must be included at the initial stage of any evaluation and should
serve as an instrument for feedback during the evaluation process.
• Establish quality criteria based on EMCDDA achievements: the need for com-
monly agreed evaluation quality criteria — such as clear and coherent objectives,
goals, purposes and resources available for the programme — is recognised. The
EMCDDA’s Guidelines for the evaluation of drug prevention and its Evaluation
instruments bank should be taken into account in developing such criteria. The
added value of international guidelines for evaluating drug prevention is
acknowledged. Nevertheless, it is crucial to adapt these to cultural specificities.
• Cooperative development: close cooperation should be established between the
authorities (political and others) and professional bodies dealing with drug pre-
vention in developing any evaluation procedure.
• Involve actors and stakeholders in evaluation: the evaluation procedure should
be devised in close cooperation with the programme designers and implemen-
ters as well as with the main players who will use the evaluation results. Key
programme personnel should be involved in planning the evaluation and all 
stakeholders should receive continuous feedback during the process.
• Make effective use of evaluation results: evaluation results should be used for
developing new and refining existing drug-prevention programmes and, where
appropriate, for selecting which projects should be implemented in practice.
• Interpret evaluation results adequately: mechanisms should be developed to
facilitate the dialogue between practitioners and policy-makers on what evalua-
tion findings mean for the further development of drug-prevention programmes.
• Role of internal evaluation: internal evaluation of projects and programmes is essen-
tial and should be undertaken throughout the planning and implementation phases.
• Role of external evaluation: the stakeholders and actors involved in a drug-
prevention programme should establish whether additional, external evaluation
is required before the project or programme is initiated. The external evaluator’s
involvement should last at least for the duration of the project or programme.
• Training in evaluation, for different levels and audiences: evaluation training
programmes at all levels should be set up:
– for those involved in developing prevention strategies to facilitate the
integration of evaluation at the planning stage; 
– for those involved in planning and implementing drug-prevention projects.
The EMCDDA could play an advisory role in developing such training courses
and facilities.
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• Exchange of skills and experiences within the EU and with third countries: the
exchange of knowledge and tools in the field of drug-prevention evaluation
should be reinforced at European level as well as with international organisa-
tions and third countries, especially with a view to the evaluation needs and cor-
responding training and logistic requirements in the candidate countries for
accession to the European Union. Therefore, information on evaluation results
and research should be compiled at national and European level and published
as a resource for programme planners. The EMCDDA’s Exchange on drug
demand-reduction action (EDDRA) information system should be considered an
important instrument for such exchange of experiences (62).
• Use ethnographic research for evaluation: taking account of the ethnographic
factors in the target groups’ social context (norms, values, lifestyles) is more like-
ly to enhance their acceptance of an intervention, and target groups should be
considered the key source of information in the needs-assessment process.
• Integrate innovative methods: needs assessment among target groups and client-
based evaluation require innovative and qualitative methods in addition to
traditional questionnaire surveys. Mapping is a dynamic and proactive example
of such methods.
• Develop new approaches: the need for further research into evaluation is recog-
nised and should be encouraged, in particular at EU level.
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(62) For more on the EDDRA information system, see Chapters 11 and 12.
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Evaluation of the second European conference
on the evaluation of drug prevention
Ulrik Solberg
A conference on evaluation would not be credible if it were not itself evaluated. The
EMCDDA therefore prepared two questionnaires, one to assess the conference in
general, and one to evaluate the workshop sessions. The questionnaires consisted of
a series of open and closed questions and were relatively brief. The general evalua-
tion questionnaire was distributed at the start of the final plenary session to be
returned at the close of the conference, while participants were requested to com-
plete the workshop questionnaire at the end of each session. A total of 93 general
evaluation and 159 workshop questionnaires were completed.
The evaluation of the second European conference on the evaluation of drug pre-
vention was affected to some extent by two unforeseen external events. First, a trans-
port strike on the second day of the meeting caused much disruption and led to serious
delays in the agenda. Second, a short-circuit left the final conference session without
translation facilities for some time before the participants were moved to another room.
Overall evaluation of the conference
The following overall evaluation of the conference is based on the 93 questionnaires
completed. The results of quantitative analysis of the closed questions are set out in Table 1.
Table 1: General evaluation of the conference
Question Average response (a)
1. How important to you were the following aspects of 
the second European conference on the evaluation 
of drug prevention (before participating)? 
Acquaintance with evaluation techniques 2.62
‘Brushing-up’ your knowledge 2.66
Scientific-level presentations 2.46
Professional exchange with colleagues 1.97
Informal communication with other participants 2.04
Question Average response (a)
2. How would you rate coverage of the abovementioned aspects? 
Acquaintance with evaluation techniques 3.76 
‘Brushing-up’ your knowledge 3.38
Scientific-level presentations 3.22
Professional exchange with colleagues 2.41
Informal communication with other participants 2.33
3. What effects will the conference have on future 
evaluation practice?
It will change evaluation practice for the better 3.00
It will focus political attention on the issue 2.73
It will improve the quality of future evaluations 2.86
4. What aspects would you find most interesting at a future 
evaluation conference?
Acquaintance with evaluation techniques 1.87
‘Brushing-up’ your knowledge 2.09
Scientific-level presentations 1.79
Professional exchange with colleagues 1.66
Social programme 2.74
5. How would you rate the following organisational aspects 
of the evaluation conference?
Overall efficiency of the organisation 2.28
Quality of the meeting rooms 1.83
Technical aspects of the conference 2.50
Length of the conference 2.63
Social programme 2.38
Accommodation 3.06
Meals 2.76
NB:
The number of registered participants was set at 150 as nine people were either organisers or only
took part in the conference for a day and therefore did not complete the general evaluation ques-
tionnaire. The estimated response rate was 62 %.
(a) On a scale from 1 (the most positive reply) to 6, the average being 3.5.
Analysis of the general conference-evaluation questionnaires reveals that the two
most popular aspects of the conference were ‘professional exchange with col-
leagues’ and ‘informal communication with other participants’. Conversely, the least
interesting aspects for the participants were ‘acquaintance with evaluation tech-
niques’ and ‘“brushing-up” your knowledge’.
By comparing replies to question 1 on expectations with those to question 2 on out-
come it is clear that none of the expectations were fully met — in other words,
expectations were higher than the perceived outcome. However, it should be noted
that the two aspects that shared the highest expectations — ‘professional exchange
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with colleagues’ and ‘informal communication with other participants’ — were
judged to have been the best covered, receiving ratings of 2.41 and 2.33
respectively. Furthermore, the difference between the figures for expectations and
those for outcome is smaller for questions 1 and 2 than for the other questions
(around 0.35). One interpretation for this might be that the participants were already
very well acquainted with evaluation methodology and therefore found little new in
the conference presentations, whereas they found interaction with other participants
more rewarding.
Responses to question 3 on the effects of future evaluation practice show modest but
confident expectations, with replies all more positive than the average value of 3.5.
This again might suggest a very competent audience.
If the replies to questions 1 and 2 are compared to those to question 4, it is note-
worthy that despite the high rating of ‘informal communication with other partici-
pants’ in questions 1 and 2, ‘social programme’ is rated lowest in question 4. This
suggests that informal communication with other participants is not perceived only
in the framework of official dinners, but much more in terms of informal meetings
in the corridors during the conference. Question 4 does, however, confirm that the
most important aspect of a conference is considered to be ‘professional exchange
with colleagues’, as this is once again ranked highest.
Question number 5 on satisfaction with the overall organisation of the conference
gave quite high ratings. A vote of 2.28 showed that the participants were very satis-
fied with the overall organisation and particularly with the quality of the meeting
rooms which received a vote of 1.83.
The comments made in the open questions included the following:
• 12 participants stated that the workshops were too short and three mentioned the
need for more concrete themes for these sessions. The bus strike caused a ‘force
majeure’ that was especially detrimental to the workshops.
• 10 questionnaires complained of a lack of simultaneous interpretation into
Spanish during the workshops.
• Six people said they were dissatisfied with the recommendations: two found the
process of formulating these points too fast and undemocratic; two found them
too general; one was afraid of the implications; and one found the large number
of recommendations rendered them meaningless.
• Four entries stated that the conference speakers should have been given more
time for their presentations.
Some observations diverged. For example, two participants thought that the level of
the conference was too high, while another two thought that it was too low.
Similarly, some thought that there should have been a greater focus on methodol-
ogy and research while others had expected a more practical approach.
Of the positive comments, eight participants stated that the conference had been
well organised and congratulated the EMCDDA staff responsible for it.
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Evaluation of the workshops
The conference participants were expected to register for one of three workshops in
each of two workshop blocks. The themes of the workshops were:
• First block:
– needs assessment;
– the costs and benefits of evaluation; 
– common goals for policy-makers and professionals.
• Second block:
– evaluation skills;
– improving prevention quality criteria through evaluation; 
– transferring experience.
The results of evaluating the completed evaluation questionnaires are set out in Table 2.
Table 2: Evaluation of the workshops
Workshop Workshop Workshop Workshop Workshop Workshop
1 2 3 4 5 6
Questionnaires received n = 49 n = 10 n = 32 n = 23 n = 31 n = 14
Registered participants n = 50 n = 19 n = 40 n = 25 n = 52 n = 20
Estimated response rate (a) 98 % 53 % 80 % 92 % 60 % 70 %
Question Average response (b)
Workshop Workshop Workshop Workshop Workshop Workshop
1 2 3 4 5 6
1. How would you rate the following 
aspects of the workshops?
Scientific level 3.31 3.80 3.03 2.22 3.21 2.71
Practical relevance 
for your work 3.06 3.70 3.00 2.65 3.30 2.21
Exchange of new 
information 3.10 3.90 2.93 2.70 3.17 2.36
2. How would you rate the following issues?
Personal interest 
in the subject 1.94 2.10 1.77 1.73 2.03 1.57
Quality of participants 2.56 3.10 2.16 1.82 2.38 1.64
Overall satisfaction 
with session 3.15 3.60 2.70 2.15 2.90 2.14
3. How would you rate 
the extent to which the topics
discussed corresponded 
to what had been 
announced beforehand? 2.76 3.40 2.24 1.95 2.73 2.00
NB:
(a) This figure is based on the number of completed questionnaires divided by the number of reg-
istered participants in each workshop.
(b) On a scale from 1 (the most positive reply) to 6, with the average being 3.5.
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It should be noted that the numbers registered for each block of workshops do not
correspond to the 160 who participated in the conference as a whole since this fig-
ure includes the organisers, speakers who only attended the conference for one day
and participants who did not register in advance.
Evaluation of the workshop questionnaires reveals that workshop 4 on evaluation
skills and workshop 6 on transferring experience were the most popular. These ses-
sions both score highly on the participants’ overall satisfaction, interest in the sub-
ject and the quality of the participants.
All participants reported very high personal interest in the subject of the workshops
of their choice with these ratings ranging from 1.57 to 2.10, whereas relevance to
practical work was somewhat lower with ratings from 2.21 to 3.70. ‘Scientific level’
and ‘exchange of new information’ came lower still with averages from 2.22 to 3.80
and from 2.36 to 3.90 respectively.
In general, however, the conference participants appear to have been satisfied
overall with the workshop sessions as only one received ratings on the negative 
side of the average value of 3.5.
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General conclusions
Margareta Nilson
What is evaluation?
I breath, therefore I evaluate’, Jacques A. Bury said in the opening speech of the
second European conference on the evaluation of drug prevention. In any activity,
the objectives and how best to meet them are defined, results are examined and, if
they are not satisfactory, the activity is modified. In the context of health promotion
and drug prevention, evaluation is a procedure by which to determine, obtain, ana-
lyse and disseminate information to allow decisions to be made based on scientific
facts rather than mere speculation.
As Rui Rodrigues stated, it is very encouraging for those committed to evaluation
that whether or not to evaluate is no longer at issue, although when and what to eva-
luate — and why — still need to be determined. Sabine Haas pointed out that des-
pite the growing demand for, and interest in, evaluation in the EU, the necessary
skills are still greatly lacking. In central and eastern Europe, confronting the drug
phenomenon has become such an urgent need since the early 1990s that despite
the recognition that evaluation is important, interventions are often implemented
when no evidence exists to justify them or to indicate their effectiveness.
However, to avoid the impossible search for perfection from incapacitating the field
altogether, Alfred Uhl recommended that the basic methodological limitations of
evaluation be accepted rather than ignored, the inevitable uncertainties surrounding
it acknowledged, and the fact that some things simply cannot be accomplished at
present recognised.
Involving all parties: a key issue
Those deciding on an evaluation and those implementing the programmes being
evaluated must all agree on their objectives, and have the necessary skills and
knowledge to fulfil their respective roles. Evaluation can only achieve its aim if all
the parties concerned — whether political decision-makers, funding authorities,
evaluators, drug-prevention professionals or their target groups — are fully involved.
From a bottom-up perspective, the motivation and understanding of all actors is
essential. Drug-prevention professionals and their target groups must be convinced
of the utility of evaluation and not fear it. From a top-down perspective, the com-
mitment of decision-makers and funding authorities is essential in order to make
available the resources required to conduct the evaluation properly and in order to
ensure that the results will be taken into consideration.
The quality of an evaluation depends on the reliability of the data collected as well
as on the awareness of all those involved of the utility of the exercise. Many of the
conference participants had very strong opinions on this issue, and good knowledge
and acceptance of the evaluation procedure is clearly a key factor in assuring the
validity of the results.
There are arguments both for and against internal and external evaluations, and
most of the participants agreed that a combination of internal and external evalua-
tion is the most rewarding approach.
The funds allocated to evaluate a programme clearly affect its implementation.
Jacques A. Bury proposed that the evaluation budget should be between 2 and 15 %
of the global programme budget, and the more innovative and visible the project,
the higher the budget should be. Clearly under no illusions, he stated that the most
common way to sabotage an evaluation is to under-finance it.
Promoting evaluation techniques
Needs assessment
Needs assessment is a prerequisite both for implementing a drug-prevention pro-
gramme and for its evaluation. Prevalence data and analysis on a macro level, such
as the European school survey project on alcohol and other drugs (ESPAD) study,
can be useful, but more local investigations, for example into new patterns of drug
use, or those focusing on a restricted population like a particular school or neigh-
bourhood, are usually necessary for ‘fine-tuning’. In his presentation, Mark Morgan
demonstrated that the specific cultural needs of different target groups can have a
major impact on what does and does not work.
Process evaluation
Process evaluation uses a systematic approach to assess how a programme works in
its environment. The quality of the programme delivery might, for example, have an
important effect on its routine implementation. Process evaluation also examines
unexpected effects. An example of process evaluation was given by Krzysztof
Ostaszewski’s description of the Program Domowych Detektywów which illustrated
the role of qualitative evaluation methods in the cross-cultural adaptation of a drug-
prevention programme and the assessment of its effectiveness, as well as the way it
was modified according to the evaluation results.
Outcome evaluation
Outcome evaluation measures whether the objectives of a specific programme have
been fulfilled. This enables programme-makers to provide evidence of the outputs
of their work — in other words, what has been achieved by the money they have
spent, the posts they have created and the time they have allocated. However,
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outcome-evaluation data can only be interpreted with background knowledge of
the progress and should never stand alone. Such data can even be useful for identi-
fying flaws in programme delivery, as occurred in Program Domowych
Detektywów.
Clear indicators and targets for outcomes are crucial, but, as Mark Morgan pointed
out, they can be misleading if intermediate variables are relied upon. Amador Calafat
questioned the use of ‘classical’ intermediate variables, such as self-esteem and social
skills, and highlighted the need for awareness of the specific objective of the drug-
prevention programme: does the expected outcome actually reduce drug problems?
Convincing policy-makers
Susanne Schardt from the European Cities on Drug Policy network pointed out that
in order to give policy-makers the concrete support and synthetic advice they need
for informed decision-making, scientific evaluation results need to be ‘translated’
into an appropriate form. It is not enough to present this information clearly; it must
also be transposed into clear policy options in an effort to bridge the gap between
science and policy.
Policy-makers love statistics, Schardt stated, and use them to assess what measures
are being implemented in other settings and to compare the effectiveness of those
strategies with their own. In this way, politicians can be convinced to use evaluation
results either to communicate what they think should be done, to reject what they
do not want to do, or to legitimise what they will do anyway.
Tom Bucke gave some interesting examples of how to have an impact on policy-
makers.
• The effect of evaluation on policy depends above all on timing and recognising
opportunities. Providing policy-makers with evidence of effectiveness when they
need it can have a major impact on practice, but results that appear too late are
useless.
• Evaluations do not have to be large and resource-intensive to influence practice.
Applying examples of effective drug-prevention practice from the international lite-
rature to a specific country — with due adaptation to the respective cultural context
— is one way of seeking to shape practice. The media can be an important partner
in publicising evaluation results and bringing public opinion to bear on policy.
• Negative evaluation findings can be just as valuable as positive ones. Evaluation
may highlight approaches which were not very effective, but instead of being
interpreted as ‘prevention does not work’, such results should lead practitioners
to develop more effective approaches and more efficient practice.
Using the example of the Galician plan on drugs, Manuel Araujo Gallego showed
that, with the good will of policy-makers, a whole regional demand-reduction
strategy can be systematically evaluated.
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From theory to practice
The workshop sessions developed specific practical themes in a more informal
setting. The following are some of the most inspiring points raised during these
sessions.
• The main benefit of evaluation lies in the systematic learning process through
success and failure.
• Evaluation should be included in all drug-prevention interventions, regardless of
the size of their budget.
• Drug prevention should not, however, be too restricted by evaluation require-
ments as this could inhibit new initiatives.
• Process evaluation should not be neglected. This may require more investment
in identifying adequate methodologies.
• International and national seminars should be organised to spread evaluation
knowledge and skills.
• Quality is not only a scientific concept, but is also relevant at both the practical
and political level. The quality of an evaluation can be enhanced by defining
objectives and methods which then determine the appropriate choice of evalua-
tion indicators.
• While quality standards are essential, they can be difficult to define, although
there is consensus about minimal quality criteria. Guiding principles might be:
– consistence and coherence;
– operational indicators;
– consensus among, and participation of, all actors; 
– the equal importance of process and outcome evaluation.
• There are both similarities and differences in the goals of policy-makers and
drug-prevention professionals, as well as in the nature of the dialogue between
them and the role that evaluation can play to facilitate this dialogue.
• Dialogue and communication skills are essential to create understanding among
professionals and policy-makers of their respective goals and needs. To this end,
several countries have established either formal structures at national or local
level or other mechanisms to facilitate this communication. These structures
must now establish their legitimacy by providing better-quality drug prevention.
• Information must be increasingly well structured to enable all parties to find their
way through the ‘information jungle’.
• There should be a balance between old and new technologies, and it should be
borne in mind that many grass-roots workers do not have access to the Internet.
• Electronic communication and the Internet, however essential they are for infor-
mation exchange, cannot substitute human networking. Training, networking,
individual contacts and personal feedback thus remain vital.
The Reitox national focal points have a crucial role to play in promoting the
evaluation of drug prevention. In this context, it will be necessary to increase their
visibility and ensure they receive the recognition and support they need at both
national and European level.
176
General conclusions
The EMCDDA’s support for drug-prevention professionals
Annual report on the state of the drugs problem in the European Union
The EMCDDA’s annual report provides a valuable overview of the drug situation in
Europe and of what is being done to change it (63). Although including more infor-
mation about activities at local level has been requested, the report relies on the
information the EMCDDA receives from its national focal points which may not
always have access to the national networks necessary to obtain this information.
Guidelines for the evaluation of drug prevention
Christoph Kröger’s model of eight stages of readiness includes the phases of initia-
tion, standardisation and professionalisation. While the evaluation of drug preven-
tion has clearly passed the initiation stage, it has not yet reached the standardisation
phase and this should now be the aim of all drug-prevention practitioners. It will,
however, take much longer to reach the professional stage.
The EMCDDA Guidelines for the evaluation of drug prevention are valuable in this
context, and their implementation and adaptation at national level are encour-
aging (64). It has become clear that the more institutionalised the distribution of the
guidelines in a particular country, the more members of the target group receive them.
Exchange on drug demand-reduction action
The Exchange on drug demand-reduction action (EDDRA) information system was
created to promote the development of an evaluation culture (65). Few demand-
reduction projects in Europe are being, or have been, evaluated, and collecting and
disseminating information that does not exist is clearly an impossible challenge. But
far from being seen as an obstacle, this fundamental limitation is itself a strength and
should allow the development of a European-wide evaluation culture to be both
monitored and quantified. As a largely unintended by-product, EDDRA has also
proved to be a useful training and communication instrument.
Evaluation instruments bank
The Evaluation instruments bank (EIB) includes quality evaluation tools devised for
specific situations and/or target groups, guidelines for their use and related litera-
ture (66). The EMCDDA will establish a mailing list from the entries in the EIB data-
base to ensure continuing dialogue and feedback.
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(63) Annual report on the state of the drugs problem in the European Union, Lisbon, EMCDDA, 1995, 1997,
1998, 1999.
(64) Guidelines for the evaluation of drug prevention, Manuals No 1, Lisbon, EMCDDA, 1998.
(65) The EDDRA system is available at (http://www.emcdda.org/databases/databases_eddra.shtml).
(66) The Evaluation instruments bank will be available via the EMCDDA website in 2000.
Training in evaluation practice and the EDDRA system
Training seminars in evaluation practice and how to use the EDDRA system, atten-
ded by the national focal points and other national experts, have proved very use-
ful and will be continued. Through these seminars, the EMCDDA can motivate
national evaluators and enhance their skills.
Other issues: treatment, outreach work, criminal-justice system
The EMCDDA’s work on evaluation does not stop with drug prevention. Together
with the World Health Organisation, the Centre began disseminating workbooks for
the evaluation of treatment from 2000 onwards. It is also launching a project to
develop evaluation guidelines for outreach work and for demand-reduction activ-
ities in the criminal-justice system. Gradually, it is hoped to build up a pool of
expertise in the area of evaluation which will come close to the help desk that
Sabine Haas proposed.
Future perspectives
The EMCDDA is increasing its information-collection and dissemination role at EU
level. In so doing, it is taking advantage of the opportunities offered by Community
programmes, above all the European Union Drugs Strategy (2000–04). In addition,
the Community action programme for the prevention of drug dependence has been
extended to the end of 2002, and there may be further benefits from the fifth 
framework programme, which includes a drug and drug-addiction component (67).
All this underlines that the results of the second European conference on the eva-
luation of drug prevention are wider than simply the recommendations it adopted,
and this richness will be integrated into the routine work of the EMCDDA. As both
Françoise Moyen and Saini Mustalampi pointed out, evaluation will be an integral
part of all Community initiatives and programmes in the framework of the new EU
drugs strategy — an aspect that will be stressed by the French Presidency of the EU
in 2000 — and the EMCDDA will contribute to this integration. The EMCDDA will
also provide the European Commission with the recommendations and conclusions
of the second European conference on the evaluation of drug prevention to facili-
tate appropriate follow-up at Community level.
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(67) Information on the Community action programme for the prevention of drug dependence is
available at (http://europa.eu.int/comm/health/ph/programmes/drugs/index_en.htm). The fifth 
framework programme defines the European Union’s strategic priorities for research and tech-
nological development for the period 1998 to 2002. For further details, see (http://www.cordis.
lu/fp5/home.html).
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